Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives

<!DOCTYPE html> <html lang="en" xmlns:og="http://ogp.me/ns#" xmlns:fb="https://www.facebook.com/2008/fbml"> <head> <meta charset="utf-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"> <meta content="mdpi" name="sso-service" /> <meta content="width=device-width, initial-scale=1.0" name="viewport" /> <title>Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives</title><link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/font-awesome.min.css?eb190a3a77e5e1ee?1732615622"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/jquery.multiselect.css?f56c135cbf4d1483?1732615622"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/chosen.min.css?d7ca5ca9441ef9e1?1732615622"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/main2.css?69b39374e6b554b7?1732615622"> <link rel="mask-icon" href="https://pub.mdpi-res.com/img/mask-icon-128.svg?c1c7eca266cd7013?1732615622" color="#4f5671"> <link rel="apple-touch-icon" sizes="180x180" href="https://pub.mdpi-res.com/icon/apple-touch-icon-180x180.png?1732615622"> <link rel="apple-touch-icon" sizes="152x152" href="https://pub.mdpi-res.com/icon/apple-touch-icon-152x152.png?1732615622"> <link rel="apple-touch-icon" sizes="144x144" href="https://pub.mdpi-res.com/icon/apple-touch-icon-144x144.png?1732615622"> <link rel="apple-touch-icon" sizes="120x120" href="https://pub.mdpi-res.com/icon/apple-touch-icon-120x120.png?1732615622"> <link rel="apple-touch-icon" sizes="114x114" href="https://pub.mdpi-res.com/icon/apple-touch-icon-114x114.png?1732615622"> <link rel="apple-touch-icon" sizes="76x76" href="https://pub.mdpi-res.com/icon/apple-touch-icon-76x76.png?1732615622"> <link rel="apple-touch-icon" sizes="72x72" href="https://pub.mdpi-res.com/icon/apple-touch-icon-72x72.png?1732615622"> <link rel="apple-touch-icon" sizes="57x57" href="https://pub.mdpi-res.com/icon/apple-touch-icon-57x57.png?1732615622"> <link rel="apple-touch-icon" href="https://pub.mdpi-res.com/icon/apple-touch-icon-57x57.png?1732615622"> <link rel="apple-touch-icon-precomposed" href="https://pub.mdpi-res.com/icon/apple-touch-icon-57x57.png?1732615622"> <link rel="manifest" href="/manifest.json"> <meta name="theme-color" content="#ffffff"> <meta name="application-name" content=" "/> <link rel="apple-touch-startup-image" href="https://pub.mdpi-res.com/img/journals/medsci-logo-sq.png?3568b168e67d2809"> <link rel="apple-touch-icon" href="https://pub.mdpi-res.com/img/journals/medsci-logo-sq.png?3568b168e67d2809"> <meta name="msapplication-TileImage" content="https://pub.mdpi-res.com/img/journals/medsci-logo-sq.png?3568b168e67d2809"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/jquery-ui-1.10.4.custom.min.css?80647d88647bf347?1732615622"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/magnific-popup.min.css?04d343e036f8eecd?1732615622"> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/xml2html/article-html.css?230b005b39af4260?1732615622"> <style> h2, #abstract .related_suggestion_title { } .batch_articles a { color: #000; } a, .batch_articles .authors a, a:focus, a:hover, a:active, .batch_articles a:focus, .batch_articles a:hover, li.side-menu-li a { } span.label a { color: #fff; } #main-content a.title-link:hover, #main-content a.title-link:focus, #main-content div.generic-item a.title-link:hover, #main-content div.generic-item a.title-link:focus { } #main-content #middle-column .generic-item.article-item a.title-link:hover, #main-content #middle-column .generic-item.article-item a.title-link:focus { } .art-authors a.toEncode { color: #333; font-weight: 700; } #main-content #middle-column ul li::before { } .accordion-navigation.active a.accordion__title, .accordion-navigation.active a.accordion__title::after { } .accordion-navigation li:hover::before, .accordion-navigation li:hover a, .accordion-navigation li:focus a { } .relative-size-container .relative-size-image .relative-size { } .middle-column__help__fixed a:hover i, } input[type="checkbox"]:checked:after { } input[type="checkbox"]:not(:disabled):hover:before { } #main-content .bolded-text { } #main-content .hypothesis-count-container { } #main-content .hypothesis-count-container:before { } .full-size-menu ul li.menu-item .dropdown-wrapper { } .full-size-menu ul li.menu-item > a.open::after { } #title-story .title-story-orbit .orbit-caption { #background: url('/img/design/000000_background.png') !important; background: url('/img/design/ffffff_background.png') !important; color: rgb(51, 51, 51) !important; } #main-content .content__container__orbit { background-color: #000 !important; } #main-content .content__container__journal { color: #fff; } .html-article-menu .row span { } .html-article-menu .row span.active { } .accordion-navigation__journal .side-menu-li.active::before, .accordion-navigation__journal .side-menu-li.active a { color: rgba(0,91,100,0.75) !important; font-weight: 700; } .accordion-navigation__journal .side-menu-li:hover::before , .accordion-navigation__journal .side-menu-li:hover a { color: rgba(0,91,100,0.75) !important; } .side-menu-ul li.active a, .side-menu-ul li.active, .side-menu-ul li.active::before { color: rgba(0,91,100,0.75) !important; } .side-menu-ul li.active a { } .result-selected, .active-result.highlighted, .active-result:hover, .result-selected, .active-result.highlighted, .active-result:focus { } .search-container.search-container__default-scheme { } nav.tab-bar .open-small-search.active:after { } .search-container.search-container__default-scheme .custom-accordion-for-small-screen-link::after { color: #fff; } @media only screen and (max-width: 50em) { #main-content .content__container.journal-info { color: #fff; } #main-content .content__container.journal-info a { color: #fff; } } .button.button--color { } .button.button--color:hover, .button.button--color:focus { } .button.button--color-journal { position: relative; background-color: rgba(0,91,100,0.75); border-color: #fff; color: #fff !important; } .button.button--color-journal:hover::before { content: ''; position: absolute; top: 0; left: 0; height: 100%; width: 100%; background-color: #ffffff; opacity: 0.2; } .button.button--color-journal:visited, .button.button--color-journal:hover, .button.button--color-journal:focus { background-color: rgba(0,91,100,0.75); border-color: #fff; color: #fff !important; } .button.button--color path { } .button.button--color:hover path { fill: #fff; } #main-content #search-refinements .ui-slider-horizontal .ui-slider-range { } .breadcrumb__element:last-of-type a { } #main-header { } #full-size-menu .top-bar, #full-size-menu li.menu-item span.user-email { } .top-bar-section li:not(.has-form) a:not(.button) { } #full-size-menu li.menu-item .dropdown-wrapper li a:hover { } #full-size-menu li.menu-item a:hover, #full-size-menu li.menu.item a:focus, nav.tab-bar a:hover { } #full-size-menu li.menu.item a:active, #full-size-menu li.menu.item a.active { } #full-size-menu li.menu-item a.open-mega-menu.active, #full-size-menu li.menu-item div.mega-menu, a.open-mega-menu.active { } #full-size-menu li.menu-item div.mega-menu li, #full-size-menu li.menu-item div.mega-menu a { border-color: #9a9a9a; } div.type-section h2 { font-size: 20px; line-height: 26px; font-weight: 300; } div.type-section h3 { margin-left: 15px; margin-bottom: 0px; font-weight: 300; } .journal-tabs .tab-title.active a { } </style> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/slick.css?f38b2db10e01b157?1732615622"> <meta name="title" content="Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives"> <meta name="description" content="Prostate cancer therapy for locally advanced and metastatic diseases includes androgen deprivation therapy (ADT). Second-generation antiandrogens have a role in castration-resistant prostate cancer. Nevertheless, some patients do not respond to this therapy, and eventually all the patients became resistant. This is due to modifications to intracellular signaling pathways, genomic alteration, cytokines production, metabolic switches, constitutional receptor activation, overexpression of some proteins, and regulation of gene expression. The aim of this review is to define the most important mechanisms that drive this resistance and the newest discoveries in this field, specifically for enzalutamide and abiraterone, with potential implications for future therapeutic targets. Furthermore, apalutamide and darolutamide share some resistance mechanisms with abiraterone and enzalutamide and could be useful in some resistance settings." > <link rel="image_src" href="https://pub.mdpi-res.com/img/journals/medsci-logo.png?3568b168e67d2809" > <meta name="dc.title" content="Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives"> <meta name="dc.creator" content="Francesco Pinto"> <meta name="dc.creator" content="Francesco Dibitetto"> <meta name="dc.creator" content="Mauro Ragonese"> <meta name="dc.creator" content="Pierfrancesco Bassi"> <meta name="dc.type" content="Review"> <meta name="dc.source" content="Medical Sciences 2022, Vol. 10, Page 25"> <meta name="dc.date" content="2022-04-28"> <meta name ="dc.identifier" content="10.3390/medsci10020025"> <meta name="dc.publisher" content="Multidisciplinary Digital Publishing Institute"> <meta name="dc.rights" content="http://creativecommons.org/licenses/by/3.0/"> <meta name="dc.format" content="application/pdf" > <meta name="dc.language" content="en" > <meta name="dc.description" content="Prostate cancer therapy for locally advanced and metastatic diseases includes androgen deprivation therapy (ADT). Second-generation antiandrogens have a role in castration-resistant prostate cancer. Nevertheless, some patients do not respond to this therapy, and eventually all the patients became resistant. This is due to modifications to intracellular signaling pathways, genomic alteration, cytokines production, metabolic switches, constitutional receptor activation, overexpression of some proteins, and regulation of gene expression. The aim of this review is to define the most important mechanisms that drive this resistance and the newest discoveries in this field, specifically for enzalutamide and abiraterone, with potential implications for future therapeutic targets. Furthermore, apalutamide and darolutamide share some resistance mechanisms with abiraterone and enzalutamide and could be useful in some resistance settings." > <meta name="dc.subject" content="prostatecancer" > <meta name="dc.subject" content="abiraterone" > <meta name="dc.subject" content="enzalutamide" > <meta name="dc.subject" content="apalutamide" > <meta name="dc.subject" content="darolutamide" > <meta name="dc.subject" content="castrationresistance" > <meta name="dc.subject" content="CRPC" > <meta name ="prism.issn" content="2076-3271"> <meta name ="prism.publicationName" content="Medical Sciences"> <meta name ="prism.publicationDate" content="2022-04-28"> <meta name ="prism.volume" content="10"> <meta name ="prism.number" content="2"> <meta name ="prism.section" content="Review" > <meta name ="prism.startingPage" content="25" > <meta name="citation_issn" content="2076-3271"> <meta name="citation_journal_title" content="Medical Sciences"> <meta name="citation_publisher" content="Multidisciplinary Digital Publishing Institute"> <meta name="citation_title" content="Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives"> <meta name="citation_publication_date" content="2022/6"> <meta name="citation_online_date" content="2022/04/28"> <meta name="citation_volume" content="10"> <meta name="citation_issue" content="2"> <meta name="citation_firstpage" content="25"> <meta name="citation_author" content="Pinto, Francesco"> <meta name="citation_author" content="Dibitetto, Francesco"> <meta name="citation_author" content="Ragonese, Mauro"> <meta name="citation_author" content="Bassi, Pierfrancesco"> <meta name="citation_doi" content="10.3390/medsci10020025"> <meta name="citation_id" content="mdpi-medsci10020025"> <meta name="citation_abstract_html_url" content="https://www.mdpi.com/2076-3271/10/2/25"> <meta name="citation_pdf_url" content="https://www.mdpi.com/2076-3271/10/2/25/pdf?version=1651129746"> <link rel="alternate" type="application/pdf" title="PDF Full-Text" href="https://www.mdpi.com/2076-3271/10/2/25/pdf?version=1651129746"> <meta name="fulltext_pdf" content="https://www.mdpi.com/2076-3271/10/2/25/pdf?version=1651129746"> <meta name="citation_fulltext_html_url" content="https://www.mdpi.com/2076-3271/10/2/25/htm"> <link rel="alternate" type="text/html" title="HTML Full-Text" href="https://www.mdpi.com/2076-3271/10/2/25/htm"> <meta name="fulltext_html" content="https://www.mdpi.com/2076-3271/10/2/25/htm"> <link rel="alternate" type="text/xml" title="XML Full-Text" href="https://www.mdpi.com/2076-3271/10/2/25/xml"> <meta name="fulltext_xml" content="https://www.mdpi.com/2076-3271/10/2/25/xml"> <meta name="citation_xml_url" content="https://www.mdpi.com/2076-3271/10/2/25/xml"> <meta name="twitter:card" content="summary" /> <meta name="twitter:site" content="@MDPIOpenAccess" /> <meta name="twitter:image" content="https://pub.mdpi-res.com/img/journals/medsci-logo-social.png?3568b168e67d2809" /> <meta property="fb:app_id" content="131189377574"/> <meta property="og:site_name" content="MDPI"/> <meta property="og:type" content="article"/> <meta property="og:url" content="https://www.mdpi.com/2076-3271/10/2/25" /> <meta property="og:title" content="Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives" /> <meta property="og:description" content="Prostate cancer therapy for locally advanced and metastatic diseases includes androgen deprivation therapy (ADT). Second-generation antiandrogens have a role in castration-resistant prostate cancer. Nevertheless, some patients do not respond to this therapy, and eventually all the patients became resistant. This is due to modifications to intracellular signaling pathways, genomic alteration, cytokines production, metabolic switches, constitutional receptor activation, overexpression of some proteins, and regulation of gene expression. The aim of this review is to define the most important mechanisms that drive this resistance and the newest discoveries in this field, specifically for enzalutamide and abiraterone, with potential implications for future therapeutic targets. Furthermore, apalutamide and darolutamide share some resistance mechanisms with abiraterone and enzalutamide and could be useful in some resistance settings." /> <meta property="og:image" content="https://pub.mdpi-res.com/img/journals/medsci-logo-social.png?3568b168e67d2809" /> <link rel="alternate" type="application/rss+xml" title="MDPI Publishing - Latest articles" href="https://www.mdpi.com/rss"> <meta name="google-site-verification" content="PxTlsg7z2S00aHroktQd57fxygEjMiNHydKn3txhvwY"> <meta name="facebook-domain-verification" content="mcoq8dtq6sb2hf7z29j8w515jjoof7" /> <script id="Cookiebot" data-cfasync="false" src="https://consent.cookiebot.com/uc.js" data-cbid="51491ddd-fe7a-4425-ab39-69c78c55829f" type="text/javascript" async></script>  <script type="text/plain" data-cookieconsent="statistics"> (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-WPK7SW5'); </script> <script type="text/plain" data-cookieconsent="statistics"> _linkedin_partner_id = "2846186"; window._linkedin_data_partner_ids = window._linkedin_data_partner_ids || []; window._linkedin_data_partner_ids.push(_linkedin_partner_id); </script><script type="text/javascript"> (function(){var s = document.getElementsByTagName("script")[0]; var b = document.createElement("script"); b.type = "text/javascript";b.async = true; b.src = "https://snap.licdn.com/li.lms-analytics/insight.min.js"; s.parentNode.insertBefore(b, s);})(); </script> <script type="text/plain" data-cookieconsent="statistics" data-cfasync="false" src="//script.crazyegg.com/pages/scripts/0116/4951.js" async="async" ></script> </head> <body> <div class="direction direction_right" id="small_right" style="border-right-width: 0px; padding:0;"> <i class="fa fa-caret-right fa-2x"></i> </div> <div class="big_direction direction_right" id="big_right" style="border-right-width: 0px;"> <div style="text-align: right;"> Next Article in Journal<br> <div><a href="/2076-3271/10/2/26">Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes</a></div> </div> </div> <div class="direction" id="small_left" style="border-left-width: 0px"> <i class="fa fa-caret-left fa-2x"></i> </div> <div class="big_direction" id="big_left" style="border-left-width: 0px;"> <div> Previous Article in Journal<br> <div><a href="/2076-3271/10/2/24">Polyamine Metabolism in <i>Leishmania</i> Parasites: A Promising Therapeutic Target</a></div> </div> </div> <div style="clear: both;"></div> <div id="menuModal" class="reveal-modal reveal-modal-new reveal-modal-menu" aria-hidden="true" data-reveal role="dialog"> <div class="menu-container"> <div class="UI_NavMenu"> <div class="content__container " > <div class="custom-accordion-for-small-screen-link " > <h2>Journals</h2> </div> <div class="target-item custom-accordion-for-small-screen-content show-for-medium-up"> <div class="menu-container__links"> <div style="width: 100%; float: left;"> <a href="/about/journals">Active Journals</a> <a href="/about/journalfinder">Find a Journal</a> <a href="/about/journals/proposal">Journal Proposal</a> <a href="/about/proceedings">Proceedings Series</a> </div> </div> </div> </div> <a href="/topics"> <h2>Topics</h2> </a> <div class="content__container " > <div class="custom-accordion-for-small-screen-link " > <h2>Information</h2> </div> <div class="target-item custom-accordion-for-small-screen-content show-for-medium-up"> <div class="menu-container__links"> <div style="width: 100%; max-width: 200px; float: left;"> <a href="/authors">For Authors</a> <a href="/reviewers">For Reviewers</a> <a href="/editors">For Editors</a> <a href="/librarians">For Librarians</a> <a href="/publishing_services">For Publishers</a> <a href="/societies">For Societies</a> <a href="/conference_organizers">For Conference Organizers</a> </div> <div style="width: 100%; max-width: 250px; float: left;"> <a href="/openaccess">Open Access Policy</a> <a href="/ioap">Institutional Open Access Program</a> <a href="/special_issues_guidelines">Special Issues Guidelines</a> <a href="/editorial_process">Editorial Process</a> <a href="/ethics">Research and Publication Ethics</a> <a href="/apc">Article Processing Charges</a> <a href="/awards">Awards</a> <a href="/testimonials">Testimonials</a> </div> </div> </div> </div> <a href="/authors/english"> <h2>Editing Services</h2> </a> <div class="content__container " > <div class="custom-accordion-for-small-screen-link " > <h2>Initiatives</h2> </div> <div class="target-item custom-accordion-for-small-screen-content show-for-medium-up"> <div class="menu-container__links"> <div style="width: 100%; float: left;"> <a href="https://sciforum.net" target="_blank" rel="noopener noreferrer">Sciforum</a> <a href="https://www.mdpi.com/books" target="_blank" rel="noopener noreferrer">MDPI Books</a> <a href="https://www.preprints.org" target="_blank" rel="noopener noreferrer">Preprints.org</a> <a href="https://www.scilit.net" target="_blank" rel="noopener noreferrer">Scilit</a> <a href="https://sciprofiles.com" target="_blank" rel="noopener noreferrer">SciProfiles</a> <a href="https://encyclopedia.pub" target="_blank" rel="noopener noreferrer">Encyclopedia</a> <a href="https://jams.pub" target="_blank" rel="noopener noreferrer">JAMS</a> <a href="/about/proceedings">Proceedings Series</a> </div> </div> </div> </div> <div class="content__container " > <div class="custom-accordion-for-small-screen-link " > <h2>About</h2> </div> <div class="target-item custom-accordion-for-small-screen-content show-for-medium-up"> <div class="menu-container__links"> <div style="width: 100%; float: left;"> <a href="/about">Overview</a> <a href="/about/contact">Contact</a> <a href="https://careers.mdpi.com" target="_blank" rel="noopener noreferrer">Careers</a> <a href="/about/announcements">News</a> <a href="/about/press">Press</a> <a href="http://blog.mdpi.com/" target="_blank" rel="noopener noreferrer">Blog</a> </div> </div> </div> </div> </div> <div class="menu-container__buttons"> <a class="button UA_SignInUpButton" href="/user/login">Sign In / Sign Up</a> </div> </div> </div> <div id="captchaModal" class="reveal-modal reveal-modal-new reveal-modal-new--small" data-reveal aria-label="Captcha" aria-hidden="true" role="dialog"></div> <div id="actionDisabledModal" class="reveal-modal" data-reveal aria-labelledby="actionDisableModalTitle" aria-hidden="true" role="dialog" style="width: 300px;"> <h2 id="actionDisableModalTitle">Notice</h2> <form action="/email/captcha" method="post" id="emailCaptchaForm"> <div class="row"> <div id="js-action-disabled-modal-text" class="small-12 columns"> </div> <div id="js-action-disabled-modal-submit" class="small-12 columns" style="margin-top: 10px; display: none;"> You can make submissions to other journals <a href="https://susy.mdpi.com/user/manuscripts/upload">here</a>. </div> </div> </form> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> <div id="rssNotificationModal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="rssNotificationModalTitle" aria-hidden="true" role="dialog"> <div class="row"> <div class="small-12 columns"> <h2 id="rssNotificationModalTitle">Notice</h2> <p> You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader. </p> </div> </div> <div class="row"> <div class="small-12 columns"> <a class="button button--color js-rss-notification-confirm">Continue</a> <a class="button button--grey" onclick="$(this).closest('.reveal-modal').find('.close-reveal-modal').click(); return false;">Cancel</a> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> <div id="drop-article-label-openaccess" class="f-dropdown medium" data-dropdown-content aria-hidden="true" tabindex="-1"> <p> All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to <a href="https://www.mdpi.com/openaccess">https://www.mdpi.com/openaccess</a>. </p> </div> <div id="drop-article-label-feature" class="f-dropdown medium" data-dropdown-content aria-hidden="true" tabindex="-1"> <p> Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications. </p> <p> Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers. </p> </div> <div id="drop-article-label-choice" class="f-dropdown medium" data-dropdown-content aria-hidden="true" tabindex="-1"> <p> Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal. <div style="margin-top: -10px;"> <div id="drop-article-label-choice-journal-link" style="display: none; margin-top: -10px; padding-top: 10px;"> </div> </div> </p> </div> <div id="drop-article-label-resubmission" class="f-dropdown medium" data-dropdown-content aria-hidden="true" tabindex="-1"> <p> Original Submission Date Received: <span id="drop-article-label-resubmission-date"></span>. </p> </div> <div id="container"> <noscript> <div id="no-javascript"> You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled. </div> </noscript> <div class="fixed"> <nav class="tab-bar show-for-medium-down"> <div class="row full-width collapse"> <div class="medium-3 small-4 columns"> <a href="/"> <img class="full-size-menu__mdpi-logo" src="https://pub.mdpi-res.com/img/design/mdpi-pub-logo-black-small1.svg?da3a8dcae975a41c?1732615622" style="width: 64px;" title="MDPI Open Access Journals"> </a> </div> <div class="medium-3 small-4 columns right-aligned"> <div class="show-for-medium-down"> <a href="#" style="display: none;"> <i class="material-icons" onclick="$('#menuModal').foundation('reveal', 'close'); return false;">clear</i> </a> <a class="js-toggle-desktop-layout-link" title="Toggle desktop layout" style="display: none;" href="/toggle_desktop_layout_cookie"> <i class="material-icons">zoom_out_map</i> </a> <a href="#" class="js-open-small-search open-small-search"> <i class="material-icons show-for-small only">search</i> </a> <a title="MDPI main page" class="js-open-menu" data-reveal-id="menuModal" href="#"> <i class="material-icons">menu</i> </a> </div> </div> </div> </nav> </div> <section class="main-section"> <header> <div class="full-size-menu show-for-large-up"> <div class="row full-width"> <div class="large-1 columns"> <a href="/"> <img class="full-size-menu__mdpi-logo" src="https://pub.mdpi-res.com/img/design/mdpi-pub-logo-black-small1.svg?da3a8dcae975a41c?1732615622" title="MDPI Open Access Journals"> </a> </div> <div class="large-8 columns text-right UI_NavMenu"> <ul> <li class="menu-item"> <a href="/about/journals" data-dropdown="journals-dropdown" aria-controls="journals-dropdown" aria-expanded="false" data-options="is_hover: true; hover_timeout: 200">Journals</a> <ul id="journals-dropdown" class="f-dropdown dropdown-wrapper dropdown-wrapper__small" data-dropdown-content aria-hidden="true" tabindex="-1"> <li> <div class="row"> <div class="small-12 columns"> <ul> <li> <a href="/about/journals"> Active Journals </a> </li> <li> <a href="/about/journalfinder"> Find a Journal </a> </li> <li> <a href="/about/journals/proposal"> Journal Proposal </a> </li> <li> <a href="/about/proceedings"> Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li class="menu-item"> <a href="/topics">Topics</a> </li> <li class="menu-item"> <a href="/authors" data-dropdown="information-dropdown" aria-controls="information-dropdown" aria-expanded="false" data-options="is_hover:true; hover_timeout:200">Information</a> <ul id="information-dropdown" class="f-dropdown dropdown-wrapper" data-dropdown-content aria-hidden="true" tabindex="-1"> <li> <div class="row"> <div class="small-5 columns right-border"> <ul> <li> <a href="/authors">For Authors</a> </li> <li> <a href="/reviewers">For Reviewers</a> </li> <li> <a href="/editors">For Editors</a> </li> <li> <a href="/librarians">For Librarians</a> </li> <li> <a href="/publishing_services">For Publishers</a> </li> <li> <a href="/societies">For Societies</a> </li> <li> <a href="/conference_organizers">For Conference Organizers</a> </li> </ul> </div> <div class="small-7 columns"> <ul> <li> <a href="/openaccess">Open Access Policy</a> </li> <li> <a href="/ioap">Institutional Open Access Program</a> </li> <li> <a href="/special_issues_guidelines">Special Issues Guidelines</a> </li> <li> <a href="/editorial_process">Editorial Process</a> </li> <li> <a href="/ethics">Research and Publication Ethics</a> </li> <li> <a href="/apc">Article Processing Charges</a> </li> <li> <a href="/awards">Awards</a> </li> <li> <a href="/testimonials">Testimonials</a> </li> </ul> </div> </div> </li> </ul> </li> <li class="menu-item"> <a href="/authors/english">Editing Services</a> </li> <li class="menu-item"> <a href="/about/initiatives" data-dropdown="initiatives-dropdown" aria-controls="initiatives-dropdown" aria-expanded="false" data-options="is_hover: true; hover_timeout: 200">Initiatives</a> <ul id="initiatives-dropdown" class="f-dropdown dropdown-wrapper dropdown-wrapper__small" data-dropdown-content aria-hidden="true" tabindex="-1"> <li> <div class="row"> <div class="small-12 columns"> <ul> <li> <a href="https://sciforum.net" target="_blank" rel="noopener noreferrer"> Sciforum </a> </li> <li> <a href="https://www.mdpi.com/books" target="_blank" rel="noopener noreferrer"> MDPI Books </a> </li> <li> <a href="https://www.preprints.org" target="_blank" rel="noopener noreferrer"> Preprints.org </a> </li> <li> <a href="https://www.scilit.net" target="_blank" rel="noopener noreferrer"> Scilit </a> </li> <li> <a href="https://sciprofiles.com" target="_blank" rel="noopener noreferrer"> SciProfiles </a> </li> <li> <a href="https://encyclopedia.pub" target="_blank" rel="noopener noreferrer"> Encyclopedia </a> </li> <li> <a href="https://jams.pub" target="_blank" rel="noopener noreferrer"> JAMS </a> </li> <li> <a href="/about/proceedings"> Proceedings Series </a> </li> </ul> </div> </div> </li> </ul> </li> <li class="menu-item"> <a href="/about" data-dropdown="about-dropdown" aria-controls="about-dropdown" aria-expanded="false" data-options="is_hover: true; hover_timeout: 200">About</a> <ul id="about-dropdown" class="f-dropdown dropdown-wrapper dropdown-wrapper__small" data-dropdown-content aria-hidden="true" tabindex="-1"> <li> <div class="row"> <div class="small-12 columns"> <ul> <li> <a href="/about"> Overview </a> </li> <li> <a href="/about/contact"> Contact </a> </li> <li> <a href="https://careers.mdpi.com" target="_blank" rel="noopener noreferrer"> Careers </a> </li> <li> <a href="/about/announcements"> News </a> </li> <li> <a href="/about/press"> Press </a> </li> <li> <a href="http://blog.mdpi.com/" target="_blank" rel="noopener noreferrer"> Blog </a> </li> </ul> </div> </div> </li> </ul> </li> </ul> </div> <div class="large-3 columns text-right full-size-menu__buttons"> <div> <a class="button button--default-inversed UA_SignInUpButton" href="/user/login">Sign In / Sign Up</a> <a class="button button--default js-journal-active-only-link js-journal-active-only-submit-link UC_NavSubmitButton" href=" https://susy.mdpi.com/user/manuscripts/upload?journal=medsci " data-disabledmessage="new submissions are not possible.">Submit</a> </div> </div> </div> </div> <div class="header-divider"> </div> <div class="search-container hide-for-small-down row search-container__homepage-scheme"> <form id="basic_search" style="background-color: inherit !important;" class="large-12 medium-12 columns " action="/search" method="get"> <div class="row search-container__main-elements"> <div class="large-2 medium-2 small-12 columns text-right1 small-only-text-left"> <div class="show-for-medium-up"> <div class="search-input-label"> </div> </div> <span class="search-container__title">Search<span class="hide-for-medium"> for Articles</span><span class="hide-for-small">:</span></span> </div> <div class="custom-accordion-for-small-screen-content"> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Title / Keyword</div> </div> <input type="text" placeholder="Title / Keyword" id="q" tabindex="1" name="q" value="" /> </div> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Author / Affiliation / Email</div> </div> <input type="text" id="authors" placeholder="Author / Affiliation / Email" tabindex="2" name="authors" value="" /> </div> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Journal</div> </div> <select id="journal" tabindex="3" name="journal" class="chosen-select"> <option value="">All Journals</option> <option value="acoustics" > Acoustics </option> <option value="amh" > Acta Microbiologica Hellenica (AMH) </option> <option value="actuators" > Actuators </option> <option value="admsci" > Administrative Sciences </option> <option value="adolescents" > Adolescents </option> <option value="arm" > Advances in Respiratory Medicine (ARM) </option> <option value="aerobiology" > Aerobiology </option> <option value="aerospace" > Aerospace </option> <option value="agriculture" > Agriculture </option> <option value="agriengineering" > AgriEngineering </option> <option value="agrochemicals" > Agrochemicals </option> <option value="agronomy" > Agronomy </option> <option value="ai" > AI </option> <option value="air" > Air </option> <option value="algorithms" > Algorithms </option> <option value="allergies" > Allergies </option> <option value="alloys" > Alloys </option> <option value="analytica" > Analytica </option> <option value="analytics" > Analytics </option> <option value="anatomia" > Anatomia </option> <option value="anesthres" > Anesthesia Research </option> <option value="animals" > Animals </option> <option value="antibiotics" > Antibiotics </option> <option value="antibodies" > Antibodies </option> <option value="antioxidants" > Antioxidants </option> <option value="applbiosci" > Applied Biosciences </option> <option value="applmech" > Applied Mechanics </option> <option value="applmicrobiol" > Applied Microbiology </option> <option value="applnano" > Applied Nano </option> <option value="applsci" > Applied Sciences </option> <option value="asi" > Applied System Innovation (ASI) </option> <option value="appliedchem" > AppliedChem </option> <option value="appliedmath" > AppliedMath </option> <option value="aquacj" > Aquaculture Journal </option> <option value="architecture" > Architecture </option> <option value="arthropoda" > Arthropoda </option> <option value="arts" > Arts </option> <option value="astronomy" > Astronomy </option> <option value="atmosphere" > Atmosphere </option> <option value="atoms" > Atoms </option> <option value="audiolres" > Audiology Research </option> <option value="automation" > Automation </option> <option value="axioms" > Axioms </option> <option value="bacteria" > Bacteria </option> <option value="batteries" > Batteries </option> <option value="behavsci" > Behavioral Sciences </option> <option value="beverages" > Beverages </option> <option value="BDCC" > Big Data and Cognitive Computing (BDCC) </option> <option value="biochem" > BioChem </option> <option value="bioengineering" > Bioengineering </option> <option value="biologics" > Biologics </option> <option value="biology" > Biology </option> <option value="blsf" > Biology and Life Sciences Forum </option> <option value="biomass" > Biomass </option> <option value="biomechanics" > Biomechanics </option> <option value="biomed" > BioMed </option> <option value="biomedicines" > Biomedicines </option> <option value="biomedinformatics" > BioMedInformatics </option> <option value="biomimetics" > Biomimetics </option> <option value="biomolecules" > Biomolecules </option> <option value="biophysica" > Biophysica </option> <option value="biosensors" > Biosensors </option> <option value="biotech" > BioTech </option> <option value="birds" > Birds </option> <option value="blockchains" > Blockchains </option> <option value="brainsci" > Brain Sciences </option> <option value="buildings" > Buildings </option> <option value="businesses" > Businesses </option> <option value="carbon" > C </option> <option value="cancers" > Cancers </option> <option value="cardiogenetics" > Cardiogenetics </option> <option value="catalysts" > Catalysts </option> <option value="cells" > Cells </option> <option value="ceramics" > Ceramics </option> <option value="challenges" > Challenges </option> <option value="ChemEngineering" > ChemEngineering </option> <option value="chemistry" > Chemistry </option> <option value="chemproc" > Chemistry Proceedings </option> <option value="chemosensors" > Chemosensors </option> <option value="children" > Children </option> <option value="chips" > Chips </option> <option value="civileng" > CivilEng </option> <option value="cleantechnol" > Clean Technologies (Clean Technol.) </option> <option value="climate" > Climate </option> <option value="ctn" > Clinical and Translational Neuroscience (CTN) </option> <option value="clinbioenerg" > Clinical Bioenergetics </option> <option value="clinpract" > Clinics and Practice </option> <option value="clockssleep" > Clocks & Sleep </option> <option value="coasts" > Coasts </option> <option value="coatings" > Coatings </option> <option value="colloids" > Colloids and Interfaces </option> <option value="colorants" > Colorants </option> <option value="commodities" > Commodities </option> <option value="complications" > Complications </option> <option value="compounds" > Compounds </option> <option value="computation" > Computation </option> <option value="csmf" > Computer Sciences & Mathematics Forum </option> <option value="computers" > Computers </option> <option value="condensedmatter" > Condensed Matter </option> <option value="conservation" > Conservation </option> <option value="constrmater" > Construction Materials </option> <option value="cmd" > Corrosion and Materials Degradation (CMD) </option> <option value="cosmetics" > Cosmetics </option> <option value="covid" > COVID </option> <option value="crops" > Crops </option> <option value="cryo" > Cryo </option> <option value="cryptography" > Cryptography </option> <option value="crystals" > Crystals </option> <option value="cimb" > Current Issues in Molecular Biology (CIMB) </option> <option value="curroncol" > Current Oncology </option> <option value="dairy" > Dairy </option> <option value="data" > Data </option> <option value="dentistry" > Dentistry Journal </option> <option value="dermato" > Dermato </option> <option value="dermatopathology" > Dermatopathology </option> <option value="designs" > Designs </option> <option value="diabetology" > Diabetology </option> <option value="diagnostics" > Diagnostics </option> <option value="dietetics" > Dietetics </option> <option value="digital" > Digital </option> <option value="disabilities" > Disabilities </option> <option value="diseases" > Diseases </option> <option value="diversity" > Diversity </option> <option value="dna" > DNA </option> <option value="drones" > Drones </option> <option value="ddc" > Drugs and Drug Candidates (DDC) </option> <option value="dynamics" > Dynamics </option> <option value="earth" > Earth </option> <option value="ecologies" > Ecologies </option> <option value="econometrics" > Econometrics </option> <option value="economies" > Economies </option> <option value="education" > Education Sciences </option> <option value="electricity" > Electricity </option> <option value="electrochem" > Electrochem </option> <option value="electronicmat" > Electronic Materials </option> <option value="electronics" > Electronics </option> <option value="ecm" > Emergency Care and Medicine </option> <option value="encyclopedia" > Encyclopedia </option> <option value="endocrines" > Endocrines </option> <option value="energies" > Energies </option> <option value="esa" > Energy Storage and Applications (ESA) </option> <option value="eng" > Eng </option> <option value="engproc" > Engineering Proceedings </option> <option value="entropy" > Entropy </option> <option value="environsciproc" > Environmental Sciences Proceedings </option> <option value="environments" > Environments </option> <option value="epidemiologia" > Epidemiologia </option> <option value="epigenomes" > Epigenomes </option> <option value="ebj" > European Burn Journal (EBJ) </option> <option value="ejihpe" > European Journal of Investigation in Health, Psychology and Education (EJIHPE) </option> <option value="fermentation" > Fermentation </option> <option value="fibers" > Fibers </option> <option value="fintech" > FinTech </option> <option value="fire" > Fire </option> <option value="fishes" > Fishes </option> <option value="fluids" > Fluids </option> <option value="foods" > Foods </option> <option value="forecasting" > Forecasting </option> <option value="forensicsci" > Forensic Sciences </option> <option value="forests" > Forests </option> <option value="fossstud" > Fossil Studies </option> <option value="foundations" > Foundations </option> <option value="fractalfract" > Fractal and Fractional (Fractal Fract) </option> <option value="fuels" > Fuels </option> <option value="future" > Future </option> <option value="futureinternet" > Future Internet </option> <option value="futurepharmacol" > Future Pharmacology </option> <option value="futuretransp" > Future Transportation </option> <option value="galaxies" > Galaxies </option> <option value="games" > Games </option> <option value="gases" > Gases </option> <option value="gastroent" > Gastroenterology Insights </option> <option value="gastrointestdisord" > Gastrointestinal Disorders </option> <option value="gastronomy" > Gastronomy </option> <option value="gels" > Gels </option> <option value="genealogy" > Genealogy </option> <option value="genes" > Genes </option> <option value="geographies" > Geographies </option> <option value="geohazards" > GeoHazards </option> <option value="geomatics" > Geomatics </option> <option value="geometry" > Geometry </option> <option value="geosciences" > Geosciences </option> <option value="geotechnics" > Geotechnics </option> <option value="geriatrics" > Geriatrics </option> <option value="glacies" > Glacies </option> <option value="gucdd" > Gout, Urate, and Crystal Deposition Disease (GUCDD) </option> <option value="grasses" > Grasses </option> <option value="hardware" > Hardware </option> <option value="healthcare" > Healthcare </option> <option value="hearts" > Hearts </option> <option value="hemato" > Hemato </option> <option value="hematolrep" > Hematology Reports </option> <option value="heritage" > Heritage </option> <option value="histories" > Histories </option> <option value="horticulturae" > Horticulturae </option> <option value="hospitals" > Hospitals </option> <option value="humanities" > Humanities </option> <option value="humans" > Humans </option> <option value="hydrobiology" > Hydrobiology </option> <option value="hydrogen" > Hydrogen </option> <option value="hydrology" > Hydrology </option> <option value="hygiene" > Hygiene </option> <option value="immuno" > Immuno </option> <option value="idr" > Infectious Disease Reports </option> <option value="informatics" > Informatics </option> <option value="information" > Information </option> <option value="infrastructures" > Infrastructures </option> <option value="inorganics" > Inorganics </option> <option value="insects" > Insects </option> <option value="instruments" > Instruments </option> <option value="iic" > Intelligent Infrastructure and Construction </option> <option value="ijerph" > International Journal of Environmental Research and Public Health (IJERPH) </option> <option value="ijfs" > International Journal of Financial Studies (IJFS) </option> <option value="ijms" > International Journal of Molecular Sciences (IJMS) </option> <option value="IJNS" > International Journal of Neonatal Screening (IJNS) </option> <option value="ijpb" > International Journal of Plant Biology (IJPB) </option> <option value="ijt" > International Journal of Topology </option> <option value="ijtm" > International Journal of Translational Medicine (IJTM) </option> <option value="ijtpp" > International Journal of Turbomachinery, Propulsion and Power (IJTPP) </option> <option value="ime" > International Medical Education (IME) </option> <option value="inventions" > Inventions </option> <option value="IoT" > IoT </option> <option value="ijgi" > ISPRS International Journal of Geo-Information (IJGI) </option> <option value="J" > J </option> <option value="jal" > Journal of Ageing and Longevity (JAL) </option> <option value="jcdd" > Journal of Cardiovascular Development and Disease (JCDD) </option> <option value="jcto" > Journal of Clinical & Translational Ophthalmology (JCTO) </option> <option value="jcm" > Journal of Clinical Medicine (JCM) </option> <option value="jcs" > Journal of Composites Science (J. Compos. Sci.) </option> <option value="jcp" > Journal of Cybersecurity and Privacy (JCP) </option> <option value="jdad" > Journal of Dementia and Alzheimer's Disease (JDAD) </option> <option value="jdb" > Journal of Developmental Biology (JDB) </option> <option value="jeta" > Journal of Experimental and Theoretical Analyses (JETA) </option> <option value="jfb" > Journal of Functional Biomaterials (JFB) </option> <option value="jfmk" > Journal of Functional Morphology and Kinesiology (JFMK) </option> <option value="jof" > Journal of Fungi (JoF) </option> <option value="jimaging" > Journal of Imaging (J. Imaging) </option> <option value="jintelligence" > Journal of Intelligence (J. Intell.) </option> <option value="jlpea" > Journal of Low Power Electronics and Applications (JLPEA) </option> <option value="jmmp" > Journal of Manufacturing and Materials Processing (JMMP) </option> <option value="jmse" > Journal of Marine Science and Engineering (JMSE) </option> <option value="jmahp" > Journal of Market Access & Health Policy (JMAHP) </option> <option value="jmp" > Journal of Molecular Pathology (JMP) </option> <option value="jnt" > Journal of Nanotheranostics (JNT) </option> <option value="jne" > Journal of Nuclear Engineering (JNE) </option> <option value="ohbm" > Journal of Otorhinolaryngology, Hearing and Balance Medicine (JOHBM) </option> <option value="jop" > Journal of Parks </option> <option value="jpm" > Journal of Personalized Medicine (JPM) </option> <option value="jpbi" > Journal of Pharmaceutical and BioTech Industry (JPBI) </option> <option value="jor" > Journal of Respiration (JoR) </option> <option value="jrfm" > Journal of Risk and Financial Management (JRFM) </option> <option value="jsan" > Journal of Sensor and Actuator Networks (JSAN) </option> <option value="joma" > Journal of the Oman Medical Association (JOMA) </option> <option value="jtaer" > Journal of Theoretical and Applied Electronic Commerce Research (JTAER) </option> <option value="jvd" > Journal of Vascular Diseases (JVD) </option> <option value="jox" > Journal of Xenobiotics (JoX) </option> <option value="jzbg" > Journal of Zoological and Botanical Gardens (JZBG) </option> <option value="journalmedia" > Journalism and Media </option> <option value="kidneydial" > Kidney and Dialysis </option> <option value="kinasesphosphatases" > Kinases and Phosphatases </option> <option value="knowledge" > Knowledge </option> <option value="labmed" > LabMed </option> <option value="laboratories" > Laboratories </option> <option value="land" > Land </option> <option value="languages" > Languages </option> <option value="laws" > Laws </option> <option value="life" > Life </option> <option value="limnolrev" > Limnological Review </option> <option value="lipidology" > Lipidology </option> <option value="liquids" > Liquids </option> <option value="literature" > Literature </option> <option value="livers" > Livers </option> <option value="logics" > Logics </option> <option value="logistics" > Logistics </option> <option value="lubricants" > Lubricants </option> <option value="lymphatics" > Lymphatics </option> <option value="make" > Machine Learning and Knowledge Extraction (MAKE) </option> <option value="machines" > Machines </option> <option value="macromol" > Macromol </option> <option value="magnetism" > Magnetism </option> <option value="magnetochemistry" > Magnetochemistry </option> <option value="marinedrugs" > Marine Drugs </option> <option value="materials" > Materials </option> <option value="materproc" > Materials Proceedings </option> <option value="mca" > Mathematical and Computational Applications (MCA) </option> <option value="mathematics" > Mathematics </option> <option value="medsci" selected='selected'> Medical Sciences </option> <option value="msf" > Medical Sciences Forum </option> <option value="medicina" > Medicina </option> <option value="medicines" > Medicines </option> <option value="membranes" > Membranes </option> <option value="merits" > Merits </option> <option value="metabolites" > Metabolites </option> <option value="metals" > Metals </option> <option value="meteorology" > Meteorology </option> <option value="methane" > Methane </option> <option value="mps" > Methods and Protocols (MPs) </option> <option value="metrics" > Metrics </option> <option value="metrology" > Metrology </option> <option value="micro" > Micro </option> <option value="microbiolres" > Microbiology Research </option> <option value="micromachines" > Micromachines </option> <option value="microorganisms" > Microorganisms </option> <option value="microplastics" > Microplastics </option> <option value="minerals" > Minerals </option> <option value="mining" > Mining </option> <option value="modelling" > Modelling </option> <option value="mmphys" > Modern Mathematical Physics </option> <option value="molbank" > Molbank </option> <option value="molecules" > Molecules </option> <option value="mti" > Multimodal Technologies and Interaction (MTI) </option> <option value="muscles" > Muscles </option> <option value="nanoenergyadv" > Nanoenergy Advances </option> <option value="nanomanufacturing" > Nanomanufacturing </option> <option value="nanomaterials" > Nanomaterials </option> <option value="ndt" > NDT </option> <option value="network" > Network </option> <option value="neuroglia" > Neuroglia </option> <option value="neurolint" > Neurology International </option> <option value="neurosci" > NeuroSci </option> <option value="nitrogen" > Nitrogen </option> <option value="ncrna" > Non-Coding RNA (ncRNA) </option> <option value="nursrep" > Nursing Reports </option> <option value="nutraceuticals" > Nutraceuticals </option> <option value="nutrients" > Nutrients </option> <option value="obesities" > Obesities </option> <option value="oceans" > Oceans </option> <option value="onco" > Onco </option> <option value="optics" > Optics </option> <option value="oral" > Oral </option> <option value="organics" > Organics </option> <option value="organoids" > Organoids </option> <option value="osteology" > Osteology </option> <option value="oxygen" > Oxygen </option> <option value="parasitologia" > Parasitologia </option> <option value="particles" > Particles </option> <option value="pathogens" > Pathogens </option> <option value="pathophysiology" > Pathophysiology </option> <option value="pediatrrep" > Pediatric Reports </option> <option value="pets" > Pets </option> <option value="pharmaceuticals" > Pharmaceuticals </option> <option value="pharmaceutics" > Pharmaceutics </option> <option value="pharmacoepidemiology" > Pharmacoepidemiology </option> <option value="pharmacy" > Pharmacy </option> <option value="philosophies" > Philosophies </option> <option value="photochem" > Photochem </option> <option value="photonics" > Photonics </option> <option value="phycology" > Phycology </option> <option value="physchem" > Physchem </option> <option value="psf" > Physical Sciences Forum </option> <option value="physics" > Physics </option> <option value="physiologia" > Physiologia </option> <option value="plants" > Plants </option> <option value="plasma" > Plasma </option> <option value="platforms" > Platforms </option> <option value="pollutants" > Pollutants </option> <option value="polymers" > Polymers </option> <option value="polysaccharides" > Polysaccharides </option> <option value="populations" > Populations </option> <option value="poultry" > Poultry </option> <option value="powders" > Powders </option> <option value="proceedings" > Proceedings </option> <option value="processes" > Processes </option> <option value="prosthesis" > Prosthesis </option> <option value="proteomes" > Proteomes </option> <option value="psychiatryint" > Psychiatry International </option> <option value="psychoactives" > Psychoactives </option> <option value="psycholint" > Psychology International </option> <option value="publications" > Publications </option> <option value="qubs" > Quantum Beam Science (QuBS) </option> <option value="quantumrep" > Quantum Reports </option> <option value="quaternary" > Quaternary </option> <option value="radiation" > Radiation </option> <option value="reactions" > Reactions </option> <option value="realestate" > Real Estate </option> <option value="receptors" > Receptors </option> <option value="recycling" > Recycling </option> <option value="rsee" > Regional Science and Environmental Economics (RSEE) </option> <option value="religions" > Religions </option> <option value="remotesensing" > Remote Sensing </option> <option value="reports" > Reports </option> <option value="reprodmed" > Reproductive Medicine (Reprod. Med.) </option> <option value="resources" > Resources </option> <option value="rheumato" > Rheumato </option> <option value="risks" > Risks </option> <option value="robotics" > Robotics </option> <option value="ruminants" > Ruminants </option> <option value="safety" > Safety </option> <option value="sci" > Sci </option> <option value="scipharm" > Scientia Pharmaceutica (Sci. Pharm.) </option> <option value="sclerosis" > Sclerosis </option> <option value="seeds" > Seeds </option> <option value="sensors" > Sensors </option> <option value="separations" > Separations </option> <option value="sexes" > Sexes </option> <option value="signals" > Signals </option> <option value="sinusitis" > Sinusitis </option> <option value="smartcities" > Smart Cities </option> <option value="socsci" > Social Sciences </option> <option value="siuj" > Société Internationale d’Urologie Journal (SIUJ) </option> <option value="societies" > Societies </option> <option value="software" > Software </option> <option value="soilsystems" > Soil Systems </option> <option value="solar" > Solar </option> <option value="solids" > Solids </option> <option value="spectroscj" > Spectroscopy Journal </option> <option value="sports" > Sports </option> <option value="standards" > Standards </option> <option value="stats" > Stats </option> <option value="stresses" > Stresses </option> <option value="surfaces" > Surfaces </option> <option value="surgeries" > Surgeries </option> <option value="std" > Surgical Techniques Development </option> <option value="sustainability" > Sustainability </option> <option value="suschem" > Sustainable Chemistry </option> <option value="symmetry" > Symmetry </option> <option value="synbio" > SynBio </option> <option value="systems" > Systems </option> <option value="targets" > Targets </option> <option value="taxonomy" > Taxonomy </option> <option value="technologies" > Technologies </option> <option value="telecom" > Telecom </option> <option value="textiles" > Textiles </option> <option value="thalassrep" > Thalassemia Reports </option> <option value="therapeutics" > Therapeutics </option> <option value="thermo" > Thermo </option> <option value="timespace" > Time and Space </option> <option value="tomography" > Tomography </option> <option value="tourismhosp" > Tourism and Hospitality </option> <option value="toxics" > Toxics </option> <option value="toxins" > Toxins </option> <option value="transplantology" > Transplantology </option> <option value="traumacare" > Trauma Care </option> <option value="higheredu" > Trends in Higher Education </option> <option value="tropicalmed" > Tropical Medicine and Infectious Disease (TropicalMed) </option> <option value="universe" > Universe </option> <option value="urbansci" > Urban Science </option> <option value="uro" > Uro </option> <option value="vaccines" > Vaccines </option> <option value="vehicles" > Vehicles </option> <option value="venereology" > Venereology </option> <option value="vetsci" > Veterinary Sciences </option> <option value="vibration" > Vibration </option> <option value="virtualworlds" > Virtual Worlds </option> <option value="viruses" > Viruses </option> <option value="vision" > Vision </option> <option value="waste" > Waste </option> <option value="water" > Water </option> <option value="wild" > Wild </option> <option value="wind" > Wind </option> <option value="women" > Women </option> <option value="world" > World </option> <option value="wevj" > World Electric Vehicle Journal (WEVJ) </option> <option value="youth" > Youth </option> <option value="zoonoticdis" > Zoonotic Diseases </option> </select> </div> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Article Type</div> </div> <select id="article_type" tabindex="4" name="article_type" class="chosen-select"> <option value="">All Article Types</option> <option value="research-article">Article</option> <option value="review-article">Review</option> <option value="rapid-communication">Communication</option> <option value="editorial">Editorial</option> <option value="abstract">Abstract</option> <option value="book-review">Book Review</option> <option value="brief-communication">Brief Communication</option> <option value="brief-report">Brief Report</option> <option value="case-report">Case Report</option> <option value="clinicopathological-challenge">Clinicopathological Challenge</option> <option value="article-commentary">Comment</option> <option value="commentary">Commentary</option> <option value="concept-paper">Concept Paper</option> <option value="conference-report">Conference Report</option> <option value="correction">Correction</option> <option value="creative">Creative</option> <option value="data-descriptor">Data Descriptor</option> <option value="discussion">Discussion</option> <option value="Entry">Entry</option> <option value="essay">Essay</option> <option value="expression-of-concern">Expression of Concern</option> <option value="extended-abstract">Extended Abstract</option> <option value="field-guide">Field Guide</option> <option value="guidelines">Guidelines</option> <option value="hypothesis">Hypothesis</option> <option value="interesting-image">Interesting Images</option> <option value="letter">Letter</option> <option value="books-received">New Book Received</option> <option value="obituary">Obituary</option> <option value="opinion">Opinion</option> <option value="perspective">Perspective</option> <option value="proceedings">Proceeding Paper</option> <option value="project-report">Project Report</option> <option value="protocol">Protocol</option> <option value="registered-report">Registered Report</option> <option value="reply">Reply</option> <option value="retraction">Retraction</option> <option value="note">Short Note</option> <option value="study-protocol">Study Protocol</option> <option value="systematic_review">Systematic Review</option> <option value="technical-note">Technical Note</option> <option value="tutorial">Tutorial</option> <option value="viewpoint">Viewpoint</option> </select> </div> <div class="large-1 medium-1 small-6 end columns small-push-6 medium-reset-order large-reset-order js-search-collapsed-button-container"> <div class="search-input-label"> </div> <input type="submit" id="search" value="Search" class="button button--dark button--full-width searchButton1 US_SearchButton" tabindex="12"> </div> <div class="large-1 medium-1 small-6 end columns large-text-left small-only-text-center small-pull-6 medium-reset-order large-reset-order js-search-collapsed-link-container"> <div class="search-input-label"> </div> <a class="main-search-clear search-container__link" href="#" onclick="openAdvanced(''); return false;">Advanced<span class="show-for-small-only"> Search</span></a> </div> </div> </div> <div class="search-container__advanced" style="margin-top: 0; padding-top: 0px; background-color: inherit; color: inherit;"> <div class="row"> <div class="large-2 medium-2 columns show-for-medium-up"> </div> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Section</div> </div> <select id="section" tabindex="5" name="section" class="chosen-select"> <option value=""></option> </select> </div> <div class="large-2 medium-2 small-6 columns "> <div class=""> <div class="search-input-label">Special Issue</div> </div> <select id="special_issue" tabindex="6" name="special_issue" class="chosen-select"> <option value=""></option> </select> </div> <div class="large-1 medium-1 small-6 end columns "> <div class="search-input-label">Volume</div> <input type="text" id="volume" tabindex="7" name="volume" placeholder="..." value="10" /> </div> <div class="large-1 medium-1 small-6 end columns "> <div class="search-input-label">Issue</div> <input type="text" id="issue" tabindex="8" name="issue" placeholder="..." value="2" /> </div> <div class="large-1 medium-1 small-6 end columns "> <div class="search-input-label">Number</div> <input type="text" id="number" tabindex="9" name="number" placeholder="..." value="" /> </div> <div class="large-1 medium-1 small-6 end columns "> <div class="search-input-label">Page</div> <input type="text" id="page" tabindex="10" name="page" placeholder="..." value="" /> </div> <div class="large-1 medium-1 small-6 columns small-push-6 medium-reset order large-reset-order medium-reset-order js-search-expanded-button-container"></div> <div class="large-1 medium-1 small-6 columns large-text-left small-only-text-center small-pull-6 medium-reset-order large-reset-order js-search-expanded-link-container"></div> </div> </div> </form> <form id="advanced-search" class="large-12 medium-12 columns"> <div class="search-container__advanced"> <div id="advanced-search-template" class="row advanced-search-row"> <div class="large-2 medium-2 small-12 columns show-for-medium-up"> </div> <div class="large-2 medium-2 small-3 columns connector-div"> <div class="search-input-label"><span class="show-for-medium-up">Logical Operator</span><span class="show-for-small">Operator</span></div> <select class="connector"> <option value="and">AND</option> <option value="or">OR</option> </select> </div> <div class="large-3 medium-3 small-6 columns search-text-div"> <div class="search-input-label">Search Text</div> <input type="text" class="search-text" placeholder="Search text"> </div> <div class="large-2 medium-2 small-6 large-offset-0 medium-offset-0 small-offset-3 columns search-field-div"> <div class="search-input-label">Search Type</div> <select class="search-field"> <option value="all">All fields</option> <option value="title">Title</option> <option value="abstract">Abstract</option> <option value="keywords">Keywords</option> <option value="authors">Authors</option> <option value="affiliations">Affiliations</option> <option value="doi">Doi</option> <option value="full_text">Full Text</option> <option value="references">References</option> </select> </div> <div class="large-1 medium-1 small-3 columns"> <div class="search-input-label"> </div> <div class="search-action-div"> <div class="search-plus"> <i class="material-icons">add_circle_outline</i> </div> </div> <div class="search-action-div"> <div class="search-minus"> <i class="material-icons">remove_circle_outline</i> </div> </div> </div> <div class="large-1 medium-1 small-6 large-offset-0 medium-offset-0 small-offset-3 end columns"> <div class="search-input-label"> </div> <input class="advanced-search-button button button--dark search-submit" type="submit" value="Search"> </div> <div class="large-1 medium-1 small-6 end columns show-for-medium-up"></div> </div> </div> </form> </div> <div class="header-divider"> </div> <div class="breadcrumb row full-row"> <div class="breadcrumb__element"> <a href="/about/journals">Journals</a> </div> <div class="breadcrumb__element"> <a href="/journal/medsci">Medical Sciences</a> </div> <div class="breadcrumb__element"> <a href="/2076-3271/10">Volume 10</a> </div> <div class="breadcrumb__element"> <a href="/2076-3271/10/2">Issue 2</a> </div> <div class="breadcrumb__element"> <a href="#">10.3390/medsci10020025</a> </div> </div> </header> <div id="main-content" class=""> <div class="row full-width row-fixed-left-column"> <div id="left-column" class="content__column large-3 medium-3 small-12 columns"> <div class="content__container"> <a href="/journal/medsci"> <img src="https://pub.mdpi-res.com/img/journals/medsci-logo.png?3568b168e67d2809" alt="medsci-logo" title="Medical Sciences" style="max-height: 60px; margin: 0 0 0 0;"> </a> <div class="generic-item no-border"> <a class="button button--color button--full-width js-journal-active-only-link js-journal-active-only-submit-link UC_ArticleSubmitButton" href="https://susy.mdpi.com/user/manuscripts/upload?form%5Bjournal_id%5D%3D81" data-disabledmessage="creating new submissions is not possible."> Submit to this Journal </a> <a class="button button--color button--full-width js-journal-active-only-link UC_ArticleReviewButton" href="https://susy.mdpi.com/volunteer/journals/review" data-disabledmessage="volunteering as journal reviewer is not possible."> Review for this Journal </a> <a class="button button--color-inversed button--color-journal button--full-width js-journal-active-only-link UC_ArticleEditIssueButton" href="/journalproposal/sendproposalspecialissue/medsci" data-path="/2076-3271/10/2/25" data-disabledmessage="proposing new special issue is not possible."> Propose a Special Issue </a> </div> <div class="generic-item link-article-menu show-for-small"> <a href="#" class="link-article-menu show-for-small"> <span class="closed">►</span> <span class="open" style="display: none;">▼</span> Article Menu </a> </div> <div class="hide-small-down-initially UI_ArticleMenu"> <div class="generic-item"> <h2>Article Menu</h2> </div> <ul class="accordion accordion__menu" data-accordion data-options="multi_expand:true;toggleable: true"> <li class="accordion-navigation"> <a href="#academic_editors" class="accordion__title">Academic Editors</a> <div id="academic_editors" class="content active"> <div class="academic-editor-container " title=""> <div class="sciprofiles-link" style="display: inline-block"> <div class="sciprofiles-link__link"> <img class="sciprofiles-link__image" src="https://pub.mdpi-res.com/bundles/mdpisciprofileslink/img/unknown-user.png?1732615622" style="width: auto; height: 16px; border-radius: 50%;"> <span class="sciprofiles-link__name" style="line-height: 36px;">Tracy Murray-Stewart</span> </div> </div> </div> <div class="academic-editor-container " title=""> <div class="sciprofiles-link" style="display: inline-block"> <div class="sciprofiles-link__link"> <img class="sciprofiles-link__image" src="https://pub.mdpi-res.com/bundles/mdpisciprofileslink/img/unknown-user.png?1732615622" style="width: auto; height: 16px; border-radius: 50%;"> <span class="sciprofiles-link__name" style="line-height: 36px;">Francesca Sanguedolce</span> </div> </div> </div> </div> </li> <li class="accordion-direct-link"> <a href="/2076-3271/10/2/25/scifeed_display" data-reveal-id="scifeed-modal" data-reveal-ajax="true">Subscribe SciFeed</a> </li> <li class="accordion-direct-link js-article-similarity-container" style="display: none"> <a href="#" class="js-similarity-related-articles">Recommended Articles</a> </li> <li class="accordion-navigation"> <a href="#related" class="accordion__title">Related Info Links</a> <div id="related" class="content UI_ArticleMenu_RelatedLinks"> <ul> <li class="li-link"> <a href="http://www.ncbi.nlm.nih.gov/sites/entrez/35645241" target="_blank" rel="noopener noreferrer">PubMed/Medline</a> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Mechanisms%20of%20Resistance%20to%20Second-Generation%20Antiandrogen%20Therapy%20for%20Prostate%20Cancer%3A%20Actual%20Knowledge%20and%20Perspectives" target="_blank" rel="noopener noreferrer">Google Scholar</a> </li> </ul> </div> </li> <li class="accordion-navigation"> <a href="#authors" class="accordion__title">More by Authors Links</a> <div id="authors" class="content UI_ArticleMenu_AuthorsLinks"> <ul class="side-menu-ul"> <li> <a class="expand" onclick='$(this).closest("li").next("div").toggle(); return false;'>on DOAJ</a> </li> <div id="AuthorDOAJExpand" style="display:none;"> <ul class="submenu"> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Francesco%20Pinto%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">Pinto, F.</a> <li> </li> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Francesco%20Dibitetto%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">Dibitetto, F.</a> <li> </li> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Mauro%20Ragonese%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">Ragonese, M.</a> <li> </li> <li class="li-link"> <a href='http://doaj.org/search/articles?source=%7B%22query%22%3A%7B%22query_string%22%3A%7B%22query%22%3A%22%5C%22Pierfrancesco%20Bassi%5C%22%22%2C%22default_operator%22%3A%22AND%22%2C%22default_field%22%3A%22bibjson.author.name%22%7D%7D%7D' target="_blank" rel="noopener noreferrer">Bassi, P.</a> <li> </li> </ul> </div> <li> <a class="expand" onclick='$(this).closest("li").next("div").toggle(); return false;'>on Google Scholar</a> </li> <div id="AuthorGoogleExpand" style="display:none;"> <ul class="submenu"> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Francesco%20Pinto" target="_blank" rel="noopener noreferrer">Pinto, F.</a> <li> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Francesco%20Dibitetto" target="_blank" rel="noopener noreferrer">Dibitetto, F.</a> <li> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Mauro%20Ragonese" target="_blank" rel="noopener noreferrer">Ragonese, M.</a> <li> </li> <li class="li-link"> <a href="https://scholar.google.com/scholar?q=Pierfrancesco%20Bassi" target="_blank" rel="noopener noreferrer">Bassi, P.</a> <li> </li> </ul> </div> <li> <a class="expand" onclick='$(this).closest("li").next("div").toggle(); return false;'>on PubMed</a> </li> <div id="AuthorPubMedExpand" style="display:none;"> <ul class="submenu"> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Francesco%20Pinto" target="_blank" rel="noopener noreferrer">Pinto, F.</a> <li> </li> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Francesco%20Dibitetto" target="_blank" rel="noopener noreferrer">Dibitetto, F.</a> <li> </li> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Mauro%20Ragonese" target="_blank" rel="noopener noreferrer">Ragonese, M.</a> <li> </li> <li class="li-link"> <a href="http://www.pubmed.gov/?cmd=Search&term=Pierfrancesco%20Bassi" target="_blank" rel="noopener noreferrer">Bassi, P.</a> <li> </li> </ul> </div> </ul> </div> </li> </ul> <span style="display:none" id="scifeed_hidden_flag"></span> <span style="display:none" id="scifeed_subscribe_url">/ajax/scifeed/subscribe</span> </div> </div> <div class="content__container responsive-moving-container large medium active hidden" data-id="article-counters"> <div id="counts-wrapper" class="row generic-item no-border" data-equalizer> <div id="js-counts-wrapper__views" class="small-12 hide columns count-div-container"> <a href="#metrics" > <div class="count-div" data-equalizer-watch> <span class="name">Article Views</span> <span class="count view-number"></span> </div> </a> </div> <div id="js-counts-wrapper__citations" class="small-12 columns hide count-div-container"> <a href="#metrics" > <div class="count-div" data-equalizer-watch> <span class="name">Citations</span> <span class="count citations-number Var_ArticleMaxCitations">-</span> </div> </a> </div> </div> </div> <div class="content__container"> <div class="hide-small-down-initially"> <ul class="accordion accordion__menu" data-accordion data-options="multi_expand:true;toggleable: true"> <li class="accordion-navigation"> <a href="#table_of_contents" class="accordion__title">Table of Contents</a> <div id="table_of_contents" class="content active"> <div class="menu-caption" id="html-quick-links-title"></div> </div> </li> </ul> </div> </div>  <div id="pbgrd-sky"></div> <script src="https://cdn.pbgrd.com/core-mdpi.js"></script> <style>.content__container { min-width: 300px; }</style>  </div> <div id="middle-column" class="content__column large-9 medium-9 small-12 columns end middle-bordered"> <div class="middle-column__help"> <div class="middle-column__help__fixed show-for-medium-up"> <span id="js-altmetrics-donut" href="#" target="_blank" rel="noopener noreferrer" style="display: none;"> <span data-badge-type='donut' class='altmetric-embed' data-doi='10.3390/medsci10020025'></span> <span>Altmetric</span> </span> <a href="#" class="UA_ShareButton" data-reveal-id="main-share-modal" title="Share"> <i class="material-icons">share</i> <span>Share</span> </a> <a href="#" data-reveal-id="main-help-modal" title="Help"> <i class="material-icons">announcement</i> <span>Help</span> </a> <a href="javascript:void(0);" data-reveal-id="cite-modal" data-counterslink = "https://www.mdpi.com/2076-3271/10/2/25/cite" > <i class="material-icons">format_quote</i> <span>Cite</span> </a> <a href="https://sciprofiles.com/discussion-groups/public/10.3390/medsci10020025?utm_source=mpdi.com&utm_medium=publication&utm_campaign=discuss_in_sciprofiles" target="_blank" rel="noopener noreferrer" title="Discuss in Sciprofiles"> <i class="material-icons">question_answer</i> <span>Discuss in SciProfiles</span> </a> <a href="#" class="" data-hypothesis-trigger-endorses-tab title="Endorse"> <i data-hypothesis-endorse-trigger class="material-icons" >thumb_up</i> <div data-hypothesis-endorsement-count data-hypothesis-trigger-endorses-tab class="hypothesis-count-container"> ... </div> <span>Endorse</span> </a> <a href="#" data-hypothesis-trigger class="js-hypothesis-open UI_ArticleAnnotationsButton" title="Comment"> <i class="material-icons">textsms</i> <div data-hypothesis-annotation-count class="hypothesis-count-container"> ... </div> <span>Comment</span> </a> </div> <div id="main-help-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="modalTitle" aria-hidden="true" role="dialog"> <div class="row"> <div class="small-12 columns"> <h2 style="margin: 0;">Need Help?</h2> </div> <div class="small-6 columns"> <h3>Support</h3> <p> Find support for a specific problem in the support section of our website. </p> <a target="_blank" href="/about/contactform" class="button button--color button--full-width"> Get Support </a> </div> <div class="small-6 columns"> <h3>Feedback</h3> <p> Please let us know what you think of our products and services. </p> <a target="_blank" href="/feedback/send" class="button button--color button--full-width"> Give Feedback </a> </div> <div class="small-6 columns end"> <h3>Information</h3> <p> Visit our dedicated information section to learn more about MDPI. </p> <a target="_blank" href="/authors" class="button button--color button--full-width"> Get Information </a> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> </div> <div class="middle-column__main "> <div class="page-highlight"> <style type="text/css"> img.review-status { width: 30px; } </style> <div id="jmolModal" class="reveal-modal" data-reveal aria-labelledby="Captcha" aria-hidden="true" role="dialog"> <h2>JSmol Viewer</h2> <div class="row"> <div class="small-12 columns text-center"> <iframe style="width: 520px; height: 520px;" frameborder="0" id="jsmol-content"></iframe> <div class="content"></div> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> <div itemscope itemtype="http://schema.org/ScholarlyArticle" id="abstract" class="abstract_div"> <div class="js-check-update-container"></div> <div class="html-content__container content__container content__container__combined-for-large__first" style="overflow: auto; position: inherit;"> <div class='html-profile-nav'> <div class='top-bar'> <div class='nav-sidebar-btn show-for-large-up' data-status='opened' > <i class='material-icons'>first_page</i> </div> <a id="js-button-download" class="button button--color-inversed" style="display: none;" href="/2076-3271/10/2/25/pdf?version=1651129746" data-name="Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives" data-journal="medsci"> <i class="material-icons custom-download"></i> Download PDF </a> <div class='nav-btn'> <i class='material-icons'>settings</i> </div> <a href="/2076-3271/10/2/25/reprints" id="js-button-reprints" class="button button--color-inversed"> Order Article Reprints </a> </div> <div class='html-article-menu'> <div class='html-first-step row'> <div class='html-font-family large-6 medium-6 small-12 columns'> <div class='row'> <div class='html-font-label large-4 medium-4 small-12 columns'> Font Type: </div> <div class='large-8 medium-8 small-12 columns'> <span class="html-article-menu-option"><i style='font-family:Arial, Arial, Helvetica, sans-serif;' data-fontfamily='Arial, Arial, Helvetica, sans-serif'>Arial</i></span> <span class="html-article-menu-option"><i style='font-family:Georgia1, Georgia, serif;' data-fontfamily='Georgia1, Georgia, serif'>Georgia</i></span> <span class="html-article-menu-option"><i style='font-family:Verdana, Verdana, Geneva, sans-serif;' data-fontfamily='Verdana, Verdana, Geneva, sans-serif' >Verdana</i></span> </div> </div> </div> <div class='html-font-resize large-6 medium-6 small-12 columns'> <div class='row'> <div class='html-font-label large-4 medium-4 small-12 columns'>Font Size:</div> <div class='large-8 medium-8 small-12 columns'> <span class="html-article-menu-option a1" data-percent="100">Aa</span> <span class="html-article-menu-option a2" data-percent="120">Aa</span> <span class="html-article-menu-option a3" data-percent="160">Aa</span> </div> </div> </div> </div> <div class='row'> <div class='html-line-space large-6 medium-6 small-12 columns'> <div class='row'> <div class='html-font-label large-4 medium-4 small-12 columns' >Line Spacing:</div> <div class='large-8 medium-8 small-12 columns'> <span class="html-article-menu-option a1" data-line-height="1.5em"> <i class="fa"></i> </span> <span class="html-article-menu-option a2" data-line-height="1.8em"> <i class="fa"></i> </span> <span class="html-article-menu-option a3" data-line-height="2.1em"> <i class="fa"></i> </span> </div> </div> </div> <div class='html-column-width large-6 medium-6 small-12 columns'> <div class='row'> <div class='html-font-label large-4 medium-4 small-12 columns' >Column Width:</div> <div class='large-8 medium-8 small-12 columns'> <span class="html-article-menu-option a1" data-column-width="20%"> <i class="fa"></i> </span> <span class="html-article-menu-option a2" data-column-width="10%"> <i class="fa"></i> </span> <span class="html-article-menu-option a3" data-column-width="0%"> <i class="fa"></i> </span> </div> </div> </div> </div> <div class='row'> <div class='html-font-bg large-6 medium-6 small-12 columns end'> <div class='row'> <div class='html-font-label large-4 medium-4 small-12 columns'>Background:</div> <div class='large-8 medium-8 small-12 columns'> <div class="html-article-menu-option html-nav-bg html-nav-bright" data-bg="bright"> <i class="fa fa-file-text"></i> </div> <div class="html-article-menu-option html-nav-bg html-nav-dark" data-bg="dark"> <i class="fa fa-file-text-o"></i> </div> <div class="html-article-menu-option html-nav-bg html-nav-creme" data-bg="creme"> <i class="fa fa-file-text"></i> </div> </div> </div> </div> </div> </div> </div> <article ><div class='html-article-content'> <span itemprop="publisher" content="Multidisciplinary Digital Publishing Institute"></span><span itemprop="url" content="https://www.mdpi.com/2076-3271/10/2/25"></span> <div class="article-icons"><span class="label openaccess" data-dropdown="drop-article-label-openaccess" aria-expanded="false">Open Access</span><span class="label articletype">Review</span></div> <h1 class="title hypothesis_container" itemprop="name"> Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives </h1> <div class="art-authors hypothesis_container"> by <span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop7594925' data-options='is_hover:true, hover_timeout:5000'> Francesco Pinto</div><div id="profile-card-drop7594925" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/bundles/mdpisciprofileslink/img/unknown-user.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">Francesco Pinto</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/2001841?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Francesco%20Pinto" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Francesco%20Pinto&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Francesco%20Pinto" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup> *</sup><span style="display: inline; margin-left: 5px;"></span><a class="toEncode emailCaptcha visibility-hidden" data-author-id="7594925" href="/cdn-cgi/l/email-protection#604f030e044d0307094f0c4f050d01090c4d10120f14050314090f0e4350505154565650575058505550535155505550595458515650065058515250595256515650595001500650555001500650585006505550595051505350025053500150015006545850065152"><sup><i class="fa fa-envelope-o"></i></sup></a>, </span><span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop7594926' data-options='is_hover:true, hover_timeout:5000'> Francesco Dibitetto</div><div id="profile-card-drop7594926" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/bundles/mdpisciprofileslink/img/unknown-user.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">Francesco Dibitetto</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/2034176?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Francesco%20Dibitetto" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Francesco%20Dibitetto&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Francesco%20Dibitetto" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup></sup><span style="display: inline; margin-left: 5px;"></span><a class="toEncode emailCaptcha visibility-hidden" data-author-id="7594926" href="/cdn-cgi/l/email-protection#705f131e145d1317195f1c5f151d11191c5d00021f04151304191f1e5340404144464640474048404540434145404540494042401640444016414240434142414240494246404140124047401640114448404540494012"><sup><i class="fa fa-envelope-o"></i></sup></a><a href="https://orcid.org/0000-0003-0922-5962" target="_blank" rel="noopener noreferrer"><img src="https://pub.mdpi-res.com/img/design/orcid.png?0465bc3812adeb52?1732615622" title="ORCID" style="position: relative; width: 13px; margin-left: 3px; max-width: 13px !important; height: auto; top: -5px;"></a>, </span><span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop7594927' data-options='is_hover:true, hover_timeout:5000'> Mauro Ragonese</div><div id="profile-card-drop7594927" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/bundles/mdpisciprofileslink/img/unknown-user.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">Mauro Ragonese</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/2034207?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Mauro%20Ragonese" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Mauro%20Ragonese&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Mauro%20Ragonese" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup></sup><span style="display: inline; margin-left: 5px;"></span><a class="toEncode emailCaptcha visibility-hidden" data-author-id="7594927" href="/cdn-cgi/l/email-protection#507f333e347d3337397f3c7f353d31393c7d20223f24353324393f3e7360606033663461686136606261366033603160626063606861356068623461646033606560626062646360646169"><sup><i class="fa fa-envelope-o"></i></sup></a><a href="https://orcid.org/0000-0002-1919-8729" target="_blank" rel="noopener noreferrer"><img src="https://pub.mdpi-res.com/img/design/orcid.png?0465bc3812adeb52?1732615622" title="ORCID" style="position: relative; width: 13px; margin-left: 3px; max-width: 13px !important; height: auto; top: -5px;"></a> and </span><span class="inlineblock "><div class='profile-card-drop' data-dropdown='profile-card-drop7594928' data-options='is_hover:true, hover_timeout:5000'> Pierfrancesco Bassi</div><div id="profile-card-drop7594928" data-dropdown-content class="f-dropdown content profile-card-content" aria-hidden="true" tabindex="-1"><div class="profile-card__title"><div class="sciprofiles-link" style="display: inline-block"><div class="sciprofiles-link__link"><img class="sciprofiles-link__image" src="/bundles/mdpisciprofileslink/img/unknown-user.png" style="width: auto; height: 16px; border-radius: 50%;"><span class="sciprofiles-link__name">Pierfrancesco Bassi</span></div></div></div><div class="profile-card__buttons" style="margin-bottom: 10px;"><a href="https://sciprofiles.com/profile/2034208?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name" class="button button--color-inversed" target="_blank"> SciProfiles </a><a href="https://scilit.net/scholars?q=Pierfrancesco%20Bassi" class="button button--color-inversed" target="_blank"> Scilit </a><a href="https://www.preprints.org/search?search1=Pierfrancesco%20Bassi&field1=authors" class="button button--color-inversed" target="_blank"> Preprints.org </a><a href="https://scholar.google.com/scholar?q=Pierfrancesco%20Bassi" class="button button--color-inversed" target="_blank" rels="noopener noreferrer"> Google Scholar </a></div></div><sup></sup><span style="display: inline; margin-left: 5px;"></span><a class="toEncode emailCaptcha visibility-hidden" data-author-id="7594928" href="/cdn-cgi/l/email-protection#4c632f2228612f2b2563206329212d2520613c3e2338292f382523226f7c7c7c7f7a7e7d7d7d7d7c2e7d7e7c787e7e7c797c2a7c7f7c2e7c29782f7c7d7c287c2a"><sup><i class="fa fa-envelope-o"></i></sup></a></span> </div> <div class="nrm"></div> <span style="display:block; height:6px;"></span> <div></div> <div style="margin: 5px 0 15px 0;" class="hypothesis_container"> <div class="art-affiliations"> <div class="affiliation "> <div class="affiliation-name ">Urology Department, Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Catholic University of the Sacred Heart, 00168 Rome, Italy</div> </div> <div class="affiliation"> <div class="affiliation-item"><sup>*</sup></div> <div class="affiliation-name ">Author to whom correspondence should be addressed. </div> </div> </div> </div> <div class="bib-identity" style="margin-bottom: 10px;"> <em>Med. Sci.</em> <b>2022</b>, <em>10</em>(2), 25; <a href="https://doi.org/10.3390/medsci10020025">https://doi.org/10.3390/medsci10020025</a> </div> <div class="pubhistory" style="font-weight: bold; padding-bottom: 10px;"> <span style="display: inline-block">Submission received: 4 January 2022</span> / <span style="display: inline-block">Revised: 6 April 2022</span> / <span style="display: inline-block">Accepted: 22 April 2022</span> / <span style="display: inline-block">Published: 28 April 2022</span> </div> <div class="belongsTo" style="margin-bottom: 10px;"> (This article belongs to the Section <a href="/journal/medsci/sections/cancer_cancerrelated_research">Cancer and Cancer-Related Research</a>)<br/> </div> <div class="highlight-box1"> <div class="download"> <a class="button button--color-inversed button--drop-down" data-dropdown="drop-download-804152" aria-controls="drop-supplementary-804152" aria-expanded="false"> Download <i class="material-icons">keyboard_arrow_down</i> </a> <div id="drop-download-804152" class="f-dropdown label__btn__dropdown label__btn__dropdown--button" data-dropdown-content aria-hidden="true" tabindex="-1"> <a class="UD_ArticlePDF" href="/2076-3271/10/2/25/pdf?version=1651129746" data-name="Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives" data-journal="medsci">Download PDF</a> <br/> <a id="js-pdf-with-cover-access-captcha" href="#" data-target="/2076-3271/10/2/25/pdf-with-cover" class="accessCaptcha">Download PDF with Cover</a> <br/> <a id="js-xml-access-captcha" href="#" data-target="/2076-3271/10/2/25/xml" class="accessCaptcha">Download XML</a> <br/> <a href="/2076-3271/10/2/25/epub" id="epub_link">Download Epub</a> <br/> </div> <a class="button button--color-inversed" href="/2076-3271/10/2/25/review_report">Review Reports</a> <a class="button button--color-inversed" href="/2076-3271/10/2/25/notes">Versions Notes</a> </div> </div> <div class="responsive-moving-container small hidden" data-id="article-counters" style="margin-top: 15px;"></div> <div class="html-dynamic"> <section> <div class="art-abstract art-abstract-new in-tab hypothesis_container"> <p> <div><section class="html-abstract" id="html-abstract"> <h2 id="html-abstract-title">Abstract</h2><b>:</b> <div class="html-p">Prostate cancer therapy for locally advanced and metastatic diseases includes androgen deprivation therapy (ADT). Second-generation antiandrogens have a role in castration-resistant prostate cancer. Nevertheless, some patients do not respond to this therapy, and eventually all the patients became resistant. This is due to modifications to intracellular signaling pathways, genomic alteration, cytokines production, metabolic switches, constitutional receptor activation, overexpression of some proteins, and regulation of gene expression. The aim of this review is to define the most important mechanisms that drive this resistance and the newest discoveries in this field, specifically for enzalutamide and abiraterone, with potential implications for future therapeutic targets. Furthermore, apalutamide and darolutamide share some resistance mechanisms with abiraterone and enzalutamide and could be useful in some resistance settings.</div> </section> <div id="html-keywords"> <div class="html-gwd-group"><div id="html-keywords-title">Keywords: </div><a href="/search?q=prostatecancer">prostatecancer</a>; <a href="/search?q=abiraterone">abiraterone</a>; <a href="/search?q=enzalutamide">enzalutamide</a>; <a href="/search?q=apalutamide">apalutamide</a>; <a href="/search?q=darolutamide">darolutamide</a>; <a href="/search?q=castrationresistance">castrationresistance</a>; <a href="/search?q=CRPC">CRPC</a></div> <div> </div> </div> </div> </p> </div> </section> </div> <div class="hypothesis_container"> <ul class="menu html-nav" data-prev-node="#html-quick-links-title"> </ul> <div class="html-body"> <section id='sec1-medsci-10-00025' type='intro'><h2 data-nested='1'> 1. Introduction</h2><div class='html-p'>Prostate cancer is the second most common neoplasm in men with about 1.1 million new diagnoses worldwide in 2012 and the fifth most lethal [<a href="#B1-medsci-10-00025" class="html-bibr">1</a>]. Therapeutic strategies for localized disease include active surveillance, radical prostatectomy, or radiotherapy. Androgen deprivation therapy (ADT) has a role in locally advanced and metastatic disease. Despite an initial therapeutic efficiency of 80–90% [<a href="#B2-medsci-10-00025" class="html-bibr">2</a>], several patients treated with ADT will develop castration-resistant prostate cancer [<a href="#B3-medsci-10-00025" class="html-bibr">3</a>], defined as castrate serum testosterone < 50 ng/dL or 1.7 nmol/L with either biochemical progression (three consecutive rises in PSA at least one week apart, resulting in two 50% increases over the nadir, and a PSA > 2 ng/mL) or radiological progression (either two or more new bone lesions on bone scan or a soft tissue lesion) [<a href="#B4-medsci-10-00025" class="html-bibr">4</a>].</div><div class='html-p'>In recent literature, androgen receptor (AR) amplifications, mutations, expression of splice variants independent from the ligand, intratumoral androgen production, and other biochemical and biological mechanisms represent the principal mechanism of action in primary ADT resistance [<a href="#B5-medsci-10-00025" class="html-bibr">5</a>]. These mechanisms led to new compounds with different mechanisms of action that overcome these types of resistances, such as abiraterone acetate, enzalutamide, apalutamide, and darolutamide, the second-generation antiandrogens [<a href="#B6-medsci-10-00025" class="html-bibr">6</a>]. To date, second-generation antiandrogens are approved for treatment of nonmetastatic castration-resistant prostate cancer (CRPC) and metastatic CRPC (only abiraterone and enzalutamide) [<a href="#B7-medsci-10-00025" class="html-bibr">7</a>,<a href="#B8-medsci-10-00025" class="html-bibr">8</a>]. However, about 20–40% of CRPC patients have no response to abiraterone and enzalutamide [<a href="#B9-medsci-10-00025" class="html-bibr">9</a>,<a href="#B10-medsci-10-00025" class="html-bibr">10</a>] and even if the patient showed an initial response to enzalutamide or abiraterone, the rates of patients acquiring secondary resistance are high [<a href="#B11-medsci-10-00025" class="html-bibr">11</a>]. Many mechanisms have been identified to explain acquired and naïve resistance to these agents.</div><div class='html-p'>Herein, we propose a literature review on mechanisms of resistance to second-generation antiandrogen therapy for prostate cancer and new biochemical knots for applying new therapeutic strategies.</div></section><section id='sec2-medsci-10-00025' type=''><h2 data-nested='1'> 2. Abiraterone</h2><div class='html-p'>Abiraterone is an orally administered small molecule that irreversibly inhibits the products of the cytochrome P450 family 17 (CYP17) gene (including both 17,20 lyase and 17-alpha-hydroxylase). It blocks the synthesis of androgens in the tumor as well as in the testes and adrenal glands. Altered steroidogenesis was discussed as one mechanism by which CRPC develops. Adrenal androgen levels are not affected by ADT. Dehydroepiandrosterone (DHEA) and its sulfated form (DHEA-S) are converted to dihydrotestosterone (DHT) via a backdoor pathway [<a href="#B12-medsci-10-00025" class="html-bibr">12</a>].</div><div class='html-p'>The molecules are converted to androstenedione (AD) either in the prostate or adrenal gland by 3β-hydroxysteroid dehydrogenase (3βHSD), encoded by HSD3B. There are two isoforms, 3βHSD1 in the prostate and peripheral tissues, and 3βHSD2 in the adrenal gland. The conversion from AD to DHT, in the absence of ADT, goes through testosterone as an intermediary and requires 17βHSD3, AKR1C3 and steroid-5α-reductase. However, in the presence of ADT, this sequence can be reversed, leading to 5α-AD (5α-androstenedione) that acts as an intermediary agent, bypassing testosterone completely. This alternative pathway, known as the “5α-dione” pathway, has been demonstrated to predominate in CRPC. So, abiraterone-naive CRPC cells use the 5α-dione pathway to produce intra-tumoral DHT but are still dependent on adrenal androgens. By irreversibly inhibiting this critical upstream enzyme in the steroidogenesis pathway, abiraterone effectively causes a significant decrease in intratumoral androgen levels by preventing production of adrenal androgens. However, despite its effectiveness in inhibiting the steroidogenesis pathway, abiraterone’s effect is incomplete. Overexpression or mutations of CYP17A1 may also contribute to abiraterone resistance. HSD3B1 (1245C) mutation contributing to progression to CRPC has also been found in abiraterone-resistant xenograft models [<a href="#B13-medsci-10-00025" class="html-bibr">13</a>]. Mostaghel et al. demonstrated that in abiraterone-treated prostate cancer cells there is overexpression of the isoform CYP17A1, as well as other enzymes involved in steroidogenesis, such as AKR1C3 and HSD17B3 [<a href="#B14-medsci-10-00025" class="html-bibr">14</a>]. AKR1C3 facilitates the conversion of androstenedione and 5 α-androstenedione (5 α-dione) that are weak androgens to the more effective testosterone and DHT. It is not only enzyme mutations that can lead to abiraterone resistance. Another important role in resistance to abiraterone in prostate cancer cells is played by androgen accumulation, such as pregnenolone and progesterone. The progesterone receptor (PR) has been found overexpressed in mCRPC [<a href="#B15-medsci-10-00025" class="html-bibr">15</a>]. In addition, PR high density is an independent poor prognostic factor [<a href="#B16-medsci-10-00025" class="html-bibr">16</a>]. The PR and AR have 88% sequence homology in the ligand-binding domain and share common response elements. Therefore, the accumulation of progesterone could lead to transcription of androgen-dependent genes. A novel therapeutic target could be the inhibition of PR caused by onapristone, a progesterone receptor antagonist that is currently under evaluation in CPRC that has progressed after abiraterone, enzalutamide, or two lines of chemotherapy: preliminary data has shown this is safe and feasible [<a href="#B17-medsci-10-00025" class="html-bibr">17</a>].</div><div class='html-p'>When CYP17A1 is inhibited, 3βHSD is the main enzyme involved in steroid synthesis. It is responsible for synthesis of progesterone from pregnenolone, androstenedione from DHEA, and testosterone from androstenediol. The androgen receptor isoform encoded by splice variant 7 lacks the ligand-binding domain, which is the target of enzalutamide and abiraterone. This mutation leads to constitutive activation of the receptor as a transcription factor. Antonarakis et al. hypothesized that ARV-7 detection in circulating tumor cells from patients with CRPC may be associated with resistance to enzalutamide and abiraterone [<a href="#B18-medsci-10-00025" class="html-bibr">18</a>]. ErbB2 also has been proposed as an actor in resistance to abiraterone in CRPC. Studies in cell line and xenograft models have indicated that increased ErbB2 signaling can contribute to the restoration of AR activity and tumor growth in CRPC [<a href="#B19-medsci-10-00025" class="html-bibr">19</a>,<a href="#B20-medsci-10-00025" class="html-bibr">20</a>,<a href="#B21-medsci-10-00025" class="html-bibr">21</a>]. The physiologic significance of ErbB2 in CRPC is supported by studies showing increased ErbB2 expression or activity in CRPC clinical samples, although this is not a consistent finding, and increased ErbB2 has also been associated with more aggressive primary untreated prostate cancer. However, clinical trials of ErbB2-targeted therapies have not shown efficacy in prostate cancer patients prior to androgen deprivation therapy or in CRPC. Gao et al. showed that ErbB2 signaling was elevated in residual tumors following abiraterone treatment in a subset of patients and was associated with higher nuclear AR expression. ErbB2 and subsequent activation of the PI3K/AKT signaling stabilizes AR protein. Furthermore, concomitantly treating CRPC cells with the abiraterone and ErbB2 inhibitor, lapatinib, blocked AR reactivation and suppressed tumor progression [<a href="#B22-medsci-10-00025" class="html-bibr">22</a>]. Annala et al. randomized 202 patients with treatment-naïve mCRPC to abiraterone or enzalutamide and performed whole-exome and deep-targeted gene sequencing of plasma cell-free DNA prior to therapy. They found genomic alterations that were strongly correlated with rapid resistance to abiraterone or enzalutamide therapy, such as somatic arrangements in TP53 or defects in BRCA2 and ATM. AR gene structural rearrangements truncating the ligand-binding domain were identified in patients with primary resistance [<a href="#B23-medsci-10-00025" class="html-bibr">23</a>].</div><div class='html-p'>Mechanisms of resistance to abiraterone are summarized in <a href="#medsci-10-00025-t001" class="html-table">Table 1</a>.</div></section><section id='sec3-medsci-10-00025' type=''><h2 data-nested='1'> 3. Enzalutamide</h2><div class='html-p'>Enzalutamide is an androgen receptor signaling inhibitor without agonistic activity. It suppresses the nuclear translocation of active androgen receptors to prevent recruitment of androgen response elements. This leads to cellular apoptosis and inhibition of CRPC cell proliferation. Despite his efficacy, eventually all of the enzalutamide-treated patients became resistant. This could be related to different mechanisms. One of these is the androgen receptor reactivation. Yuan et al. observed that AR is highly expressed and transcriptionally active in CRPC despite enzalutamide treatment [<a href="#B24-medsci-10-00025" class="html-bibr">24</a>]. AR-persistent activation could be secondary to somatic mutations, such as the amplification of an acquired androgen receptor enhancer located at 650-kb centromere to the AR [<a href="#B19-medsci-10-00025" class="html-bibr">19</a>]. Another study [<a href="#B25-medsci-10-00025" class="html-bibr">25</a>] found that galectin-3, a member of the animal lectin family, significantly inhibited the therapeutic effect of enzalutamide by increasing the expression of several androgen receptor target genes, such as kallikrein-related peptidase 3 (KLK3) and transmembrane protease serine 2 (TMPRSS2). Such enhancement of androgen receptor transcriptional activity and expression of androgen receptor-related genes can contribute to enzalutamide resistance. Androgen hormone potentiation could also participate. Liu et al. demonstrated that AKR1C3, a critical enzyme in the biological pathways that lead to the production of testosterone and DHT from weak androgens (androstenedione and 5 α-androstenedione), is upregulated in enzalutamide-resistance prostate cancer cells and that indomethacin, an inhibitor of AKR1C3 activity, could overcome this resistance, reducing cell proliferation [<a href="#B26-medsci-10-00025" class="html-bibr">26</a>]. Another mechanism is the inhibition of AR-protein degradation by preventing E3 ligase-mediated ubiquitination. This is due to the binding of the AR by a polycomb group protein, B lymphoma Moloney murine leukemia virus insertion region 1 (BMI1). In an enzalutamide-resistant xenograft model, it was found that the BMI1 inhibitor significantly decreased the development of enzalutamide-resistant CRPC [<a href="#B27-medsci-10-00025" class="html-bibr">27</a>]. Another cellular pathway involved in AR activation is c-Myc. One study showed induction of c-Myc’s expression by erythropoietin-producing human hepatocellular (Eph) receptors, which is a key factor for enzalutamide resistance [<a href="#B28-medsci-10-00025" class="html-bibr">28</a>].</div><div class='html-p'>Enzalutamide resistance can also be achieved by AR splice variants, as discussed for abiraterone. Antonarakis et al. demonstrated a significant overexpression of AR–V7 in enzalutamide-treated patients. TK activated cdc42-associated kinase 1 (ACK1) (TNK2) could work in an epigenetic circuit, contributing to the overexpression of AR-V7 and leading to enzalutamide resistance [<a href="#B29-medsci-10-00025" class="html-bibr">29</a>]. Another possible target in AR-V7 amplification could be the vasopressin1A (V1A) receptor (AVPR1A) [<a href="#B30-medsci-10-00025" class="html-bibr">30</a>]. AR-V7 overexpression could also be related to ubiquitin E3 ligase proteasome degradation: the interaction between heat shock protein family member HSP70 and functional E3 ubiquitin ligase STIP1 homology and U-box containing protein 1 (STUB1) was required for androgen receptor variant 7 proteostasis. Suppression of HSP70 inhibited tumor growth and enzalutamide resistance by decreasing AR-V7 levels [<a href="#B31-medsci-10-00025" class="html-bibr">31</a>]. Inhibition of ubiquitination is also achieved by activation of anti-apoptotic B cell lymphoma-2 (BCL2) protein [<a href="#B32-medsci-10-00025" class="html-bibr">32</a>].</div><div class='html-p'>CRPC patients could be resistant to enzalutamide because of androgen receptor mutations. The most frequent mutation site is the carboxy-terminal ligand-binding domain [<a href="#B33-medsci-10-00025" class="html-bibr">33</a>]. For instance, the androgen receptor F876L mutation was previously found to convert the androgen receptor antagonist enzalutamide to an androgen receptor agonist [<a href="#B34-medsci-10-00025" class="html-bibr">34</a>]. The double mutation F877L/T878A converts enzalutamide into a fully functional agonist. This obstacle can be overcome by another androgen receptor inhibitor, darolutamide, which works against AR-mutated variants [<a href="#B35-medsci-10-00025" class="html-bibr">35</a>].</div><div class='html-p'>Glucocorticoid and androgen receptors have overlapped intracellular pathways, and this is the reason why AR inhibitors such as enzalutamide, via a negative feedback mechanism, prevent inhibition of glucocorticoid receptors. This leads to a re-expression of approximately 50% of the androgen receptor-responsive genes. Therefore, glucocorticoid receptor (GR) agonist dexamethasone can determine enzalutamide resistance and the GR antagonist can restore enzalutamide sensitivity [<a href="#B36-medsci-10-00025" class="html-bibr">36</a>]. The challenge in exploring therapeutic strategies related to this aspect is that complete blocking of GR is incompatible with life.</div><div class='html-p'>Another cellular pathway involved in enzalutamide resistance in CRPC is the Wnt signaling. The Wnt family consists of 19 cysteines and secreted lipo-glycoproteins that regulate stem cell self-renewal, proliferation, migration, and differentiation during organ development. Wnt can bind to different proteins to activate different signaling pathways, but the most studied is the Wnt/β-Catenin affecting cell proliferation, differentiation and transition from epithelial-to-mesenchymal in prostate cancer. In enzalutamide-resistant CRPC cells, there is an upregulation of stem-like genes upon the activation of the Wnt/β-Catenin pathway that reactivates androgen receptor signaling [<a href="#B37-medsci-10-00025" class="html-bibr">37</a>]. Another Wnt-activated pathway involves the Ca<sup>2+</sup>/Calmodulin-dependent kinase type 2 [<a href="#B38-medsci-10-00025" class="html-bibr">38</a>]. Wnt mutations are present in 10–20% of advanced prostate cancer, and these mutations could affect the response to enzalutamide therapy. A recent study found a poor response to abiraterone or enzalutamide in metastatic CRPC with WNT pathway mutations [<a href="#B39-medsci-10-00025" class="html-bibr">39</a>].</div><div class='html-p'>Even metabolic changes can participate in CRPC’s resistance to enzalutamide. In neoplastic cells there is a shift towards aerobic glycolysis (Warburg effect), and particularly in CRPC cells, there is an upregulation of glucose transporters (GLUT). GLUT1 expression is associated with a poor prognosis [<a href="#B40-medsci-10-00025" class="html-bibr">40</a>]. The GLUT1 gene promoter directly binds to AR, promoting GLUT1 transcription. While the Warburg effect is common in all cancer cells, one unique feature of prostate cancer cells is the hyperactivation of the citric acid cycle. In particular, during the evolution and progression of CRPC, there is a constant increment of malate dehydrogenase-2 (MDH2). Latonen et al. showed that the knockdown of MDH2 can decrease cell proliferation and improve drug sensitivity [<a href="#B41-medsci-10-00025" class="html-bibr">41</a>].</div><div class='html-p'>Another metabolic pathway that is related to enzalutamide resistance is autophagy through hyperactivation of the mammalian target of rapamycin (mTOR). mTOR is inhibited when, in absence of nutrients or growth factors or under hypoxia, autophagy is activated. Autophagy contributes to enzalutamide resistance by activation of AMPK and inhibition of the mTOR pathway [<a href="#B42-medsci-10-00025" class="html-bibr">42</a>].</div><div class='html-p'>As discussed for abiraterone, also for enzalutamide resistance there is a role played by the inhibition of apoptosis, especially by BCL2 proteins [<a href="#B43-medsci-10-00025" class="html-bibr">43</a>] and inhibitors of apoptosis (IAP) family [<a href="#B44-medsci-10-00025" class="html-bibr">44</a>]. In particular, IAP family member BIRC6 is upregulated in enzalutamide resistance [<a href="#B45-medsci-10-00025" class="html-bibr">45</a>]. A novel therapeutic target could be a combination between enzalutamide and IAP inhibitors [<a href="#B46-medsci-10-00025" class="html-bibr">46</a>].</div><div class='html-p'>Another mechanism that drives enzalutamide resistance in CRPC is cell lineage plasticity and phenotypic switch. As said before for the Wnt/β-Catenin complex, the epithelial-to-mesenchymal transition is significantly enhanced by enzalutamide treatment [<a href="#B47-medsci-10-00025" class="html-bibr">47</a>], and one of the most important drivers in this transition is TGF-β [<a href="#B48-medsci-10-00025" class="html-bibr">48</a>]. In particular, Pal et al. demonstrated that TGF-β pathway regulators, SMAD family member 3 (SMAD 3) and cyclin D1, participate in enzalutamide resistance [<a href="#B49-medsci-10-00025" class="html-bibr">49</a>]. It has been demonstrated by Svensson et al. that treatment with enzalutamide may reduce the expression of the repressor element 1 silencing transcription factor (REST), a mediator of AR action on gene repression that may be responsible for neuroendocrine differentiation [<a href="#B50-medsci-10-00025" class="html-bibr">50</a>]. Thus, in comparison to a single enzalutamide treatment, adding the TGF-β receptor I kinase inhibitor galunisertib (LY2157299) could enhance the efficacy of enzalutamide in inhibiting castration-resistant prostate cancer xenograft tumor growth and metastasis [<a href="#B51-medsci-10-00025" class="html-bibr">51</a>].</div><div class='html-p'>Prostate cancer cells express autocrine IL-6, which activates the JAK/STAT3 pathway. IL-6/STAT3 is associated with enzalutamide-resistant CRPC [<a href="#B52-medsci-10-00025" class="html-bibr">52</a>]. Other cytokines involved in CRPC progression are IL-23 and C–X–C motif chemokine ligand 12 (CXCL12). CXCL12 and its ligand, CXCR4, are overexpressed in prostate cancer cells. The intracellular CXCL12γ isoform has been found to be expressed in circulating tumor cells of mCRPC and prostate cancer cells with neuroendocrine phenotype; its overexpression could lead to the activation of intracellular pathways associated with cancer progression and drug resistance [<a href="#B53-medsci-10-00025" class="html-bibr">53</a>].</div><div class='html-p'>Regulation of all these endogenous processes is achieved via different mechanisms. One of them involves microRNAs (miRNAs). miRNAs are short (19–25 nucleotides) endogenous RNA molecules that regulate gene expression after transcription. In CRPC, there are several miRNAs controlling some of the pathways that lead to enzalutamide resistance and cancer progression, such as miR-346, miR-361–3p, and miR-197, that augment androgen receptor activity [<a href="#B54-medsci-10-00025" class="html-bibr">54</a>]. miRNA-194 could drive the transdifferentiation of prostate cancer cells into neuroendocrine-like cells by targeting FOXA1 [<a href="#B55-medsci-10-00025" class="html-bibr">55</a>]. Some other miRNAs can sensitize response to enzalutamide in CRPC and suppress pathologic biochemical pathways: miR-644a, for example, contributes to the blocking of the the epithelial-to-mesenchymal transition and suppresses the Warburg effect, therefore possibly becoming an auxiliary agent in the treatment of enzalutamide resistance [<a href="#B56-medsci-10-00025" class="html-bibr">56</a>].</div><div class='html-p'>Other pathways associated with enzalutamide resistance include the NOTCH signaling pathway, independent from AR [<a href="#B57-medsci-10-00025" class="html-bibr">57</a>], and the cholesterol synthesis pathway involving 3-hydroxy3-methylglutaryl-CoA reductase (HMGCR), an enzyme found to be upregulated in enzalutamide-resistant CRPC [<a href="#B58-medsci-10-00025" class="html-bibr">58</a>]. Khort at. al identified three candidate genes, acetyl-CoA acetyltransferase 1, mixed-lineage kinase 3 (MLK3), and proteasome 26S subunit, non-ATPase 12 (PSMD12), validated as supporters of enzalutamide resistance in vitro, although in vivo behavior needs to be verified [<a href="#B59-medsci-10-00025" class="html-bibr">59</a>].</div><div class='html-p'>Mechanisms of resistance to enzalutamide are summarized in <a href="#medsci-10-00025-t002" class="html-table">Table 2</a>.</div></section><section id='sec4-medsci-10-00025' type=''><h2 data-nested='1'> 4. Darolutamide and Apalutamide</h2><div class='html-p'>Darolutamide is a novel AR antagonist that has the capacity of binding both wild-type and mutated AR, trying to overcome enzalutamide resistance. Moreover, compared to apalutamide and enzalutamide, it has a low penetration of the brain blood barrier and a low binding affinity for the gamma-aminobutyric acid (GABA) type A receptor. Borgman et al. evaluated the efficacy of darolutamide in inhibiting cell growth and tumor progression in enzalutamide-resistant CRPC and in mutated AR patients previously treated with abiraterone, enzalutamide, or bicalutamide. Darolutamide significantly inhibited cell growth and AR transcription activity in vitro while decreased tumor volume and serum prostate-specific antigen levels in vivo. In addition, it had a significative inhibition of transcriptional activity of AR-mutated variants, such as F877L, F877L/T878A and T878G, that, as said before, transform enzalutamide into an agonist (Borgmann et al.). </div><div class='html-p'>Apalutamide is a new nonsteroidal AR antagonist that binds directly to the ligand-binding domain of the AR and prevents its translocation and its related transcriptional pathway. Apalutamide has demonstrated an improvement in overall survival (OS) compared to placebo in nonmetastatic CRPC and a longer metastasis-free survival [<a href="#B60-medsci-10-00025" class="html-bibr">60</a>].</div><div class='html-p'>Currently, there are not many studies that evaluate darolutamide’s and apalutamide’s unique resistance mechanisms. It has been demonstrated that there is a cross-resistance mechanism between darolutamide, apalutamide, enzalutamide, and abiraterone.</div></section><section id='sec5-medsci-10-00025' type=''><h2 data-nested='1'> 5. Cross-Resistance</h2><div class='html-p'>It is interesting to highlight that those patients who receive abiraterone or enzalutamide as the first line of therapy have a 15–30% response rate to the alternative agents as second-line CRPC treatment. This underlines that there clearly exists a cross-resistance between enzalutamide and abiraterone. Resistance to second-line therapy takes about 3–6 months to develop, significantly shortening the duration of benefits from this treatment by at least 50% compared with that of the first-line [<a href="#B61-medsci-10-00025" class="html-bibr">61</a>].</div><div class='html-p'>As suggested before, some biological mechanisms of resistance to these drugs overlap. Upregulation of CYP17 occurs both in resistance to enzalutamide and abiraterone. A second mechanism that leads to cross-resistance is the upregulation of the AR, due to the amplification of the gene or the overexpression of the protein. Another mechanism common to the two drugs is the emergence of AR splice variants (for example ARV-7), in which abnormal splicing of the AR messenger RNA (mRNA) leads to the formation of a truncated AR protein that is constitutively active without the necessity of a ligand [<a href="#B62-medsci-10-00025" class="html-bibr">62</a>].</div><div class='html-p'>What is interesting is that cross-resistance can also involve darolutamide and apalutamide, in addition to enzalutamide and abiraterone. Zhao et al. demonstrated that enzalutamide- and abiraterone-resistant prostate cancer cells are also resistant to apalutamide and darolutamide. In particular, the presence of ARV-7 conferred resistance to enzalutamide and apalutamide [<a href="#B63-medsci-10-00025" class="html-bibr">63</a>].</div><div class='html-p'>Moreover, the emergence of resistance to antiandrogens such as enzalutamide determine the potential for accelerating metastatic disease, as Simon et al. discovered. This implies that the treatment must not be interrupted, even when drug resistance has been achieved [<a href="#B64-medsci-10-00025" class="html-bibr">64</a>].</div></section><section id='sec6-medsci-10-00025' type=''><h2 data-nested='1'> 6. Future Perspectives</h2><div class='html-p'>New therapeutic approaches are being studied for CRPC. One randomized trial evaluated the efficacy of Olaparib, a poly(adenosine diphosphate–ribose) polymerase (PARP) inhibitor in mCRPC patients who had a disease progression while receiving a new generation antiandrogen (i.e., enzalutamide or abiraterone). All these patients had alterations in predetermined genes related to homologous combination repair of DNA and were divided into two cohorts, based on the mutations found on tumor tissue: cohort A had at least one alteration in BRCA1, BRCA2 or ATM, cohort B had alterations on 12 other prespecified genes. Patients in cohort A treated with Olaparib had a significantly longer overall survival (18.5 vs. 15.1 months) compared to the control group (that received enzalutamide or abiraterone/prednisone). A significant benefit for Olaparib for imaging-based progression-free survival was seen in the overall population [<a href="#B65-medsci-10-00025" class="html-bibr">65</a>].</div><div class='html-p'>AKR1C3 could also be a potential therapeutic target for CRPC: Endo et al. found a potent novel AKR1C3 inhibitor, N-(4-fluorophenyl)-8-hydroxy-2-imino-2H-chromene-3-carboxamide, that had the capacity of suppressing the proliferation of prostate cancer cells and augmenting apoptotic cell death induced by enzalutamide and abiraterone [<a href="#B66-medsci-10-00025" class="html-bibr">66</a>]. </div><div class='html-p'>The point mutation of androgen receptor AR<sup>F876L</sup> is stimulated instead of inhibited by enzalutamide. Wu et al. found a novel antagonist of the androgen receptor, JJ-450, capable of inhibiting both wild type AR and mutated one AR<sup>F876L</sup> [<a href="#B67-medsci-10-00025" class="html-bibr">67</a>], but in vivo studies are necessary to understand the potential of this molecule in the therapeutic approach to CRPC. The most important AR mutation, the ARV-7 splice variant, could be targeted by the N-terminal domain antagonists EPI-002 (Ralaniten) and EPI-7170 (that has 8–9 times improved potency that ralaniten). A combination of EPI-7170 and enzalutamide resulted in the inhibition of the proliferation of enzalutamide-resistant prostate cancer cells in vitro with a synergistic action. Moreover, this drug enhanced the effect of enzalutamide in enzalutamide-resistant CRPC preclinical models [<a href="#B68-medsci-10-00025" class="html-bibr">68</a>,<a href="#B69-medsci-10-00025" class="html-bibr">69</a>].</div><div class='html-p'>Targeting the c-Myc pathway via the inhibition of 5-lipoxygenase (5Lox) kills the enzalutamide-resistant prostate cancer cells in vitro while not affecting normal cells in the same experimental conditions [<a href="#B70-medsci-10-00025" class="html-bibr">70</a>].</div><div class='html-p'>Other potential targets under investigation are STAT5 and carnitine palmitoyltransferase 1B (CPT1B) [<a href="#B71-medsci-10-00025" class="html-bibr">71</a>,<a href="#B72-medsci-10-00025" class="html-bibr">72</a>].</div></section><section id='sec7-medsci-10-00025' type='conclusions'><h2 data-nested='1'> 7. Conclusions </h2><div class='html-p'>Second generation antiandrogens are newer therapeutic weapons against CRPC. They offer benefits in terms of a longer OS and metastasis-free survival, but eventually all patients become resistant. Understanding the mechanisms behind acquired and naive resistance is important in order to define adjuvant therapies or new therapeutic targets that could extend the time before the appearance of resistance and the overall survival for these patients. There are many important biochemical pathways that prostate cancer cells could modulate in order to achieve resistance to second generation antiandrogens. This modulation is due to different mechanisms: upregulation, overexpression, mutations, metabolic switches, and many more. Not all these patterns are activated in one single CRPC cell and in one single patient, and this makes the therapeutic approach very hard; what can act in one patient could not work in another. This perspective makes it necessary, in our opinion, to find new compounds that can act on different biochemical knots in order to tailor patient care.</div><div class='html-p'>The understanding of these new mechanism could lead to a new way of labeling castration-resistant prostate cancer: in the future, it is likely there will be different “phenotypes” in prostate cancer resistant to second-generation antiandrogens defined by the biochemical pathways activated to escape from ADT, and each phenotype could be treated by using different drugs alone or in combination with ADT. Further studies are needed to find out new compounds and evaluate their efficacy in vitro and especially in vivo.</div></section> </div> <div class="html-back"> <section class='html-notes'><h2 >Author Contributions</h2><div class='html-p'>F.D. and M.R. contributed to conception and design of this paper and have been involved in drafting the manuscript. F.P. and P.B. contributed to the critical revision. All authors have read and agreed to the published version of the manuscript. </div></section><section class='html-notes'><h2>Funding</h2><div class='html-p'>This research received no external funding.</div></section><section class='html-notes'><h2 >Institutional Review Board Statement</h2><div class='html-p'>Not applicable.</div></section><section class='html-notes'><h2 >Informed Consent Statement</h2><div class='html-p'>Not applicable.</div></section><section class='html-notes'><h2 >Data Availability Statement</h2><div class='html-p'>Not applicable.</div></section><section class='html-notes'><h2 >Conflicts of Interest</h2><div class='html-p'>The authors declare no conflict of interest. </div></section><section id='html-references_list'><h2>References</h2><ol class='html-xx'><li id='B1-medsci-10-00025' class='html-x' data-content='1.'>GLOBOCAN, International Agency for Research on Cancer. 2020. Available online: <a href='http://gco.iarc.fr/' target='_blank' rel="noopener noreferrer" >http://gco.iarc.fr/</a> (accessed on 11 April 2022).</li><li id='B2-medsci-10-00025' class='html-x' data-content='2.'>Trewartha, D.; Carter, K. Advances in prostate cancer treatment. <span class='html-italic'>Nat. Rev. Drug Discov.</span> <b>2013</b>, <span class='html-italic'>12</span>, 823–824. [<a href="https://scholar.google.com/scholar_lookup?title=Advances+in+prostate+cancer+treatment&author=Trewartha,+D.&author=Carter,+K.&publication_year=2013&journal=Nat.+Rev.+Drug+Discov.&volume=12&pages=823%E2%80%93824&doi=10.1038/nrd4068" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/nrd4068" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B3-medsci-10-00025' class='html-x' data-content='3.'>Davies, A.H.; Beltran, H.; Zoubeidi, A. Cellular plasticity and the neuroendocrine phenotype in prostate cancer. <span class='html-italic'>Nat. Rev. Urol.</span> <b>2018</b>, <span class='html-italic'>15</span>, 271–286. [<a href="https://scholar.google.com/scholar_lookup?title=Cellular+plasticity+and+the+neuroendocrine+phenotype+in+prostate+cancer&author=Davies,+A.H.&author=Beltran,+H.&author=Zoubeidi,+A.&publication_year=2018&journal=Nat.+Rev.+Urol.&volume=15&pages=271%E2%80%93286&doi=10.1038/nrurol.2018.22" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/nrurol.2018.22" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B4-medsci-10-00025' class='html-x' data-content='4.'>Crocerossa, F.; Marchioni, M.; Novara, G.; Carbonara, U.; Ferro, M.; Russo, G.I.; Porpiglia, F.; Di Nicola, M.; Damiano, R.; Autorino, R.; et al. Detection Rate of Prostate Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis. <span class='html-italic'>J. Urol.</span> <b>2021</b>, <span class='html-italic'>205</span>, 356–369. [<a href="https://scholar.google.com/scholar_lookup?title=Detection+Rate+of+Prostate+Specific+Membrane+Antigen+Tracers+for+Positron+Emission+Tomography/Computerized+Tomography+in+Prostate+Cancer+Biochemical+Recurrence:+A+Systematic+Review+and+Network+Meta-Analysis&author=Crocerossa,+F.&author=Marchioni,+M.&author=Novara,+G.&author=Carbonara,+U.&author=Ferro,+M.&author=Russo,+G.I.&author=Porpiglia,+F.&author=Di+Nicola,+M.&author=Damiano,+R.&author=Autorino,+R.&publication_year=2021&journal=J.+Urol.&volume=205&pages=356%E2%80%93369&doi=10.1097/JU.0000000000001369&pmid=32935652" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1097/JU.0000000000001369" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/32935652" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B5-medsci-10-00025' class='html-x' data-content='5.'>Knudsen, K.E.; Kelly, W.K. Outsmarting androgen receptor: Creative approaches for targeting aberrant androgen signaling in advanced prostate cancer. <span class='html-italic'>Expert. Rev. Endocrinol. Metab.</span> <b>2011</b>, <span class='html-italic'>6</span>, 483–493. [<a href="https://scholar.google.com/scholar_lookup?title=Outsmarting+androgen+receptor:+Creative+approaches+for+targeting+aberrant+androgen+signaling+in+advanced+prostate+cancer&author=Knudsen,+K.E.&author=Kelly,+W.K.&publication_year=2011&journal=Expert.+Rev.+Endocrinol.+Metab.&volume=6&pages=483%E2%80%93493&doi=10.1586/eem.11.33&pmid=22389648" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1586/eem.11.33" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/22389648" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="http://europepmc.org/articles/pmc3289283?pdf=render" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B6-medsci-10-00025' class='html-x' data-content='6.'>De Bono, J.S.; Logothetis, C.J.; Molina, A.; Fizazi, K.; North, S.; Chu, L.; Chi, K.N.; Jones, R.J.; Goodman, O.B., Jr.; Saad, F.; et al. Abiraterone and increased survival in metastatic prostate cancer. <span class='html-italic'>N. Engl. J. Med.</span> <b>2011</b>, <span class='html-italic'>364</span>, 1995–2005. [<a href="https://scholar.google.com/scholar_lookup?title=Abiraterone+and+increased+survival+in+metastatic+prostate+cancer&author=De+Bono,+J.S.&author=Logothetis,+C.J.&author=Molina,+A.&author=Fizazi,+K.&author=North,+S.&author=Chu,+L.&author=Chi,+K.N.&author=Jones,+R.J.&author=Goodman,+O.B.,+Jr.&author=Saad,+F.&publication_year=2011&journal=N.+Engl.+J.+Med.&volume=364&pages=1995%E2%80%932005&doi=10.1056/NEJMoa1014618&pmid=21612468" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1056/NEJMoa1014618" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/21612468" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B7-medsci-10-00025' class='html-x' data-content='7.'>Ryan, C.J.; Smith, M.R.; De Bono, J.S.; Molina, A.; Logothetis, C.J.; De Souza, P.; Fizazi, K.; Mainwaring, P.; Piulats, J.M.; Ng, S.; et al. Abiraterone in metastatic prostate cancer without previous chemotherapy. <span class='html-italic'>N. Engl. J. Med.</span> <b>2013</b>, <span class='html-italic'>368</span>, 138–148. [<a href="https://scholar.google.com/scholar_lookup?title=Abiraterone+in+metastatic+prostate+cancer+without+previous+chemotherapy&author=Ryan,+C.J.&author=Smith,+M.R.&author=De+Bono,+J.S.&author=Molina,+A.&author=Logothetis,+C.J.&author=De+Souza,+P.&author=Fizazi,+K.&author=Mainwaring,+P.&author=Piulats,+J.M.&author=Ng,+S.&publication_year=2013&journal=N.+Engl.+J.+Med.&volume=368&pages=138%E2%80%93148&doi=10.1056/NEJMoa1209096" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1056/NEJMoa1209096" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://europepmc.org/articles/pmc3683570?pdf=render" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B8-medsci-10-00025' class='html-x' data-content='8.'>Beer, T.M.; Armstrong, A.J.; Rathkopf, D.E.; Loriot, Y.; Sternberg, C.N.; Higano, C.S.; Iversen, P.; Bhattacharya, S.; Carles, J.; Chowdhury, S.; et al. Enzalutamide in metastatic prostate cancer before chemotherapy. <span class='html-italic'>N. Engl. J. Med.</span> <b>2014</b>, <span class='html-italic'>371</span>, 424–433. [<a href="https://scholar.google.com/scholar_lookup?title=Enzalutamide+in+metastatic+prostate+cancer+before+chemotherapy&author=Beer,+T.M.&author=Armstrong,+A.J.&author=Rathkopf,+D.E.&author=Loriot,+Y.&author=Sternberg,+C.N.&author=Higano,+C.S.&author=Iversen,+P.&author=Bhattacharya,+S.&author=Carles,+J.&author=Chowdhury,+S.&publication_year=2014&journal=N.+Engl.+J.+Med.&volume=371&pages=424%E2%80%93433&doi=10.1056/NEJMoa1405095&pmid=24881730" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1056/NEJMoa1405095" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/24881730" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="https://repository.ubn.ru.nl/bitstream/2066/137932/1/137932.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B9-medsci-10-00025' class='html-x' data-content='9.'>Scher, H.I.; Beer, T.M.; Higano, C.S.; Anand, A.; Taplin, M.-E.; Efstathiou, E.; Rathkopf, D.; Shelkey, J.; Yu, E.Y.; Alumkal, J.; et al. Antitumour activity of MDV3100 in castration-resistant prostate cancer: A phase 1–2 study. <span class='html-italic'>Lancet</span> <b>2010</b>, <span class='html-italic'>375</span>, 1437–1446. [<a href="https://scholar.google.com/scholar_lookup?title=Antitumour+activity+of+MDV3100+in+castration-resistant+prostate+cancer:+A+phase+1%E2%80%932+study&author=Scher,+H.I.&author=Beer,+T.M.&author=Higano,+C.S.&author=Anand,+A.&author=Taplin,+M.-E.&author=Efstathiou,+E.&author=Rathkopf,+D.&author=Shelkey,+J.&author=Yu,+E.Y.&author=Alumkal,+J.&publication_year=2010&journal=Lancet&volume=375&pages=1437%E2%80%931446&doi=10.1016/S0140-6736(10)60172-9" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/S0140-6736(10)60172-9" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://europepmc.org/articles/pmc2948179?pdf=render" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B10-medsci-10-00025' class='html-xx' data-content='10.'>Scher, H.I.; Fizazi, K.; Saad, F.; Taplin, M.-E.; Sternberg, C.N.; Miller, K.; De Wit, R.; Mulders, P.; Chi, K.N.; Shore, N.D.; et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. <span class='html-italic'>N. Engl. J. Med.</span> <b>2012</b>, <span class='html-italic'>367</span>, 1187–1197. [<a href="https://scholar.google.com/scholar_lookup?title=Increased+survival+with+enzalutamide+in+prostate+cancer+after+chemotherapy&author=Scher,+H.I.&author=Fizazi,+K.&author=Saad,+F.&author=Taplin,+M.-E.&author=Sternberg,+C.N.&author=Miller,+K.&author=De+Wit,+R.&author=Mulders,+P.&author=Chi,+K.N.&author=Shore,+N.D.&publication_year=2012&journal=N.+Engl.+J.+Med.&volume=367&pages=1187%E2%80%931197&doi=10.1056/NEJMoa1207506" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1056/NEJMoa1207506" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://repository.ubn.ru.nl/bitstream/2066/108324/1/108324.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B11-medsci-10-00025' class='html-xx' data-content='11.'>Nelson, W.G.; Yegnasubramanian, S. Resistance emerges to second-generation antiandrogens in prostate cancer. <span class='html-italic'>Cancer Discov.</span> <b>2013</b>, <span class='html-italic'>3</span>, 971–974. [<a href="https://scholar.google.com/scholar_lookup?title=Resistance+emerges+to+second-generation+antiandrogens+in+prostate+cancer&author=Nelson,+W.G.&author=Yegnasubramanian,+S.&publication_year=2013&journal=Cancer+Discov.&volume=3&pages=971%E2%80%93974&doi=10.1158/2159-8290.CD-13-0405&pmid=24019330" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/2159-8290.CD-13-0405" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/24019330" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="https://cancerdiscovery.aacrjournals.org/content/candisc/3/9/971.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B12-medsci-10-00025' class='html-xx' data-content='12.'>Chang, K.H.; Ercole, C.E.; Sharifi, N. Androgen metabolism in prostate cancer: From molecular mechanisms to clinical consequences. <span class='html-italic'>Br. J. Cancer</span> <b>2014</b>, <span class='html-italic'>111</span>, 1249–1254. [<a href="https://scholar.google.com/scholar_lookup?title=Androgen+metabolism+in+prostate+cancer:+From+molecular+mechanisms+to+clinical+consequences&author=Chang,+K.H.&author=Ercole,+C.E.&author=Sharifi,+N.&publication_year=2014&journal=Br.+J.+Cancer&volume=111&pages=1249%E2%80%931254&doi=10.1038/bjc.2014.268&pmid=24867689" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/bjc.2014.268" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/24867689" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="https://www.nature.com/articles/bjc2014268.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B13-medsci-10-00025' class='html-xx' data-content='13.'>Chang, K.-H.; Li, R.; Kuri, B.; Lotan, Y.; Roehrborn, C.G.; Liu, J.; Vessella, R.; Nelson, P.S.; Kapur, P.; Guo, X.; et al. A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer. <span class='html-italic'>Cell</span> <b>2013</b>, <span class='html-italic'>154</span>, 1074–1084. [<a href="https://scholar.google.com/scholar_lookup?title=A+gain-of-function+mutation+in+DHT+synthesis+in+castration-resistant+prostate+cancer&author=Chang,+K.-H.&author=Li,+R.&author=Kuri,+B.&author=Lotan,+Y.&author=Roehrborn,+C.G.&author=Liu,+J.&author=Vessella,+R.&author=Nelson,+P.S.&author=Kapur,+P.&author=Guo,+X.&publication_year=2013&journal=Cell&volume=154&pages=1074%E2%80%931084&doi=10.1016/j.cell.2013.07.029&pmid=23993097" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.cell.2013.07.029" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23993097" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="http://www.cell.com/article/S0092867413009008/pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B14-medsci-10-00025' class='html-xx' data-content='14.'>Mostaghel, E.A.; Marck, B.T.; Plymate, S.R.; Vessella, R.L.; Balk, S.; Matsumoto, A.M.; Nelson, P.S.; Montgomery, R.B. Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: Induction of steroidogenesis and androgen receptor splice variants. <span class='html-italic'>Clin. Cancer Res.</span> <b>2011</b>, <span class='html-italic'>17</span>, 5913–5925. [<a href="https://scholar.google.com/scholar_lookup?title=Resistance+to+CYP17A1+inhibition+with+abiraterone+in+castration-resistant+prostate+cancer:+Induction+of+steroidogenesis+and+androgen+receptor+splice+variants&author=Mostaghel,+E.A.&author=Marck,+B.T.&author=Plymate,+S.R.&author=Vessella,+R.L.&author=Balk,+S.&author=Matsumoto,+A.M.&author=Nelson,+P.S.&author=Montgomery,+R.B.&publication_year=2011&journal=Clin.+Cancer+Res.&volume=17&pages=5913%E2%80%935925&doi=10.1158/1078-0432.CCR-11-0728" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/1078-0432.CCR-11-0728" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://clincancerres.aacrjournals.org/content/clincanres/17/18/5913.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B15-medsci-10-00025' class='html-xx' data-content='15.'>Bonkhoff, H.; Fixemer, T.; Hunsicker, I.; Remberger, K. Progesterone receptor expression in human prostate cancer: Correlation with tumor progression. <span class='html-italic'>Prostate</span> <b>2001</b>, <span class='html-italic'>48</span>, 285–291. [<a href="https://scholar.google.com/scholar_lookup?title=Progesterone+receptor+expression+in+human+prostate+cancer:+Correlation+with+tumor+progression&author=Bonkhoff,+H.&author=Fixemer,+T.&author=Hunsicker,+I.&author=Remberger,+K.&publication_year=2001&journal=Prostate&volume=48&pages=285%E2%80%93291&doi=10.1002/pros.1108&pmid=11536308" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/pros.1108" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/11536308" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B16-medsci-10-00025' class='html-xx' data-content='16.'>Grindstad, T.; Andersen, S.; Al-Saad, S.; Donnem, T.; Kiselev, Y.; Melbø-Jørgensen, C.N.; Skjefstad, K.; Busund, L.-T.; Bremnes, R.M.; Richardsen, E. High progesterone receptor expression in prostate cancer is associated with clinical failure. <span class='html-italic'>PLoS ONE</span> <b>2015</b>, <span class='html-italic'>10</span>, e0116691. [<a href="https://scholar.google.com/scholar_lookup?title=High+progesterone+receptor+expression+in+prostate+cancer+is+associated+with+clinical+failure&author=Grindstad,+T.&author=Andersen,+S.&author=Al-Saad,+S.&author=Donnem,+T.&author=Kiselev,+Y.&author=Melb%C3%B8-J%C3%B8rgensen,+C.N.&author=Skjefstad,+K.&author=Busund,+L.-T.&author=Bremnes,+R.M.&author=Richardsen,+E.&publication_year=2015&journal=PLoS+ONE&volume=10&pages=e0116691&doi=10.1371/journal.pone.0116691" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1371/journal.pone.0116691" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B17-medsci-10-00025' class='html-xx' data-content='17.'>Cottu, P.H.; Jayaram, A.; Italiano, A.; Pacey, S.; Leary, A.; Jones, R.J.; Watkins, P.B. Pooled analysis of onapristone extended release (ONA ER) in metastatic cancer patients (pts): A review of liver safety. <span class='html-italic'>J. Clin. Oncol.</span> <b>2019</b>, <span class='html-italic'>37</span>, 15. [<a href="https://scholar.google.com/scholar_lookup?title=Pooled+analysis+of+onapristone+extended+release+(ONA+ER)+in+metastatic+cancer+patients+(pts):+A+review+of+liver+safety&author=Cottu,+P.H.&author=Jayaram,+A.&author=Italiano,+A.&author=Pacey,+S.&author=Leary,+A.&author=Jones,+R.J.&author=Watkins,+P.B.&publication_year=2019&journal=J.+Clin.+Oncol.&volume=37&pages=15&doi=10.1200/JCO.2019.37.15_suppl.e14647" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1200/JCO.2019.37.15_suppl.e14647" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B18-medsci-10-00025' class='html-xx' data-content='18.'>Antonarakis, E.S.; Lu, C.; Wang, H.; Luber, B.; Nakazawa, M.; Roeser, J.C.; Chen, Y.; Mohammad, T.A.; Chen, Y.; Fedor, H.L.; et al. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. <span class='html-italic'>N. Engl. J. Med.</span> <b>2014</b>, <span class='html-italic'>371</span>, 1028–1038. [<a href="https://scholar.google.com/scholar_lookup?title=AR-V7+and+resistance+to+enzalutamide+and+abiraterone+in+prostate+cancer&author=Antonarakis,+E.S.&author=Lu,+C.&author=Wang,+H.&author=Luber,+B.&author=Nakazawa,+M.&author=Roeser,+J.C.&author=Chen,+Y.&author=Mohammad,+T.A.&author=Chen,+Y.&author=Fedor,+H.L.&publication_year=2014&journal=N.+Engl.+J.+Med.&volume=371&pages=1028%E2%80%931038&doi=10.1056/NEJMoa1315815&pmid=25184630" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1056/NEJMoa1315815" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/25184630" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="http://europepmc.org/articles/pmc4201502?pdf=render" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B19-medsci-10-00025' class='html-xx' data-content='19.'>Berger, R.; Lin, D.I.; Nieto, M.; Sicinska, E.; Garraway, L.A.; Adams, H.; Loda, M. Androgen-dependent regulation of Her-2/neu in prostate cancer cells. <span class='html-italic'>Cancer Res.</span> <b>2006</b>, <span class='html-italic'>66</span>, 5723–5728. [<a href="https://scholar.google.com/scholar_lookup?title=Androgen-dependent+regulation+of+Her-2/neu+in+prostate+cancer+cells&author=Berger,+R.&author=Lin,+D.I.&author=Nieto,+M.&author=Sicinska,+E.&author=Garraway,+L.A.&author=Adams,+H.&author=Loda,+M.&publication_year=2006&journal=Cancer+Res.&volume=66&pages=5723%E2%80%935728&doi=10.1158/0008-5472.CAN-05-3928&pmid=16740710" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/0008-5472.CAN-05-3928" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/16740710" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="http://cancerres.aacrjournals.org/content/66/11/5723.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B20-medsci-10-00025' class='html-xx' data-content='20.'>Chen, L.; Mooso, B.A.; Jathal, M.K.; Madhav, A.; Johnson, S.D.; van Spyk, E.; Mikhailova, M.; Zierenberg-Ripoll, A.; Xue, L.; Vinall, R.L.; et al. Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3. <span class='html-italic'>Clin. Cancer Res.</span> <b>2011</b>, <span class='html-italic'>17</span>, 6218–6228. [<a href="https://scholar.google.com/scholar_lookup?title=Dual+EGFR/HER2+inhibition+sensitizes+prostate+cancer+cells+to+androgen+withdrawal+by+suppressing+ErbB3&author=Chen,+L.&author=Mooso,+B.A.&author=Jathal,+M.K.&author=Madhav,+A.&author=Johnson,+S.D.&author=van+Spyk,+E.&author=Mikhailova,+M.&author=Zierenberg-Ripoll,+A.&author=Xue,+L.&author=Vinall,+R.L.&publication_year=2011&journal=Clin.+Cancer+Res.&volume=17&pages=6218%E2%80%936228&doi=10.1158/1078-0432.CCR-11-1548&pmid=21844010" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/1078-0432.CCR-11-1548" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/21844010" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="http://clincancerres.aacrjournals.org/content/17/19/6218.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B21-medsci-10-00025' class='html-xx' data-content='21.'>Craft, N.; Shostak, Y.; Carey, M.; Sawyers, C.L. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. <span class='html-italic'>Nat. Med.</span> <b>1999</b>, <span class='html-italic'>5</span>, 280–285. [<a href="https://scholar.google.com/scholar_lookup?title=A+mechanism+for+hormone-independent+prostate+cancer+through+modulation+of+androgen+receptor+signaling+by+the+HER-2/neu+tyrosine+kinase&author=Craft,+N.&author=Shostak,+Y.&author=Carey,+M.&author=Sawyers,+C.L.&publication_year=1999&journal=Nat.+Med.&volume=5&pages=280%E2%80%93285&doi=10.1038/6495&pmid=10086382" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/6495" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/10086382" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B22-medsci-10-00025' class='html-xx' data-content='22.'>Gao, S.; Ye, H.; Gerrin, S.; Wang, H.; Sharma, A.; Chen, S.; Patnaik, A.; Sowalsky, A.G.; Voznesensky, O.; Han, W.; et al. ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer. <span class='html-italic'>Clin. Cancer Res.</span> <b>2016</b>, <span class='html-italic'>22</span>, 3672–3682. [<a href="https://scholar.google.com/scholar_lookup?title=ErbB2+Signaling+Increases+Androgen+Receptor+Expression+in+Abiraterone-Resistant+Prostate+Cancer&author=Gao,+S.&author=Ye,+H.&author=Gerrin,+S.&author=Wang,+H.&author=Sharma,+A.&author=Chen,+S.&author=Patnaik,+A.&author=Sowalsky,+A.G.&author=Voznesensky,+O.&author=Han,+W.&publication_year=2016&journal=Clin.+Cancer+Res.&volume=22&pages=3672%E2%80%933682&doi=10.1158/1078-0432.CCR-15-2309&pmid=26936914" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/1078-0432.CCR-15-2309" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/26936914" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="https://clincancerres.aacrjournals.org/content/clincanres/22/14/3672.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B23-medsci-10-00025' class='html-xx' data-content='23.'>Annala, M.; Vandekerkhove, G.; Khalaf, D.; Taavitsainen, S.; Beja, K.; Warner, E.W.; Sunderland, K.; Kollmannsberger, C.; Eigl, B.J.; Finch, D.; et al. Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer. <span class='html-italic'>Cancer Discov.</span> <b>2018</b>, <span class='html-italic'>8</span>, 444–457. [<a href="https://scholar.google.com/scholar_lookup?title=Circulating+Tumor+DNA+Genomics+Correlate+with+Resistance+to+Abiraterone+and+Enzalutamide+in+Prostate+Cancer&author=Annala,+M.&author=Vandekerkhove,+G.&author=Khalaf,+D.&author=Taavitsainen,+S.&author=Beja,+K.&author=Warner,+E.W.&author=Sunderland,+K.&author=Kollmannsberger,+C.&author=Eigl,+B.J.&author=Finch,+D.&publication_year=2018&journal=Cancer+Discov.&volume=8&pages=444%E2%80%93457&doi=10.1158/2159-8290.CD-17-0937" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/2159-8290.CD-17-0937" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://cancerdiscovery.aacrjournals.org/content/candisc/8/4/444.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B24-medsci-10-00025' class='html-xx' data-content='24.'>Yuan, X.; Cai, C.; Chen, S.; Yu, Z.; Balk, S.P. Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis. <span class='html-italic'>Oncogene</span> <b>2014</b>, <span class='html-italic'>33</span>, 2815–2825. [<a href="https://scholar.google.com/scholar_lookup?title=Androgen+receptor+functions+in+castration-resistant+prostate+cancer+and+mechanisms+of+resistance+to+new+agents+targeting+the+androgen+axis&author=Yuan,+X.&author=Cai,+C.&author=Chen,+S.&author=Yu,+Z.&author=Balk,+S.P.&publication_year=2014&journal=Oncogene&volume=33&pages=2815%E2%80%932825&doi=10.1038/onc.2013.235&pmid=23752196" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/onc.2013.235" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/23752196" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="https://www.nature.com/articles/onc2013235.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B25-medsci-10-00025' class='html-xx' data-content='25.'>Takeda, D.Y.; Spisák, S.; Seo, J.-H.; Bell, C.; O’Connor, E.; Korthauer, K.; Ribli, D.; Csabai, I.; Solymosi, N.; Szallasi, Z.; et al. A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer. <span class='html-italic'>Cell</span> <b>2018</b>, <span class='html-italic'>174</span>, 422–432.e13. [<a href="https://scholar.google.com/scholar_lookup?title=A+Somatically+Acquired+Enhancer+of+the+Androgen+Receptor+Is+a+Noncoding+Driver+in+Advanced+Prostate+Cancer&author=Takeda,+D.Y.&author=Spis%C3%A1k,+S.&author=Seo,+J.-H.&author=Bell,+C.&author=O%E2%80%99Connor,+E.&author=Korthauer,+K.&author=Ribli,+D.&author=Csabai,+I.&author=Solymosi,+N.&author=Szallasi,+Z.&publication_year=2018&journal=Cell&volume=174&pages=422%E2%80%93432.e13&doi=10.1016/j.cell.2018.05.037&pmid=29909987" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.cell.2018.05.037" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/29909987" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="http://www.cell.com/article/S0092867418306494/pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B26-medsci-10-00025' class='html-xx' data-content='26.'>Dondoo, T.-O.; Fukumori, T.; Daizumoto, K.; Fukawa, T.; Kohzuki, M.; Kowada, M.; Kusuhara, Y.; Mori, H.; Nakatsuji, H.; Takahashi, M.; et al. Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug through Regulation of Androgen Receptor Signaling in Prostate Cancer. <span class='html-italic'>Anticancer Res.</span> <b>2017</b>, <span class='html-italic'>37</span>, 125–134. [<a href="https://scholar.google.com/scholar_lookup?title=Galectin-3+Is+Implicated+in+Tumor+Progression+and+Resistance+to+Anti-androgen+Drug+through+Regulation+of+Androgen+Receptor+Signaling+in+Prostate+Cancer&author=Dondoo,+T.-O.&author=Fukumori,+T.&author=Daizumoto,+K.&author=Fukawa,+T.&author=Kohzuki,+M.&author=Kowada,+M.&author=Kusuhara,+Y.&author=Mori,+H.&author=Nakatsuji,+H.&author=Takahashi,+M.&publication_year=2017&journal=Anticancer+Res.&volume=37&pages=125%E2%80%93134&doi=10.21873/anticanres.11297" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.21873/anticanres.11297" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://ar.iiarjournals.org/content/37/1/125.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B27-medsci-10-00025' class='html-xx' data-content='27.'>Zhu, S.; Zhao, D.; Yan, L.; Jiang, W.; Kim, J.S.; Gu, B.; Cao, Q. BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1. <span class='html-italic'>Nat. Commun.</span> <b>2018</b>, <span class='html-italic'>9</span>, 500. [<a href="https://scholar.google.com/scholar_lookup?title=BMI1+regulates+androgen+receptor+in+prostate+cancer+independently+of+the+polycomb+repressive+complex+1&author=Zhu,+S.&author=Zhao,+D.&author=Yan,+L.&author=Jiang,+W.&author=Kim,+J.S.&author=Gu,+B.&author=Cao,+Q.&publication_year=2018&journal=Nat.+Commun.&volume=9&pages=500&doi=10.1038/s41467-018-02863-3&pmid=29402932" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/s41467-018-02863-3" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/29402932" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B28-medsci-10-00025' class='html-xx' data-content='28.'>Li, C.; Lanman, N.A.; Kong, Y.; He, D.; Mao, F.; Farah, E.; Zhang, Y.; Liu, J.; Wang, C.; Wei, Q.; et al. Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance. <span class='html-italic'>J. Biol. Chem.</span> <b>2020</b>, <span class='html-italic'>295</span>, 5470–5483. [<a href="https://scholar.google.com/scholar_lookup?title=Inhibition+of+the+erythropoietin-producing+receptor+EPHB4+antagonizes+androgen+receptor+overexpression+and+reduces+enzalutamide+resistance&author=Li,+C.&author=Lanman,+N.A.&author=Kong,+Y.&author=He,+D.&author=Mao,+F.&author=Farah,+E.&author=Zhang,+Y.&author=Liu,+J.&author=Wang,+C.&author=Wei,+Q.&publication_year=2020&journal=J.+Biol.+Chem.&volume=295&pages=5470%E2%80%935483&doi=10.1074/jbc.RA119.011385" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1074/jbc.RA119.011385" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.jbc.org/content/early/2020/03/16/jbc.RA119.011385.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B29-medsci-10-00025' class='html-xx' data-content='29.'>Mahajan, K.; Malla, P.; Lawrence, H.R.; Chen, Z.; Kumar-Sinha, C.; Malik, R.; Mahajan, N.P. ACK1/TNK2 Regulates Histone H4 Tyr88-phosphorylation and AR Gene Expression in Castration-Resistant Prostate Cancer. <span class='html-italic'>Cancer Cell.</span> <b>2017</b>, <span class='html-italic'>31</span>, 790–803.e8. [<a href="https://scholar.google.com/scholar_lookup?title=ACK1/TNK2+Regulates+Histone+H4+Tyr88-phosphorylation+and+AR+Gene+Expression+in+Castration-Resistant+Prostate+Cancer&author=Mahajan,+K.&author=Malla,+P.&author=Lawrence,+H.R.&author=Chen,+Z.&author=Kumar-Sinha,+C.&author=Malik,+R.&author=Mahajan,+N.P.&publication_year=2017&journal=Cancer+Cell.&volume=31&pages=790%E2%80%93803.e8&doi=10.1016/j.ccell.2017.05.003" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.ccell.2017.05.003" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.cell.com/article/S153561081730199X/pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B30-medsci-10-00025' class='html-xx' data-content='30.'>Zhao, N.; Peacock, S.O.; Lo, C.H.; Heidman, L.M.; Rice, M.A.; Fahrenholtz, C.D.; Greene, A.M.; Magani, F.; Copello, V.A.; Martinez, M.J.; et al. Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer. <span class='html-italic'>Sci. Transl. Med.</span> <b>2019</b>, <span class='html-italic'>11</span>, eaaw4636. [<a href="https://scholar.google.com/scholar_lookup?title=Arginine+vasopressin+receptor+1a+is+a+therapeutic+target+for+castration-resistant+prostate+cancer&author=Zhao,+N.&author=Peacock,+S.O.&author=Lo,+C.H.&author=Heidman,+L.M.&author=Rice,+M.A.&author=Fahrenholtz,+C.D.&author=Greene,+A.M.&author=Magani,+F.&author=Copello,+V.A.&author=Martinez,+M.J.&publication_year=2019&journal=Sci.+Transl.+Med.&volume=11&pages=eaaw4636&doi=10.1126/scitranslmed.aaw4636" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1126/scitranslmed.aaw4636" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B31-medsci-10-00025' class='html-xx' data-content='31.'>Liu, C.; Lou, W.; Yang, J.C.; Liu, L.; Armstrong, C.M.; Lombard, A.P.; Gao, A.C. Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer. <span class='html-italic'>Nat. Commun.</span> <b>2018</b>, <span class='html-italic'>9</span>, 4700. [<a href="https://scholar.google.com/scholar_lookup?title=Proteostasis+by+STUB1/HSP70+complex+controls+sensitivity+to+androgen+receptor+targeted+therapy+in+advanced+prostate+cancer&author=Liu,+C.&author=Lou,+W.&author=Yang,+J.C.&author=Liu,+L.&author=Armstrong,+C.M.&author=Lombard,+A.P.&author=Gao,+A.C.&publication_year=2018&journal=Nat.+Commun.&volume=9&pages=4700&doi=10.1038/s41467-018-07178-x" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/s41467-018-07178-x" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B32-medsci-10-00025' class='html-xx' data-content='32.'>Xu, L.; Chen, J.; Liu, W.; Liang, C.; Hu, H.; Huang, J. Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer. <span class='html-italic'>Asian J. Urol.</span> <b>2019</b>, <span class='html-italic'>6</span>, 91–98. [<a href="https://scholar.google.com/scholar_lookup?title=Targeting+androgen+receptor-independent+pathways+in+therapy-resistant+prostate+cancer&author=Xu,+L.&author=Chen,+J.&author=Liu,+W.&author=Liang,+C.&author=Hu,+H.&author=Huang,+J.&publication_year=2019&journal=Asian+J.+Urol.&volume=6&pages=91%E2%80%9398&doi=10.1016/j.ajur.2018.11.002" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.ajur.2018.11.002" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B33-medsci-10-00025' class='html-xx' data-content='33.'>Snow, O.; Lallous, N.; Singh, K.; Lack, N.; Rennie, P.; Cherkasov, A. Androgen receptor plasticity and its implications for prostate cancer therapy. <span class='html-italic'>Cancer Treat. Rev.</span> <b>2019</b>, <span class='html-italic'>81</span>, 101871. [<a href="https://scholar.google.com/scholar_lookup?title=Androgen+receptor+plasticity+and+its+implications+for+prostate+cancer+therapy&author=Snow,+O.&author=Lallous,+N.&author=Singh,+K.&author=Lack,+N.&author=Rennie,+P.&author=Cherkasov,+A.&publication_year=2019&journal=Cancer+Treat.+Rev.&volume=81&pages=101871&doi=10.1016/j.ctrv.2019.05.001&pmid=31698174" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.ctrv.2019.05.001" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/31698174" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B34-medsci-10-00025' class='html-xx' data-content='34.'>Korpal, M.; Korn, J.M.; Gao, X.; Rakiec, D.P.; Ruddy, D.A.; Doshi, S.; Yuan, J.; Kovats, S.G.; Kim, S.; Cooke, V.G.; et al. An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide). <span class='html-italic'>Cancer Discov.</span> <b>2013</b>, <span class='html-italic'>3</span>, 1030–1043. [<a href="https://scholar.google.com/scholar_lookup?title=An+F876L+mutation+in+androgen+receptor+confers+genetic+and+phenotypic+resistance+to+MDV3100+(enzalutamide)&author=Korpal,+M.&author=Korn,+J.M.&author=Gao,+X.&author=Rakiec,+D.P.&author=Ruddy,+D.A.&author=Doshi,+S.&author=Yuan,+J.&author=Kovats,+S.G.&author=Kim,+S.&author=Cooke,+V.G.&publication_year=2013&journal=Cancer+Discov.&volume=3&pages=1030%E2%80%931043&doi=10.1158/2159-8290.CD-13-0142" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/2159-8290.CD-13-0142" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://cancerdiscovery.aacrjournals.org/content/candisc/3/9/1030.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B35-medsci-10-00025' class='html-xx' data-content='35.'>Borgmann, H.; Lallous, N.; Ozistanbullu, D.; Beraldi, E.; Paul, N.; Dalal, K.; Gleave, M.E. Moving towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201). <span class='html-italic'>Eur. Urol.</span> <b>2018</b>, <span class='html-italic'>73</span>, 4–8. [<a href="https://scholar.google.com/scholar_lookup?title=Moving+towards+Precision+Urologic+Oncology:+Targeting+Enzalutamide-resistant+Prostate+Cancer+and+Mutated+Forms+of+the+Androgen+Receptor+Using+the+Novel+Inhibitor+Darolutamide+(ODM-201)&author=Borgmann,+H.&author=Lallous,+N.&author=Ozistanbullu,+D.&author=Beraldi,+E.&author=Paul,+N.&author=Dalal,+K.&author=Gleave,+M.E.&publication_year=2018&journal=Eur.+Urol.&volume=73&pages=4%E2%80%938&doi=10.1016/j.eururo.2017.08.012&pmid=28851578" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.eururo.2017.08.012" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/28851578" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B36-medsci-10-00025' class='html-xx' data-content='36.'>Arora, V.K.; Schenkein, E.; Murali, R.; Subudhi, S.K.; Wongvipat, J.; Balbas, M.D.; Shah, N.; Cai, L.; Efstathiou, E.; Logothetis, C.; et al. Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade. <span class='html-italic'>Cell</span> <b>2013</b>, <span class='html-italic'>155</span>, 1309–1322. [<a href="https://scholar.google.com/scholar_lookup?title=Glucocorticoid+receptor+confers+resistance+to+antiandrogens+by+bypassing+androgen+receptor+blockade&author=Arora,+V.K.&author=Schenkein,+E.&author=Murali,+R.&author=Subudhi,+S.K.&author=Wongvipat,+J.&author=Balbas,+M.D.&author=Shah,+N.&author=Cai,+L.&author=Efstathiou,+E.&author=Logothetis,+C.&publication_year=2013&journal=Cell&volume=155&pages=1309%E2%80%931322&doi=10.1016/j.cell.2013.11.012" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.cell.2013.11.012" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.cell.com/article/S0092867413014256/pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B37-medsci-10-00025' class='html-xx' data-content='37.'>Zhang, Z.; Cheng, L.; Li, J.; Farah, E.; Atallah, N.M.; Pascuzzi, P.E.; Liu, X. Inhibition of the Wnt/β-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer. <span class='html-italic'>Cancer Res.</span> <b>2018</b>, <span class='html-italic'>78</span>, 3147–3162. [<a href="https://scholar.google.com/scholar_lookup?title=Inhibition+of+the+Wnt/%CE%B2-Catenin+Pathway+Overcomes+Resistance+to+Enzalutamide+in+Castration-Resistant+Prostate+Cancer&author=Zhang,+Z.&author=Cheng,+L.&author=Li,+J.&author=Farah,+E.&author=Atallah,+N.M.&author=Pascuzzi,+P.E.&author=Liu,+X.&publication_year=2018&journal=Cancer+Res.&volume=78&pages=3147%E2%80%933162&doi=10.1158/0008-5472.CAN-17-3006" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/0008-5472.CAN-17-3006" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://cancerres.aacrjournals.org/content/canres/78/12/3147.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B38-medsci-10-00025' class='html-xx' data-content='38.'>Murillo-Garzón, V.; Kypta, R. WNT signalling in prostate cancer. <span class='html-italic'>Nat. Rev. Urol.</span> <b>2017</b>, <span class='html-italic'>14</span>, 683–696. [<a href="https://scholar.google.com/scholar_lookup?title=WNT+signalling+in+prostate+cancer&author=Murillo-Garz%C3%B3n,+V.&author=Kypta,+R.&publication_year=2017&journal=Nat.+Rev.+Urol.&volume=14&pages=683%E2%80%93696&doi=10.1038/nrurol.2017.144" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/nrurol.2017.144" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B39-medsci-10-00025' class='html-xx' data-content='39.'>Velho, P.I.; Fu, W.; Wang, H.; Mirkheshti, N.; Qazi, F.; Lima, F.A.; Antonarakis, E.S. Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer. <span class='html-italic'>Eur. Urol.</span> <b>2020</b>, <span class='html-italic'>77</span>, 14–21. [<a href="https://scholar.google.com/scholar_lookup?title=Wnt-pathway+Activating+Mutations+Are+Associated+with+Resistance+to+First-line+Abiraterone+and+Enzalutamide+in+Castration-resistant+Prostate+Cancer&author=Velho,+P.I.&author=Fu,+W.&author=Wang,+H.&author=Mirkheshti,+N.&author=Qazi,+F.&author=Lima,+F.A.&author=Antonarakis,+E.S.&publication_year=2020&journal=Eur.+Urol.&volume=77&pages=14%E2%80%9321&doi=10.1016/j.eururo.2019.05.032" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.eururo.2019.05.032" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B40-medsci-10-00025' class='html-xx' data-content='40.'>Wang, J.; Xu, W.; Wang, B.; Lin, G.; Wei, Y.; Abudurexiti, M.; Zhu, W.; Liu, C.; Qin, X.; Dai, B.; et al. GLUT1 is an AR target contributing to tumor growth and glycolysis in castration-resistant and enzalutamide-resistant prostate cancers. <span class='html-italic'>Cancer Lett.</span> <b>2020</b>, <span class='html-italic'>485</span>, 45–55. [<a href="https://scholar.google.com/scholar_lookup?title=GLUT1+is+an+AR+target+contributing+to+tumor+growth+and+glycolysis+in+castration-resistant+and+enzalutamide-resistant+prostate+cancers&author=Wang,+J.&author=Xu,+W.&author=Wang,+B.&author=Lin,+G.&author=Wei,+Y.&author=Abudurexiti,+M.&author=Zhu,+W.&author=Liu,+C.&author=Qin,+X.&author=Dai,+B.&publication_year=2020&journal=Cancer+Lett.&volume=485&pages=45%E2%80%9355&doi=10.1016/j.canlet.2020.05.007" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.canlet.2020.05.007" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B41-medsci-10-00025' class='html-xx' data-content='41.'>Latonen, L.; Afyounian, E.; Jylhä, A.; Nättinen, J.; Aapola, U.; Annala, M.; Kivinummi, K.K.; Tammela, T.T.L.; Beuerman, R.W.; Uusitalo, H.; et al. Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression. <span class='html-italic'>Nat. Commun.</span> <b>2018</b>, <span class='html-italic'>9</span>, 1176. [<a href="https://scholar.google.com/scholar_lookup?title=Integrative+proteomics+in+prostate+cancer+uncovers+robustness+against+genomic+and+transcriptomic+aberrations+during+disease+progression&author=Latonen,+L.&author=Afyounian,+E.&author=Jylh%C3%A4,+A.&author=N%C3%A4ttinen,+J.&author=Aapola,+U.&author=Annala,+M.&author=Kivinummi,+K.K.&author=Tammela,+T.T.L.&author=Beuerman,+R.W.&author=Uusitalo,+H.&publication_year=2018&journal=Nat.+Commun.&volume=9&pages=1176&doi=10.1038/s41467-018-03573-6&pmid=29563510" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/s41467-018-03573-6" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/29563510" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B42-medsci-10-00025' class='html-xx' data-content='42.'>Nguyen, H.G.; Yang, J.C.; Kung, H.-J.; Shi, X.-B.; Tilki, D.; Lara, P.N.; White, R.W.D.; Gao, A.C.; Evans, C.P. Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model. <span class='html-italic'>Oncogene</span> <b>2014</b>, <span class='html-italic'>33</span>, 4521–4530. [<a href="https://scholar.google.com/scholar_lookup?title=Targeting+autophagy+overcomes+Enzalutamide+resistance+in+castration-resistant+prostate+cancer+cells+and+improves+therapeutic+response+in+a+xenograft+model&author=Nguyen,+H.G.&author=Yang,+J.C.&author=Kung,+H.-J.&author=Shi,+X.-B.&author=Tilki,+D.&author=Lara,+P.N.&author=White,+R.W.D.&author=Gao,+A.C.&author=Evans,+C.P.&publication_year=2014&journal=Oncogene&volume=33&pages=4521%E2%80%934530&doi=10.1038/onc.2014.25" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/onc.2014.25" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://europepmc.org/articles/pmc4155805?pdf=render" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B43-medsci-10-00025' class='html-xx' data-content='43.'>Siddiqui, W.A.; Ahad, A.; Ahsan, H. The mystery of BCL2 family: Bcl-2 proteins and apoptosis: An update. <span class='html-italic'>Arch. Toxicol.</span> <b>2015</b>, <span class='html-italic'>89</span>, 289–317. [<a href="https://scholar.google.com/scholar_lookup?title=The+mystery+of+BCL2+family:+Bcl-2+proteins+and+apoptosis:+An+update&author=Siddiqui,+W.A.&author=Ahad,+A.&author=Ahsan,+H.&publication_year=2015&journal=Arch.+Toxicol.&volume=89&pages=289%E2%80%93317&doi=10.1007/s00204-014-1448-7" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/s00204-014-1448-7" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B44-medsci-10-00025' class='html-xx' data-content='44.'>Krajewska, M.; Krajewski, S.; Banares, S.; Huang, X.; Turner, B.; Bubendorf, L.; Kallioniemi, O.-P.; Shabaik, A.; Vitiello, A.; Peehl, D.; et al. Elevated expression of inhibitor of apoptosis proteins in prostate cancer. <span class='html-italic'>Clin. Cancer Res.</span> <b>2003</b>, <span class='html-italic'>9</span>, 4914–4925. [<a href="https://scholar.google.com/scholar_lookup?title=Elevated+expression+of+inhibitor+of+apoptosis+proteins+in+prostate+cancer&author=Krajewska,+M.&author=Krajewski,+S.&author=Banares,+S.&author=Huang,+X.&author=Turner,+B.&author=Bubendorf,+L.&author=Kallioniemi,+O.-P.&author=Shabaik,+A.&author=Vitiello,+A.&author=Peehl,+D.&publication_year=2003&journal=Clin.+Cancer+Res.&volume=9&pages=4914%E2%80%934925&pmid=14581366" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/14581366" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B45-medsci-10-00025' class='html-xx' data-content='45.'>Luk IS, U.; Shrestha, R.; Xue, H.; Wang, Y.; Zhang, F.; Lin, D.; Wang, Y. BIRC6Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer. <span class='html-italic'>Clin. Cancer Res.</span> <b>2017</b>, <span class='html-italic'>23</span>, 1542–1551. [<a href="https://scholar.google.com/scholar_lookup?title=BIRC6Targeting+as+Potential+Therapy+for+Advanced,+Enzalutamide-Resistant+Prostate+Cancer&author=Luk+IS,+U.&author=Shrestha,+R.&author=Xue,+H.&author=Wang,+Y.&author=Zhang,+F.&author=Lin,+D.&author=Wang,+Y.&publication_year=2017&journal=Clin.+Cancer+Res.&volume=23&pages=1542%E2%80%931551&doi=10.1158/1078-0432.CCR-16-0718" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/1078-0432.CCR-16-0718" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://clincancerres.aacrjournals.org/content/clincanres/23/6/1542.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B46-medsci-10-00025' class='html-xx' data-content='46.'>Pilling, A.B.; Hwang, O.; Boudreault, A.; Laurent, A.; Hwang, C. IAP Antagonists Enhance Apoptotic Response to Enzalutamide in Castration-Resistant Prostate Cancer Cells via Autocrine TNF-α Signaling. <span class='html-italic'>Prostate</span> <b>2017</b>, <span class='html-italic'>77</span>, 866–877. [<a href="https://scholar.google.com/scholar_lookup?title=IAP+Antagonists+Enhance+Apoptotic+Response+to+Enzalutamide+in+Castration-Resistant+Prostate+Cancer+Cells+via+Autocrine+TNF-%CE%B1+Signaling&author=Pilling,+A.B.&author=Hwang,+O.&author=Boudreault,+A.&author=Laurent,+A.&author=Hwang,+C.&publication_year=2017&journal=Prostate&volume=77&pages=866%E2%80%93877&doi=10.1002/pros.23327&pmid=28240376" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/pros.23327" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/28240376" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B47-medsci-10-00025' class='html-xx' data-content='47.'>Miao, L.; Yang, L.; Li, R.; Rodrigues, D.N.; Crespo, M.; Hsieh, J.-T.; Tilley, W.; De Bono, J.; Selth, L.; Raj, G.V. Disrupting Androgen Receptor Signaling Induces Snail-Mediated Epithelial-Mesenchymal Plasticity in Prostate Cancer. <span class='html-italic'>Cancer Res.</span> <b>2017</b>, <span class='html-italic'>77</span>, 3101–3112. [<a href="https://scholar.google.com/scholar_lookup?title=Disrupting+Androgen+Receptor+Signaling+Induces+Snail-Mediated+Epithelial-Mesenchymal+Plasticity+in+Prostate+Cancer&author=Miao,+L.&author=Yang,+L.&author=Li,+R.&author=Rodrigues,+D.N.&author=Crespo,+M.&author=Hsieh,+J.-T.&author=Tilley,+W.&author=De+Bono,+J.&author=Selth,+L.&author=Raj,+G.V.&publication_year=2017&journal=Cancer+Res.&volume=77&pages=3101%E2%80%933112&doi=10.1158/0008-5472.CAN-16-2169" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/0008-5472.CAN-16-2169" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://cancerres.aacrjournals.org/content/canres/77/11/3101.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B48-medsci-10-00025' class='html-xx' data-content='48.'>Quintanal-Villalonga, Á.; Chan, J.M.; Yu, H.A.; Pe’er, D.; Sawyers, C.L.; Sen, T.; Rudin, C.M. Lineage plasticity in cancer: A shared pathway of therapeutic resistance. <span class='html-italic'>Nat. Rev. Clin. Oncol.</span> <b>2020</b>, <span class='html-italic'>17</span>, 360–371. [<a href="https://scholar.google.com/scholar_lookup?title=Lineage+plasticity+in+cancer:+A+shared+pathway+of+therapeutic+resistance&author=Quintanal-Villalonga,+%C3%81.&author=Chan,+J.M.&author=Yu,+H.A.&author=Pe%E2%80%99er,+D.&author=Sawyers,+C.L.&author=Sen,+T.&author=Rudin,+C.M.&publication_year=2020&journal=Nat.+Rev.+Clin.+Oncol.&volume=17&pages=360%E2%80%93371&doi=10.1038/s41571-020-0340-z&pmid=32152485" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/s41571-020-0340-z" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/32152485" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B49-medsci-10-00025' class='html-xx' data-content='49.'>Pal, S.K.; Patel, J.; He, M.; Foulk, B.; Kraft, K.; Smirnov, D.A.; Twardowski, P.; Kortylewski, M.; Bhargava, V.; Jones, J.O. Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC). <span class='html-italic'>Cancer</span> <b>2018</b>, <span class='html-italic'>124</span>, 1216–1224. [<a href="https://scholar.google.com/scholar_lookup?title=Identification+of+mechanisms+of+resistance+to+treatment+with+abiraterone+acetate+or+enzalutamide+in+patients+with+castration-resistant+prostate+cancer+(CRPC)&author=Pal,+S.K.&author=Patel,+J.&author=He,+M.&author=Foulk,+B.&author=Kraft,+K.&author=Smirnov,+D.A.&author=Twardowski,+P.&author=Kortylewski,+M.&author=Bhargava,+V.&author=Jones,+J.O.&publication_year=2018&journal=Cancer&volume=124&pages=1216%E2%80%931224&doi=10.1002/cncr.31161&pmid=29266182" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/cncr.31161" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/29266182" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B50-medsci-10-00025' class='html-xx' data-content='50.'>Svensson, C.; Ceder, J.; Iglesias-Gato, D.; Chuan, Y.-C.; Pang, S.T.; Bjartell, A.; Martinez, R.M.; Bott, L.; Helczynski, L.; Ulmert, D.; et al. REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer. <span class='html-italic'>Nucleic Acids Res.</span> <b>2014</b>, <span class='html-italic'>42</span>, 999–1015. [<a href="https://scholar.google.com/scholar_lookup?title=REST+mediates+androgen+receptor+actions+on+gene+repression+and+predicts+early+recurrence+of+prostate+cancer&author=Svensson,+C.&author=Ceder,+J.&author=Iglesias-Gato,+D.&author=Chuan,+Y.-C.&author=Pang,+S.T.&author=Bjartell,+A.&author=Martinez,+R.M.&author=Bott,+L.&author=Helczynski,+L.&author=Ulmert,+D.&publication_year=2014&journal=Nucleic+Acids+Res.&volume=42&pages=999%E2%80%931015&doi=10.1093/nar/gkt921&pmid=24163104" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1093/nar/gkt921" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/24163104" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B51-medsci-10-00025' class='html-xx' data-content='51.'>Paller, C.; Pu, H.; Begemann, D.E.; Wade, C.A.; Hensley, P.J.; Kyprianou, N. TGF-β receptor I inhibitor enhances response to enzalutamide in a pre-clinical model of advanced prostate cancer. <span class='html-italic'>Prostate</span> <b>2019</b>, <span class='html-italic'>79</span>, 31–43. [<a href="https://scholar.google.com/scholar_lookup?title=TGF-%CE%B2+receptor+I+inhibitor+enhances+response+to+enzalutamide+in+a+pre-clinical+model+of+advanced+prostate+cancer&author=Paller,+C.&author=Pu,+H.&author=Begemann,+D.E.&author=Wade,+C.A.&author=Hensley,+P.J.&author=Kyprianou,+N.&publication_year=2019&journal=Prostate&volume=79&pages=31%E2%80%9343&doi=10.1002/pros.23708&pmid=30155899" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/pros.23708" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/30155899" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pros.23708" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B52-medsci-10-00025' class='html-xx' data-content='52.'>Canesin, G.; Krzyzanowska, A.; Hellsten, R.; Bjartell, A. Cytokines and Janus kinase/signal transducer and activator of transcription signaling in prostate cancer: Overview and therapeutic opportunities. <span class='html-italic'>Curr. Opin. Endocr. Metab. Res.</span> <b>2020</b>, <span class='html-italic'>10</span>, 36–42. [<a href="https://scholar.google.com/scholar_lookup?title=Cytokines+and+Janus+kinase/signal+transducer+and+activator+of+transcription+signaling+in+prostate+cancer:+Overview+and+therapeutic+opportunities&author=Canesin,+G.&author=Krzyzanowska,+A.&author=Hellsten,+R.&author=Bjartell,+A.&publication_year=2020&journal=Curr.+Opin.+Endocr.+Metab.+Res.&volume=10&pages=36%E2%80%9342&doi=10.1016/j.coemr.2020.02.004" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.coemr.2020.02.004" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B53-medsci-10-00025' class='html-xx' data-content='53.'>Jung, Y.; Cackowski, F.C.; Yumoto, K.; Decker, A.M.; Wang, J.; Kim, J.K.; Taichman, R.S. CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes. <span class='html-italic'>Cancer Res.</span> <b>2018</b>, <span class='html-italic'>78</span>, 2026–2039. [<a href="https://scholar.google.com/scholar_lookup?title=CXCL12%CE%B3+Promotes+Metastatic+Castration-Resistant+Prostate+Cancer+by+Inducing+Cancer+Stem+Cell+and+Neuroendocrine+Phenotypes&author=Jung,+Y.&author=Cackowski,+F.C.&author=Yumoto,+K.&author=Decker,+A.M.&author=Wang,+J.&author=Kim,+J.K.&author=Taichman,+R.S.&publication_year=2018&journal=Cancer+Res.&volume=78&pages=2026%E2%80%932039&doi=10.1158/0008-5472.CAN-17-2332" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/0008-5472.CAN-17-2332" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://cancerres.aacrjournals.org/content/canres/78/8/2026.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B54-medsci-10-00025' class='html-xx' data-content='54.'>Fletcher, C.E.; Sulpice, E.; Combe, S.; Shibakawa, A.; Leach, D.A.; Hamilton, M.P.; Chrysostomou, S.L.; Sharp, A.; Welti, J.; Yuan, W.; et al. Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer. <span class='html-italic'>Oncogene</span> <b>2019</b>, <span class='html-italic'>38</span>, 5700–5724. [<a href="https://scholar.google.com/scholar_lookup?title=Androgen+receptor-modulatory+microRNAs+provide+insight+into+therapy+resistance+and+therapeutic+targets+in+advanced+prostate+cancer&author=Fletcher,+C.E.&author=Sulpice,+E.&author=Combe,+S.&author=Shibakawa,+A.&author=Leach,+D.A.&author=Hamilton,+M.P.&author=Chrysostomou,+S.L.&author=Sharp,+A.&author=Welti,+J.&author=Yuan,+W.&publication_year=2019&journal=Oncogene&volume=38&pages=5700%E2%80%935724&doi=10.1038/s41388-019-0823-5&pmid=31043708" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/s41388-019-0823-5" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/31043708" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>] [<a href="https://www.nature.com/articles/s41388-019-0823-5.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B55-medsci-10-00025' class='html-xx' data-content='55.'>Fernandes, R.C.; Toubia, J.; Townley, S.; Hanson, A.R.; Dredge, B.K.; Pillman, K.A.; Bert, A.G.; Winter, J.M.; Iggo, R.; Das, R.; et al. Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate Cancer. <span class='html-italic'>Cell Rep.</span> <b>2021</b>, <span class='html-italic'>34</span>, 108585. [<a href="https://scholar.google.com/scholar_lookup?title=Post-transcriptional+Gene+Regulation+by+MicroRNA-194+Promotes+Neuroendocrine+Transdifferentiation+in+Prostate+Cancer&author=Fernandes,+R.C.&author=Toubia,+J.&author=Townley,+S.&author=Hanson,+A.R.&author=Dredge,+B.K.&author=Pillman,+K.A.&author=Bert,+A.G.&author=Winter,+J.M.&author=Iggo,+R.&author=Das,+R.&publication_year=2021&journal=Cell+Rep.&volume=34&pages=108585&doi=10.1016/j.celrep.2020.108585" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.celrep.2020.108585" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B56-medsci-10-00025' class='html-xx' data-content='56.'>Ebron, J.S.; Shankar, E.; Singh, J.; Sikand, K.; Weyman, C.M.; Gupta, S.; Lindner, D.J.; Liu, X.; Campbell, M.J.; Shukla, G.C. MiR-644a Disrupts Oncogenic Transformation and Warburg Effect by Direct Modulation of Multiple Genes of Tumor-Promoting Pathways. <span class='html-italic'>Cancer Res.</span> <b>2019</b>, <span class='html-italic'>79</span>, 1844–1856. [<a href="https://scholar.google.com/scholar_lookup?title=MiR-644a+Disrupts+Oncogenic+Transformation+and+Warburg+Effect+by+Direct+Modulation+of+Multiple+Genes+of+Tumor-Promoting+Pathways&author=Ebron,+J.S.&author=Shankar,+E.&author=Singh,+J.&author=Sikand,+K.&author=Weyman,+C.M.&author=Gupta,+S.&author=Lindner,+D.J.&author=Liu,+X.&author=Campbell,+M.J.&author=Shukla,+G.C.&publication_year=2019&journal=Cancer+Res.&volume=79&pages=1844%E2%80%931856&doi=10.1158/0008-5472.CAN-18-2993" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/0008-5472.CAN-18-2993" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="https://cancerres.aacrjournals.org/content/canres/79/8/1844.full.pdf" target='_blank' rel="noopener noreferrer">Green Version</a>]</li><li id='B57-medsci-10-00025' class='html-xx' data-content='57.'>Farah, E.; Li, C.; Cheng, L.; Kong, Y.; Lanman, N.A.; Pascuzzi, P.; Lorenz, G.R.; Zhang, Y.; Ahmad, N.; Li, L.; et al. NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells. <span class='html-italic'>J. Biol. Chem.</span> <b>2019</b>, <span class='html-italic'>294</span>, 8543–8554. [<a href="https://scholar.google.com/scholar_lookup?title=NOTCH+signaling+is+activated+in+and+contributes+to+resistance+in+enzalutamide-resistant+prostate+cancer+cells&author=Farah,+E.&author=Li,+C.&author=Cheng,+L.&author=Kong,+Y.&author=Lanman,+N.A.&author=Pascuzzi,+P.&author=Lorenz,+G.R.&author=Zhang,+Y.&author=Ahmad,+N.&author=Li,+L.&publication_year=2019&journal=J.+Biol.+Chem.&volume=294&pages=8543%E2%80%938554&doi=10.1074/jbc.RA118.006983&pmid=30940724" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1074/jbc.RA118.006983" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/30940724" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B58-medsci-10-00025' class='html-xx' data-content='58.'>Yuan, M.; Gao, Y.; Li, L.; Sun, W.; Cheng, H.; Li, T.; Wu, X. Phospholipase C (PLC)ε Promotes Androgen Receptor Antagonist Resistance via the Bone Morphogenetic Protein (BMP)-6/SMAD Axis in a Castration-Resistant Prostate Cancer Cell Line. <span class='html-italic'>Med. Sci. Monit.</span> <b>2019</b>, <span class='html-italic'>25</span>, 4438–4449. [<a href="https://scholar.google.com/scholar_lookup?title=Phospholipase+C+(PLC)%CE%B5+Promotes+Androgen+Receptor+Antagonist+Resistance+via+the+Bone+Morphogenetic+Protein+(BMP)-6/SMAD+Axis+in+a+Castration-Resistant+Prostate+Cancer+Cell+Line&author=Yuan,+M.&author=Gao,+Y.&author=Li,+L.&author=Sun,+W.&author=Cheng,+H.&author=Li,+T.&author=Wu,+X.&publication_year=2019&journal=Med.+Sci.+Monit.&volume=25&pages=4438%E2%80%934449&doi=10.12659/MSM.915828" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.12659/MSM.915828" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B59-medsci-10-00025' class='html-xx' data-content='59.'>Kohrt, S.E.; Awadallah, W.N.; Phillips, R.A.; Case, T.C.; Jin, R.; Nanda, J.S.; Grabowska, M.M. Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells In Vitro. <span class='html-italic'>Mol. Cancer Ther.</span> <b>2021</b>, <span class='html-italic'>20</span>, 398–409. [<a href="https://scholar.google.com/scholar_lookup?title=Identification+of+Genes+Required+for+Enzalutamide+Resistance+in+Castration-Resistant+Prostate+Cancer+Cells+In+Vitro&author=Kohrt,+S.E.&author=Awadallah,+W.N.&author=Phillips,+R.A.&author=Case,+T.C.&author=Jin,+R.&author=Nanda,+J.S.&author=Grabowska,+M.M.&publication_year=2021&journal=Mol.+Cancer+Ther.&volume=20&pages=398%E2%80%93409&doi=10.1158/1535-7163.MCT-20-0244&pmid=33298586" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/1535-7163.MCT-20-0244" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/33298586" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B60-medsci-10-00025' class='html-xx' data-content='60.'>Smith, M.R.; Saad, F.; Chowdhury, S.; Oudard, S.; Hadaschik, B.A.; Graff, J.N.; Olmos, D.; Mainwaring, P.N.; Lee, J.Y.; Uemura, H.; et al. Apalutamide and Overall Survival in Prostate Cancer. <span class='html-italic'>Eur. Urol.</span> <b>2021</b>, <span class='html-italic'>79</span>, 150–158. [<a href="https://scholar.google.com/scholar_lookup?title=Apalutamide+and+Overall+Survival+in+Prostate+Cancer&author=Smith,+M.R.&author=Saad,+F.&author=Chowdhury,+S.&author=Oudard,+S.&author=Hadaschik,+B.A.&author=Graff,+J.N.&author=Olmos,+D.&author=Mainwaring,+P.N.&author=Lee,+J.Y.&author=Uemura,+H.&publication_year=2021&journal=Eur.+Urol.&volume=79&pages=150%E2%80%93158&doi=10.1016/j.eururo.2020.08.011&pmid=32907777" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.eururo.2020.08.011" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/32907777" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B61-medsci-10-00025' class='html-xx' data-content='61.'>Buttigliero, C.; Tucci, M.; Bertaglia, V.; Vignani, F.; Bironzo, P.; Di Maio, M.; Scagliotti, G.V. Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer. <span class='html-italic'>Cancer Treat. Rev.</span> <b>2015</b>, <span class='html-italic'>41</span>, 884–892. [<a href="https://scholar.google.com/scholar_lookup?title=Understanding+and+overcoming+the+mechanisms+of+primary+and+acquired+resistance+to+abiraterone+and+enzalutamide+in+castration+resistant+prostate+cancer&author=Buttigliero,+C.&author=Tucci,+M.&author=Bertaglia,+V.&author=Vignani,+F.&author=Bironzo,+P.&author=Di+Maio,+M.&author=Scagliotti,+G.V.&publication_year=2015&journal=Cancer+Treat.+Rev.&volume=41&pages=884%E2%80%93892&doi=10.1016/j.ctrv.2015.08.002&pmid=26342718" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1016/j.ctrv.2015.08.002" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/26342718" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B62-medsci-10-00025' class='html-xx' data-content='62.'>Jentzmik, F.; Azoitei, A.; Zengerling, F.; Damjanoski, I.; Cronauer, M.V. Androgen receptor aberrations in the era of abiraterone and enzalutamide. <span class='html-italic'>World J. Urol.</span> <b>2016</b>, <span class='html-italic'>34</span>, 297–303. [<a href="https://scholar.google.com/scholar_lookup?title=Androgen+receptor+aberrations+in+the+era+of+abiraterone+and+enzalutamide&author=Jentzmik,+F.&author=Azoitei,+A.&author=Zengerling,+F.&author=Damjanoski,+I.&author=Cronauer,+M.V.&publication_year=2016&journal=World+J.+Urol.&volume=34&pages=297%E2%80%93303&doi=10.1007/s00345-015-1624-2&pmid=26100946" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1007/s00345-015-1624-2" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/26100946" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B63-medsci-10-00025' class='html-xx' data-content='63.'>Zhao, J.; Ning, S.; Lou, W.; Yang, J.C.; Armstrong, C.M.; Lombard, A.P.; Liu, C. Cross-Resistance Among Next-Generation Antiandrogen Drugs through the AKR1C3/AR-V7 Axis in Advanced Prostate Cancer. <span class='html-italic'>Mol. Cancer Ther.</span> <b>2020</b>, <span class='html-italic'>19</span>, 1708–1718. [<a href="https://scholar.google.com/scholar_lookup?title=Cross-Resistance+Among+Next-Generation+Antiandrogen+Drugs+through+the+AKR1C3/AR-V7+Axis+in+Advanced+Prostate+Cancer&author=Zhao,+J.&author=Ning,+S.&author=Lou,+W.&author=Yang,+J.C.&author=Armstrong,+C.M.&author=Lombard,+A.P.&author=Liu,+C.&publication_year=2020&journal=Mol.+Cancer+Ther.&volume=19&pages=1708%E2%80%931718&doi=10.1158/1535-7163.MCT-20-0015&pmid=32430485" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1158/1535-7163.MCT-20-0015" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/32430485" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B64-medsci-10-00025' class='html-xx' data-content='64.'>Simon, I.; Perales, S.; Casado-Medina, L.; Rodríguez-Martínez, A.; Garrido-Navas, M.; Puche-Sanz, I.; Diaz-Mochon, J.; Alaminos, C.; Lupiañez, P.; Lorente, J.; et al. Cross-Resistance to Abiraterone and Enzalutamide in Castration Resistance Prostate Cancer Cellular Models Is Mediated by AR Transcriptional Reactivation. <span class='html-italic'>Cancers</span> <b>2021</b>, <span class='html-italic'>13</span>, 1483. [<a href="https://scholar.google.com/scholar_lookup?title=Cross-Resistance+to+Abiraterone+and+Enzalutamide+in+Castration+Resistance+Prostate+Cancer+Cellular+Models+Is+Mediated+by+AR+Transcriptional+Reactivation&author=Simon,+I.&author=Perales,+S.&author=Casado-Medina,+L.&author=Rodr%C3%ADguez-Mart%C3%ADnez,+A.&author=Garrido-Navas,+M.&author=Puche-Sanz,+I.&author=Diaz-Mochon,+J.&author=Alaminos,+C.&author=Lupia%C3%B1ez,+P.&author=Lorente,+J.&publication_year=2021&journal=Cancers&volume=13&pages=1483&doi=10.3390/cancers13061483" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.3390/cancers13061483" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B65-medsci-10-00025' class='html-xx' data-content='65.'>De Bono, J.; Mateo, J.; Fizazi, K.; Saad, F.; Shore, N.; Sandhu, S.; Hussain, M. Olaparib for Metastatic Castration-Resistant Prostate Cancer. <span class='html-italic'>N. Engl. J. Med.</span> <b>2020</b>, <span class='html-italic'>382</span>, 2091–2102. [<a href="https://scholar.google.com/scholar_lookup?title=Olaparib+for+Metastatic+Castration-Resistant+Prostate+Cancer&author=De+Bono,+J.&author=Mateo,+J.&author=Fizazi,+K.&author=Saad,+F.&author=Shore,+N.&author=Sandhu,+S.&author=Hussain,+M.&publication_year=2020&journal=N.+Engl.+J.+Med.&volume=382&pages=2091%E2%80%932102&doi=10.1056/NEJMoa1911440&pmid=32343890" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1056/NEJMoa1911440" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/32343890" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B66-medsci-10-00025' class='html-xx' data-content='66.'>Endo, S.; Oguri, H.; Segawa, J.; Kawai, M.; Hu, D.; Xia, S.; Ikari, A. Development of Novel AKR1C3 Inhibitors as New Potential Treatment for Castration-Resistant Prostate Cancer. <span class='html-italic'>J. Med. Chem.</span> <b>2020</b>, <span class='html-italic'>63</span>, 10396–10411. [<a href="https://scholar.google.com/scholar_lookup?title=Development+of+Novel+AKR1C3+Inhibitors+as+New+Potential+Treatment+for+Castration-Resistant+Prostate+Cancer&author=Endo,+S.&author=Oguri,+H.&author=Segawa,+J.&author=Kawai,+M.&author=Hu,+D.&author=Xia,+S.&author=Ikari,+A.&publication_year=2020&journal=J.+Med.+Chem.&volume=63&pages=10396%E2%80%9310411&doi=10.1021/acs.jmedchem.0c00939&pmid=32847363" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1021/acs.jmedchem.0c00939" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/32847363" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B67-medsci-10-00025' class='html-xx' data-content='67.'>Wu, Z.; Wang, K.; Yang, Z.; Pascal, L.E.; Nelson, J.B.; Takubo, K.; Wang, Z. A novel androgen receptor antagonist JJ-450 inhibits enzalutamide-resistant mutant AR<sup>F876L</sup> nuclear import and function. <span class='html-italic'>Prostate</span> <b>2020</b>, <span class='html-italic'>80</span>, 319–328. [<a href="https://scholar.google.com/scholar_lookup?title=A+novel+androgen+receptor+antagonist+JJ-450+inhibits+enzalutamide-resistant+mutant+ARF876L+nuclear+import+and+function&author=Wu,+Z.&author=Wang,+K.&author=Yang,+Z.&author=Pascal,+L.E.&author=Nelson,+J.B.&author=Takubo,+K.&author=Wang,+Z.&publication_year=2020&journal=Prostate&volume=80&pages=319%E2%80%93328&doi=10.1002/pros.23945" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/pros.23945" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B68-medsci-10-00025' class='html-xx' data-content='68.'>Banuelos, C.A.; Ito, Y.; Obst, J.K.; Mawji, N.R.; Wang, J.; Hirayama, Y.; Leung, J.; Tam, T.; Tien, A.H.; Andersen, R.J.; et al. Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants. <span class='html-italic'>Cancers</span> <b>2020</b>, <span class='html-italic'>12</span>, 1991. [<a href="https://scholar.google.com/scholar_lookup?title=Ralaniten+Sensitizes+Enzalutamide-Resistant+Prostate+Cancer+to+Ionizing+Radiation+in+Prostate+Cancer+Cells+that+Express+Androgen+Receptor+Splice+Variants&author=Banuelos,+C.A.&author=Ito,+Y.&author=Obst,+J.K.&author=Mawji,+N.R.&author=Wang,+J.&author=Hirayama,+Y.&author=Leung,+J.&author=Tam,+T.&author=Tien,+A.H.&author=Andersen,+R.J.&publication_year=2020&journal=Cancers&volume=12&pages=1991&doi=10.3390/cancers12071991&pmid=32708219" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.3390/cancers12071991" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/32708219" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B69-medsci-10-00025' class='html-xx' data-content='69.'>Hirayama, Y.; Tam, T.; Jian, K.; Andersen, R.J.; Sadar, M.D. Combination therapy with androgen receptor N-terminal domain antagonist EPI-7170 and enzalutamide yields synergistic activity in AR-V7-positive prostate cancer. <span class='html-italic'>Mol. Oncol.</span> <b>2020</b>, <span class='html-italic'>14</span>, 2455–2470. [<a href="https://scholar.google.com/scholar_lookup?title=Combination+therapy+with+androgen+receptor+N-terminal+domain+antagonist+EPI-7170+and+enzalutamide+yields+synergistic+activity+in+AR-V7-positive+prostate+cancer&author=Hirayama,+Y.&author=Tam,+T.&author=Jian,+K.&author=Andersen,+R.J.&author=Sadar,+M.D.&publication_year=2020&journal=Mol.+Oncol.&volume=14&pages=2455%E2%80%932470&doi=10.1002/1878-0261.12770" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/1878-0261.12770" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B70-medsci-10-00025' class='html-xx' data-content='70.'>Monga, J.; Subramani, D.; Bharathan, A.; Ghosh, J. Pharmacological and genetic targeting of 5-lipoxygenase interrupts c-Myc oncogenic signaling and kills enzalutamide-resistant prostate cancer cells via apoptosis. <span class='html-italic'>Sci. Rep.</span> <b>2020</b>, <span class='html-italic'>10</span>, 6649. [<a href="https://scholar.google.com/scholar_lookup?title=Pharmacological+and+genetic+targeting+of+5-lipoxygenase+interrupts+c-Myc+oncogenic+signaling+and+kills+enzalutamide-resistant+prostate+cancer+cells+via+apoptosis&author=Monga,+J.&author=Subramani,+D.&author=Bharathan,+A.&author=Ghosh,+J.&publication_year=2020&journal=Sci.+Rep.&volume=10&pages=6649&doi=10.1038/s41598-020-62845-8&pmid=32313135" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1038/s41598-020-62845-8" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/32313135" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li><li id='B71-medsci-10-00025' class='html-xx' data-content='71.'>Abudurexiti, M.; Zhu, W.; Wang, Y.; Wang, J.; Xu, W.; Huang, Y.; Ye, D. Targeting CPT1B as a potential therapeutic strategy in castration-resistant and enzalutamide-resistant prostate cancer. <span class='html-italic'>Prostate</span> <b>2020</b>, <span class='html-italic'>80</span>, 950–961. [<a href="https://scholar.google.com/scholar_lookup?title=Targeting+CPT1B+as+a+potential+therapeutic+strategy+in+castration-resistant+and+enzalutamide-resistant+prostate+cancer&author=Abudurexiti,+M.&author=Zhu,+W.&author=Wang,+Y.&author=Wang,+J.&author=Xu,+W.&author=Huang,+Y.&author=Ye,+D.&publication_year=2020&journal=Prostate&volume=80&pages=950%E2%80%93961&doi=10.1002/pros.24027" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1002/pros.24027" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>]</li><li id='B72-medsci-10-00025' class='html-xx' data-content='72.'>Erb, H.H.H.; Bodenbender, J.; Handle, F.; Diehl, T.; Donix, L.; Tsaur, I.; Gleave, M.; Haferkamp, A.; Huber, J.; Fuessel, S.; et al. Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. <span class='html-italic'>PLoS ONE</span> <b>2020</b>, <span class='html-italic'>15</span>, e0237248. [<a href="https://scholar.google.com/scholar_lookup?title=Assessment+of+STAT5+as+a+potential+therapy+target+in+enzalutamide-resistant+prostate+cancer&author=Erb,+H.H.H.&author=Bodenbender,+J.&author=Handle,+F.&author=Diehl,+T.&author=Donix,+L.&author=Tsaur,+I.&author=Gleave,+M.&author=Haferkamp,+A.&author=Huber,+J.&author=Fuessel,+S.&publication_year=2020&journal=PLoS+ONE&volume=15&pages=e0237248&doi=10.1371/journal.pone.0237248&pmid=32790723" class='google-scholar' target='_blank' rel='noopener noreferrer'>Google Scholar</a>] [<a href="https://doi.org/10.1371/journal.pone.0237248" class='cross-ref' target='_blank' rel='noopener noreferrer'>CrossRef</a>] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/32790723" class='cross-ref' data-typ='pmid' target='_blank' rel='noopener noreferrer'>PubMed</a>]</li></ol></section><section id='Tables' type='display-objects'><div class="html-table-wrap" id="medsci-10-00025-t001"> <div class="html-table_wrap_td" > <div class="html-tablepopup html-tablepopup-link" data-counterslinkmanual = "https://www.mdpi.com/2076-3271/10/2/25/display" href='#table_body_display_medsci-10-00025-t001'> <img alt="Table" data-lsrc="https://www.mdpi.com/img/table.png" /> <a class="html-expand html-tablepopup" data-counterslinkmanual = "https://www.mdpi.com/2076-3271/10/2/25/display" href="#table_body_display_medsci-10-00025-t001"></a> </div> </div> <div class="html-table_wrap_discription"> <b>Table 1.</b> Mechanisms of resistance to abiraterone. </div> </div> <div class="html-table_show mfp-hide " id ="table_body_display_medsci-10-00025-t001" > <div class="html-caption" ><b>Table 1.</b> Mechanisms of resistance to abiraterone.</div> <table > <tbody ><tr ><td align='center' valign='middle' style='border-top:solid thin;background:black' class='html-align-center' > </td><td align='center' valign='middle' style='border-top:solid thin;background:black' class='html-align-center' > </td></tr><tr ><td align='center' valign='middle' class='html-align-center' >Activation of the “5α-dione” pathway</td><td align='center' valign='middle' class='html-align-center' >Chang et al. [<a href="#B10-medsci-10-00025" class="html-bibr">10</a>]</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >Overexpression of CYP17A1</td><td align='center' valign='middle' class='html-align-center' >Mostaghel et al. [<a href="#B11-medsci-10-00025" class="html-bibr">11</a>]</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >Androgen-receptor splice variant 7 (constitutive activity)</td><td align='center' valign='middle' class='html-align-center' >Antonarakis et al. [<a href="#B12-medsci-10-00025" class="html-bibr">12</a>]</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >Increased ErbB2 signaling</td><td align='center' valign='middle' class='html-align-center' >Gao et al. [<a href="#B16-medsci-10-00025" class="html-bibr">16</a>]</td></tr><tr ><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >Genomic alterations (TP53-BRCA2-ATM-AR)</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >Annala et al. [<a href="#B17-medsci-10-00025" class="html-bibr">17</a>]</td></tr></tbody> </table> </div><div class="html-table-wrap" id="medsci-10-00025-t002"> <div class="html-table_wrap_td" > <div class="html-tablepopup html-tablepopup-link" data-counterslinkmanual = "https://www.mdpi.com/2076-3271/10/2/25/display" href='#table_body_display_medsci-10-00025-t002'> <img alt="Table" data-lsrc="https://www.mdpi.com/img/table.png" /> <a class="html-expand html-tablepopup" data-counterslinkmanual = "https://www.mdpi.com/2076-3271/10/2/25/display" href="#table_body_display_medsci-10-00025-t002"></a> </div> </div> <div class="html-table_wrap_discription"> <b>Table 2.</b> Mechanisms of resistance to enzalutamide. </div> </div> <div class="html-table_show mfp-hide " id ="table_body_display_medsci-10-00025-t002" > <div class="html-caption" ><b>Table 2.</b> Mechanisms of resistance to enzalutamide.</div> <table > <tbody ><tr ><td align='center' valign='middle' style='border-top:solid thin;background:black' class='html-align-center' > </td><td align='center' valign='middle' style='border-top:solid thin;background:black' class='html-align-center' > </td></tr><tr ><td align='center' valign='middle' class='html-align-center' >Androgen receptor (AR) persistent activation</td><td align='center' valign='middle' class='html-align-center' >Yuan et al. [<a href="#B18-medsci-10-00025" class="html-bibr">18</a>]</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >AR splice variants</td><td align='center' valign='middle' class='html-align-center' >Antonarakis et al. [<a href="#B12-medsci-10-00025" class="html-bibr">12</a>], Zhao et al. [<a href="#B24-medsci-10-00025" class="html-bibr">24</a>]</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >AR mutations</td><td align='center' valign='middle' class='html-align-center' >Snow et al. [<a href="#B27-medsci-10-00025" class="html-bibr">27</a>], Korpal et al. [<a href="#B28-medsci-10-00025" class="html-bibr">28</a>]</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >Glucocorticoids receptor upregulation</td><td align='center' valign='middle' class='html-align-center' >Arora et al. [<a href="#B30-medsci-10-00025" class="html-bibr">30</a>]</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >Activation of Wnt pathway</td><td align='center' valign='middle' class='html-align-center' >Zhang et al. [<a href="#B31-medsci-10-00025" class="html-bibr">31</a>]</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >Metabolic modifications</td><td align='center' valign='middle' class='html-align-center' >Wang et al. [<a href="#B34-medsci-10-00025" class="html-bibr">34</a>], Latonen et al. [<a href="#B35-medsci-10-00025" class="html-bibr">35</a>], Nguyen et al. [<a href="#B36-medsci-10-00025" class="html-bibr">36</a>]</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >Inhibition of apoptosis</td><td align='center' valign='middle' class='html-align-center' >Siddiqui et al. [<a href="#B37-medsci-10-00025" class="html-bibr">37</a>], Krajewska et al. [<a href="#B38-medsci-10-00025" class="html-bibr">38</a>]</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >Phenotypic switch</td><td align='center' valign='middle' class='html-align-center' >Miao et al. [<a href="#B41-medsci-10-00025" class="html-bibr">41</a>], Pal et al. [<a href="#B43-medsci-10-00025" class="html-bibr">43</a>]</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >Cytokine signaling </td><td align='center' valign='middle' class='html-align-center' >Canesin et al. [<a href="#B45-medsci-10-00025" class="html-bibr">45</a>], Jung et al. [<a href="#B46-medsci-10-00025" class="html-bibr">46</a>]</td></tr><tr ><td align='center' valign='middle' class='html-align-center' >miRNA regulation of gene expression</td><td align='center' valign='middle' class='html-align-center' >Fletcher et al. [<a href="#B47-medsci-10-00025" class="html-bibr">47</a>], Ebron et al. [<a href="#B49-medsci-10-00025" class="html-bibr">49</a>]</td></tr><tr ><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >Other pathways (NOTCH, HMGCR)</td><td align='center' valign='middle' style='border-bottom:solid thin' class='html-align-center' >Farah et al. [<a href="#B50-medsci-10-00025" class="html-bibr">50</a>], Yuan et al. [<a href="#B51-medsci-10-00025" class="html-bibr">51</a>]</td></tr></tbody> </table> </div></section><section class='html-fn_group'><table><tr id=''><td></td><td><div class='html-p'><b>Publisher’s Note:</b> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</div></td></tr></table></section> <section id="html-copyright"><br>© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href='https://creativecommons.org/licenses/by/4.0/' target='_blank' rel="noopener noreferrer" >https://creativecommons.org/licenses/by/4.0/</a>).</section> </div> </div> <div class="additional-content"> <h2><a name="cite"></a>Share and Cite</h2> <div class="social-media-links" style="text-align: left;"> <a href="/cdn-cgi/l/email-protection#e5dac3848895de9690878f808691d8a3978a88c0d7d5a8a1b5acc0d6a4c0d7d5c0d7d7a880868d848b8c968896c0d7d58a83c0d7d5b780968c9691848b8680c0d7d5918ac0d7d5b680868a8b81c8a2808b809784918c8a8bc0d7d5a48b918c848b81978a82808bc0d7d5b18d809784959cc0d7d5838a97c0d7d5b5978a9691849180c0d7d5a6848b868097c0d6a4c0d7d5a48691908489c0d7d5ae8b8a928980818280c0d7d5848b81c0d7d5b5809796958086918c938096c394908a91dec3848895de878a819cd88d91919596dfcaca929292cb8881958ccb868a88cad4d3d5ddd6d5d1c0d6a4c0d5a4c0d5a4a880868d848b8c968896c0d7d58a83c0d7d5b780968c9691848b8680c0d7d5918ac0d7d5b680868a8b81c8a2808b809784918c8a8bc0d7d5a48b918c848b81978a82808bc0d7d5b18d809784959cc0d7d5838a97c0d7d5b5978a9691849180c0d7d5a6848b868097c0d6a4c0d7d5a48691908489c0d7d5ae8b8a928980818280c0d7d5848b81c0d7d5b5809796958086918c938096c0d5a4c0d5a4a487969197848691c0d6a4c0d7d5b5978a9691849180c0d7d586848b868097c0d7d5918d809784959cc0d7d5838a97c0d7d5898a868489899cc0d7d5848193848b868081c0d7d5848b81c0d7d588809184969184918c86c0d7d5818c968084968096c0d7d58c8b868990818096c0d7d5848b81978a82808bc0d7d5818095978c9384918c8a8bc0d7d5918d809784959cc0d7d5c0d7dda4a1b1c0d7dccbc0d7d5b680868a8b81c882808b809784918c8a8bc0d7d5848b918c848b81978a82808b96c0d7d58d849380c0d7d584c0d7d5978a8980c0d7d58c8bc0d7d5868496919784918c8a8bc89780968c9691848b91c0d7d595978a9691849180c0d7d586848b868097cbc0d7d5ab80938097918d8089809696c0d7a6c0d7d5968a8880c0d7d59584918c808b9196c0d7d5818ac0d7d58b8a91c0d7d5978096958a8b81c0d7d5918ac0d7d5918d8c96c0d7d5918d809784959cc0d7a6c0d7d5848b81c0d7d58093808b91908489899cc0d7d5848989c0d7d5918d80c0d7d59584918c808b9196c0d7d5878086848880c0d7d59780968c9691848b91cbc0d7d5b18d8c96c0d7d58c96c0d7d5819080c0d7d5918ac0d7d5888a818c838c8684918c8a8b96c0d7d5918ac0d7d58c8b9197848680898990898497c0d7d5968c828b84898c8b82c0d7d59584918d92849c96c0d7a6c0d7d582808b8a888c86c0d7d5848991809784918c8a8bc0d7a6c0d7d5869c918a8e8c8b8096c0d7d595978a819086918c8a8bc0d7a6c0d7d588809184878a898c86c0d7d596928c91868d8096c0d7a6c0d7d5868a8b96918c9190918c8a8b8489c0d7d59780868095918a97c0d7d58486918c9384918c8a8bc0d7a6c0d7d58a938097809d95978096968c8a8bc0d7d58a83c0d7d5968a8880c0d7d595978a91808c8b96c0d7a6c0d7d5848b81c0d7d5978082908984918c8a8bc0d7d58a83c0d7d582808b80c0d7d5809d95978096968c8a8bcbc0d7d5b18d80c0d7d5848c88c0d7d58a83c0d7d5918d8c96c0d7d59780938c8092c0d7d58c96c0d7d5918ac0d7d58180838c8b80c0d7d5918d80c0d7d5888a9691c0d7d58c88958a9791848b91c0d7d58880868d848b8c968896c0d7d5918d8491c0d7d581978c9380c0d7d5918d8c96c0d7d59780968c9691848b8680c0d7d5848b81c0d7d5918d80c0d7d58b8092809691c0d7d5818c96868a9380978c8096c0d7d58c8bc0d7d5918d8c96c0d7d5838c808981c0d7a6c0d7d5969580868c838c868489899cc0d7d5838a97c0d7d5808b9f8489909184888c8180c0d7d5848b81c0d7d584878c97849180978a8b80c0d7a6c0d7d5928c918dc0d7d5958a91808b918c8489c0d7d58c8895898c8684918c8a8b96c0d7d5838a97c0d7d5839091909780c0d7d5918d809784958090918c86c0d7d591849782809196cbc0d7d5a39097918d8097888a9780c0d7a6c0d7d584958489909184888c8180c0d7d5848b81c0d7d58184978a89909184888c8180c0d7d5968d849780c0d7d5968a8880c0d7d59780968c9691848b8680c0d7d58880868d848b8c968896c0d7d5928c918dc0d7d584878c97849180978a8b80c0d7d5848b81c0d7d5808b9f8489909184888c8180c0d7d5848b81c0d7d5868a908981c0d7d58780c0d7d5909680839089c0d7d58c8bc0d7d5968a8880c0d7d59780968c9691848b8680c0d7d5968091918c8b8296cb" title="Email"> <i class="fa fa-envelope-square" style="font-size: 30px;"></i> </a> <a href="https://twitter.com/intent/tweet?text=Mechanisms+of+Resistance+to+Second-Generation+Antiandrogen+Therapy+for+Prostate+Cancer%3A+Actual+Knowledge+and+Perspectives&hashtags=mdpimedsci&url=https%3A%2F%2Fwww.mdpi.com%2F1608304&via=medsci_MDPI" onclick="windowOpen(this.href,600,800); return false" target="_blank" rel="noopener noreferrer"> <i class="fa fa-twitter-x-square" style="font-size: 30px;"></i> </a> <a href=" http://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.mdpi.com%2F1608304&title=Mechanisms%20of%20Resistance%20to%20Second-Generation%20Antiandrogen%20Therapy%20for%20Prostate%20Cancer%3A%20Actual%20Knowledge%20and%20Perspectives%26source%3Dhttps%3A%2F%2Fwww.mdpi.com%26summary%3DProstate%20cancer%20therapy%20for%20locally%20advanced%20and%20metastatic%20diseases%20includes%20androgen%20deprivation%20therapy%20%28ADT%29.%20Second-generation%20antiandrogens%20have%20a%20role%20in%20castration-resistant%20prostate%20cancer.%20Nevertheless%2C%20some%20patients%20do%20not%20respond%20to%20this%20%5B...%5D" onclick="windowOpen(this.href,600,800); return false" title="LinkedIn" target="_blank" rel="noopener noreferrer"> <i class="fa fa-linkedin-square" style="font-size: 30px;"></i> </a> <a href="https://www.facebook.com/sharer.php?u=https://www.mdpi.com/1608304" title="facebook" target="_blank" rel="noopener noreferrer"> <i class="fa fa-facebook-square" style="font-size: 30px;"></i> </a> <a href="javascript:void(0);" title="Wechat" data-reveal-id="weixin-share-modal"> <i class="fa fa-weixin-square" style="font-size: 26px;"></i> </a> <a href="http://www.reddit.com/submit?url=https://www.mdpi.com/1608304" title="Reddit" target="_blank" rel="noopener noreferrer"> <i class="fa fa-reddit-square" style="font-size: 30px;"></i> </a> <a href="http://www.mendeley.com/import/?url=https://www.mdpi.com/1608304" title="Mendeley" target="_blank" rel="noopener noreferrer"> <i class="fa fa-mendeley-square" style="font-size: 30px;"></i> </a> </div> <div class="in-tab" style="padding-top: 0px!important; margin-top: 15px;"> <div><b>MDPI and ACS Style</b></div> <p> Pinto, F.; Dibitetto, F.; Ragonese, M.; Bassi, P. Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives. <em>Med. Sci.</em> <b>2022</b>, <em>10</em>, 25. https://doi.org/10.3390/medsci10020025 </p> <div style="display: block"> <b>AMA Style</b><br> <p> Pinto F, Dibitetto F, Ragonese M, Bassi P. Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives. <em>Medical Sciences</em>. 2022; 10(2):25. https://doi.org/10.3390/medsci10020025 </p> <b>Chicago/Turabian Style</b><br> <p> Pinto, Francesco, Francesco Dibitetto, Mauro Ragonese, and Pierfrancesco Bassi. 2022. "Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives" <em>Medical Sciences</em> 10, no. 2: 25. https://doi.org/10.3390/medsci10020025 </p> <b>APA Style</b><br> <p> Pinto, F., Dibitetto, F., Ragonese, M., & Bassi, P. (2022). Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives. <em>Medical Sciences</em>, <em>10</em>(2), 25. https://doi.org/10.3390/medsci10020025 </p> </div> </div> <div class="info-box no-margin"> Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details <a target="_blank" href="https://www.mdpi.com/about/announcements/784">here</a>. </div> <h2><a name="metrics"></a>Article Metrics</h2> <div class="row"> <div class="small-12 columns"> <div id="loaded_cite_count" style="display:none">No</div> <div id="framed_div_cited_count" class="in-tab" style="display: none; overflow: auto;"></div> <div id="loaded" style="display:none">No</div> <div id="framed_div" class="in-tab" style="display: none; margin-top: 10px;"></div> </div> <div class="small-12 columns"> <div id="article_stats_div" style="display: none; margin-bottom: 1em;"> <h3>Article Access Statistics</h3> <div id="article_stats_swf" ></div> <div class="info-box"> Multiple requests from the same IP address are counted as one view. </div> </div> </div> </div> </div> </div> </article> </div> </div></div> <div class="webpymol-controls webpymol-controls-template" style="margin-top: 10px; display: none;"> <a class="bzoom">Zoom</a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="borient"> Orient </a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="blines"> As Lines </a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="bsticks"> As Sticks </a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="bcartoon"> As Cartoon </a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="bsurface"> As Surface </a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="bprevscene">Previous Scene</a> <span style="display: inline-block; margin-left: 5px; margin-right: 5px;">|</span> <a class="bnextscene">Next Scene</a> </div> <div id="scifeed-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="modalTitle" aria-hidden="true" role="dialog"> </div> <div id="recommended-articles-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="modalTitle" aria-hidden="true" role="dialog"> </div> <div id="author-biographies-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="modalTitle" aria-hidden="true" role="dialog"> </div> <div id="cite-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="Captcha" aria-hidden="true" role="dialog"> <div class="row"> <div class="small-12 columns"> <h2 style="margin: 0;">Cite</h2> </div> <div class="small-12 columns">  <form style="margin:0; padding:0; display:inline;" name="export-bibtex" method="POST" action="/export"> <input type="hidden" name="articles_ids[]" value="804152"> <input type="hidden" name="export_format_top" value="bibtex"> <input type="hidden" name="export_submit_top" value=""> </form>  <form style="margin:0; padding:0; display:inline;" name="export-endnote" method="POST" action="/export"> <input type="hidden" name="articles_ids[]" value="804152"> <input type="hidden" name="export_format_top" value="endnote_no_abstract"> <input type="hidden" name="export_submit_top" value=""> </form>  <form style="margin:0; padding:0; display:inline;" name="export-ris" method="POST" action="/export"> <input type="hidden" name="articles_ids[]" value="804152"> <input type="hidden" name="export_format_top" value="ris"> <input type="hidden" name="export_submit_top" value=""> </form> <div> Export citation file: <a href="javascript:window.document.forms['export-bibtex'].submit()">BibTeX</a> | <a href="javascript:window.document.forms['export-endnote'].submit()">EndNote</a> | <a href="javascript:window.document.forms['export-ris'].submit()">RIS</a> </div> </div> <div class="small-12 columns"> <div class="in-tab"> <div><b>MDPI and ACS Style</b></div> <p> Pinto, F.; Dibitetto, F.; Ragonese, M.; Bassi, P. Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives. <em>Med. Sci.</em> <b>2022</b>, <em>10</em>, 25. https://doi.org/10.3390/medsci10020025 </p> <div style="display: block"> <b>AMA Style</b><br> <p> Pinto F, Dibitetto F, Ragonese M, Bassi P. Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives. <em>Medical Sciences</em>. 2022; 10(2):25. https://doi.org/10.3390/medsci10020025 </p> <b>Chicago/Turabian Style</b><br> <p> Pinto, Francesco, Francesco Dibitetto, Mauro Ragonese, and Pierfrancesco Bassi. 2022. "Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives" <em>Medical Sciences</em> 10, no. 2: 25. https://doi.org/10.3390/medsci10020025 </p> <b>APA Style</b><br> <p> Pinto, F., Dibitetto, F., Ragonese, M., & Bassi, P. (2022). Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives. <em>Medical Sciences</em>, <em>10</em>(2), 25. https://doi.org/10.3390/medsci10020025 </p> </div> </div> <div class="info-box no-margin"> Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details <a target="_blank" href="https://www.mdpi.com/about/announcements/784">here</a>. </div> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> </div> </div> </div> </div> </section> <div id="footer"> <div class="journal-info"> <span> <em><a class="Var_JournalInfo" href="/journal/medsci">Med. Sci.</a></em>, EISSN 2076-3271, Published by MDPI </span> <div class="large-right"> <span> <a href="/rss/journal/medsci" class="rss-link">RSS</a> </span> <span> <a href="/journal/medsci/toc-alert">Content Alert</a> </span> </div> </div> <div class="row full-width footer-links" data-equalizer="footer" data-equalizer-mq="small"> <div class="large-2 large-push-4 medium-3 small-6 columns" data-equalizer-watch="footer"> <h3> Further Information </h3> <a href="/apc"> Article Processing Charges </a> <a href="/about/payment"> Pay an Invoice </a> <a href="/openaccess"> Open Access Policy </a> <a href="/about/contact"> Contact MDPI </a> <a href="https://careers.mdpi.com" target="_blank" rel="noopener noreferrer"> Jobs at MDPI </a> </div> <div class="large-2 large-push-4 medium-3 small-6 columns" data-equalizer-watch="footer"> <h3> Guidelines </h3> <a href="/authors"> For Authors </a> <a href="/reviewers"> For Reviewers </a> <a href="/editors"> For Editors </a> <a href="/librarians"> For Librarians </a> <a href="/publishing_services"> For Publishers </a> <a href="/societies"> For Societies </a> <a href="/conference_organizers"> For Conference Organizers </a> </div> <div class="large-2 large-push-4 medium-3 small-6 columns"> <h3> MDPI Initiatives </h3> <a href="https://sciforum.net" target="_blank" rel="noopener noreferrer"> Sciforum </a> <a href="https://www.mdpi.com/books" target="_blank" rel="noopener noreferrer"> MDPI Books </a> <a href="https://www.preprints.org" target="_blank" rel="noopener noreferrer"> Preprints.org </a> <a href="https://www.scilit.net" target="_blank" rel="noopener noreferrer"> Scilit </a> <a href="https://sciprofiles.com?utm_source=mpdi.com&utm_medium=bottom_menu&utm_campaign=initiative" target="_blank" rel="noopener noreferrer"> SciProfiles </a> <a href="https://encyclopedia.pub" target="_blank" rel="noopener noreferrer"> Encyclopedia </a> <a href="https://jams.pub" target="_blank" rel="noopener noreferrer"> JAMS </a> <a href="/about/proceedings"> Proceedings Series </a> </div> <div class="large-2 large-push-4 medium-3 small-6 right-border-large-without columns UA_FooterFollowMDPI"> <h3> Follow MDPI </h3> <a href="https://www.linkedin.com/company/mdpi" target="_blank" rel="noopener noreferrer"> LinkedIn </a> <a href="https://www.facebook.com/MDPIOpenAccessPublishing" target="_blank" rel="noopener noreferrer"> Facebook </a> <a href="https://twitter.com/MDPIOpenAccess" target="_blank" rel="noopener noreferrer"> Twitter </a> </div> <div id="footer-subscribe" class="large-4 large-pull-8 medium-12 small-12 left-border-large columns"> <div class="footer-subscribe__container"> <img class="show-for-large-up" src="https://pub.mdpi-res.com/img/design/mdpi-pub-logo-white-small.png?71d18e5f805839ab?1732615622" alt="MDPI" title="MDPI Open Access Journals" style="height: 50px; margin-bottom: 10px;"> <form id="newsletter" method="POST" action="/subscribe"> <p> Subscribe to receive issue release notifications and newsletters from MDPI journals </p> <select multiple id="newsletter-journal" class="foundation-select" name="journals[]"> <option value="acoustics">Acoustics</option> <option value="amh">Acta Microbiologica Hellenica</option> <option value="actuators">Actuators</option> <option value="admsci">Administrative Sciences</option> <option value="adolescents">Adolescents</option> <option value="arm">Advances in Respiratory Medicine</option> <option value="aerobiology">Aerobiology</option> <option value="aerospace">Aerospace</option> <option value="agriculture">Agriculture</option> <option value="agriengineering">AgriEngineering</option> <option value="agrochemicals">Agrochemicals</option> <option value="agronomy">Agronomy</option> <option value="ai">AI</option> <option value="air">Air</option> <option value="algorithms">Algorithms</option> <option value="allergies">Allergies</option> <option value="alloys">Alloys</option> <option value="analytica">Analytica</option> <option value="analytics">Analytics</option> <option value="anatomia">Anatomia</option> <option value="anesthres">Anesthesia Research</option> <option value="animals">Animals</option> <option value="antibiotics">Antibiotics</option> <option value="antibodies">Antibodies</option> <option value="antioxidants">Antioxidants</option> <option value="applbiosci">Applied Biosciences</option> <option value="applmech">Applied Mechanics</option> <option value="applmicrobiol">Applied Microbiology</option> <option value="applnano">Applied Nano</option> <option value="applsci">Applied Sciences</option> <option value="asi">Applied System Innovation</option> <option value="appliedchem">AppliedChem</option> <option value="appliedmath">AppliedMath</option> <option value="aquacj">Aquaculture Journal</option> <option value="architecture">Architecture</option> <option value="arthropoda">Arthropoda</option> <option value="arts">Arts</option> <option value="astronomy">Astronomy</option> <option value="atmosphere">Atmosphere</option> <option value="atoms">Atoms</option> <option value="audiolres">Audiology Research</option> <option value="automation">Automation</option> <option value="axioms">Axioms</option> <option value="bacteria">Bacteria</option> <option value="batteries">Batteries</option> <option value="behavsci">Behavioral Sciences</option> <option value="beverages">Beverages</option> <option value="BDCC">Big Data and Cognitive Computing</option> <option value="biochem">BioChem</option> <option value="bioengineering">Bioengineering</option> <option value="biologics">Biologics</option> <option value="biology">Biology</option> <option value="blsf">Biology and Life Sciences Forum</option> <option value="biomass">Biomass</option> <option value="biomechanics">Biomechanics</option> <option value="biomed">BioMed</option> <option value="biomedicines">Biomedicines</option> <option value="biomedinformatics">BioMedInformatics</option> <option value="biomimetics">Biomimetics</option> <option value="biomolecules">Biomolecules</option> <option value="biophysica">Biophysica</option> <option value="biosensors">Biosensors</option> <option value="biotech">BioTech</option> <option value="birds">Birds</option> <option value="blockchains">Blockchains</option> <option value="brainsci">Brain Sciences</option> <option value="buildings">Buildings</option> <option value="businesses">Businesses</option> <option value="carbon">C</option> <option value="cancers">Cancers</option> <option value="cardiogenetics">Cardiogenetics</option> <option value="catalysts">Catalysts</option> <option value="cells">Cells</option> <option value="ceramics">Ceramics</option> <option value="challenges">Challenges</option> <option value="ChemEngineering">ChemEngineering</option> <option value="chemistry">Chemistry</option> <option value="chemproc">Chemistry Proceedings</option> <option value="chemosensors">Chemosensors</option> <option value="children">Children</option> <option value="chips">Chips</option> <option value="civileng">CivilEng</option> <option value="cleantechnol">Clean Technologies</option> <option value="climate">Climate</option> <option value="ctn">Clinical and Translational Neuroscience</option> <option value="clinbioenerg">Clinical Bioenergetics</option> <option value="clinpract">Clinics and Practice</option> <option value="clockssleep">Clocks & Sleep</option> <option value="coasts">Coasts</option> <option value="coatings">Coatings</option> <option value="colloids">Colloids and Interfaces</option> <option value="colorants">Colorants</option> <option value="commodities">Commodities</option> <option value="complications">Complications</option> <option value="compounds">Compounds</option> <option value="computation">Computation</option> <option value="csmf">Computer Sciences & Mathematics Forum</option> <option value="computers">Computers</option> <option value="condensedmatter">Condensed Matter</option> <option value="conservation">Conservation</option> <option value="constrmater">Construction Materials</option> <option value="cmd">Corrosion and Materials Degradation</option> <option value="cosmetics">Cosmetics</option> <option value="covid">COVID</option> <option value="crops">Crops</option> <option value="cryo">Cryo</option> <option value="cryptography">Cryptography</option> <option value="crystals">Crystals</option> <option value="cimb">Current Issues in Molecular Biology</option> <option value="curroncol">Current Oncology</option> <option value="dairy">Dairy</option> <option value="data">Data</option> <option value="dentistry">Dentistry Journal</option> <option value="dermato">Dermato</option> <option value="dermatopathology">Dermatopathology</option> <option value="designs">Designs</option> <option value="diabetology">Diabetology</option> <option value="diagnostics">Diagnostics</option> <option value="dietetics">Dietetics</option> <option value="digital">Digital</option> <option value="disabilities">Disabilities</option> <option value="diseases">Diseases</option> <option value="diversity">Diversity</option> <option value="dna">DNA</option> <option value="drones">Drones</option> <option value="ddc">Drugs and Drug Candidates</option> <option value="dynamics">Dynamics</option> <option value="earth">Earth</option> <option value="ecologies">Ecologies</option> <option value="econometrics">Econometrics</option> <option value="economies">Economies</option> <option value="education">Education Sciences</option> <option value="electricity">Electricity</option> <option value="electrochem">Electrochem</option> <option value="electronicmat">Electronic Materials</option> <option value="electronics">Electronics</option> <option value="ecm">Emergency Care and Medicine</option> <option value="encyclopedia">Encyclopedia</option> <option value="endocrines">Endocrines</option> <option value="energies">Energies</option> <option value="esa">Energy Storage and Applications</option> <option value="eng">Eng</option> <option value="engproc">Engineering Proceedings</option> <option value="entropy">Entropy</option> <option value="environsciproc">Environmental Sciences Proceedings</option> <option value="environments">Environments</option> <option value="epidemiologia">Epidemiologia</option> <option value="epigenomes">Epigenomes</option> <option value="ebj">European Burn Journal</option> <option value="ejihpe">European Journal of Investigation in Health, Psychology and Education</option> <option value="fermentation">Fermentation</option> <option value="fibers">Fibers</option> <option value="fintech">FinTech</option> <option value="fire">Fire</option> <option value="fishes">Fishes</option> <option value="fluids">Fluids</option> <option value="foods">Foods</option> <option value="forecasting">Forecasting</option> <option value="forensicsci">Forensic Sciences</option> <option value="forests">Forests</option> <option value="fossstud">Fossil Studies</option> <option value="foundations">Foundations</option> <option value="fractalfract">Fractal and Fractional</option> <option value="fuels">Fuels</option> <option value="future">Future</option> <option value="futureinternet">Future Internet</option> <option value="futurepharmacol">Future Pharmacology</option> <option value="futuretransp">Future Transportation</option> <option value="galaxies">Galaxies</option> <option value="games">Games</option> <option value="gases">Gases</option> <option value="gastroent">Gastroenterology Insights</option> <option value="gastrointestdisord">Gastrointestinal Disorders</option> <option value="gastronomy">Gastronomy</option> <option value="gels">Gels</option> <option value="genealogy">Genealogy</option> <option value="genes">Genes</option> <option value="geographies">Geographies</option> <option value="geohazards">GeoHazards</option> <option value="geomatics">Geomatics</option> <option value="geometry">Geometry</option> <option value="geosciences">Geosciences</option> <option value="geotechnics">Geotechnics</option> <option value="geriatrics">Geriatrics</option> <option value="glacies">Glacies</option> <option value="gucdd">Gout, Urate, and Crystal Deposition Disease</option> <option value="grasses">Grasses</option> <option value="hardware">Hardware</option> <option value="healthcare">Healthcare</option> <option value="hearts">Hearts</option> <option value="hemato">Hemato</option> <option value="hematolrep">Hematology Reports</option> <option value="heritage">Heritage</option> <option value="histories">Histories</option> <option value="horticulturae">Horticulturae</option> <option value="hospitals">Hospitals</option> <option value="humanities">Humanities</option> <option value="humans">Humans</option> <option value="hydrobiology">Hydrobiology</option> <option value="hydrogen">Hydrogen</option> <option value="hydrology">Hydrology</option> <option value="hygiene">Hygiene</option> <option value="immuno">Immuno</option> <option value="idr">Infectious Disease Reports</option> <option value="informatics">Informatics</option> <option value="information">Information</option> <option value="infrastructures">Infrastructures</option> <option value="inorganics">Inorganics</option> <option value="insects">Insects</option> <option value="instruments">Instruments</option> <option value="iic">Intelligent Infrastructure and Construction</option> <option value="ijerph">International Journal of Environmental Research and Public Health</option> <option value="ijfs">International Journal of Financial Studies</option> <option value="ijms">International Journal of Molecular Sciences</option> <option value="IJNS">International Journal of Neonatal Screening</option> <option value="ijpb">International Journal of Plant Biology</option> <option value="ijt">International Journal of Topology</option> <option value="ijtm">International Journal of Translational Medicine</option> <option value="ijtpp">International Journal of Turbomachinery, Propulsion and Power</option> <option value="ime">International Medical Education</option> <option value="inventions">Inventions</option> <option value="IoT">IoT</option> <option value="ijgi">ISPRS International Journal of Geo-Information</option> <option value="J">J</option> <option value="jal">Journal of Ageing and Longevity</option> <option value="jcdd">Journal of Cardiovascular Development and Disease</option> <option value="jcto">Journal of Clinical & Translational Ophthalmology</option> <option value="jcm">Journal of Clinical Medicine</option> <option value="jcs">Journal of Composites Science</option> <option value="jcp">Journal of Cybersecurity and Privacy</option> <option value="jdad">Journal of Dementia and Alzheimer's Disease</option> <option value="jdb">Journal of Developmental Biology</option> <option value="jeta">Journal of Experimental and Theoretical Analyses</option> <option value="jfb">Journal of Functional Biomaterials</option> <option value="jfmk">Journal of Functional Morphology and Kinesiology</option> <option value="jof">Journal of Fungi</option> <option value="jimaging">Journal of Imaging</option> <option value="jintelligence">Journal of Intelligence</option> <option value="jlpea">Journal of Low Power Electronics and Applications</option> <option value="jmmp">Journal of Manufacturing and Materials Processing</option> <option value="jmse">Journal of Marine Science and Engineering</option> <option value="jmahp">Journal of Market Access & Health Policy</option> <option value="jmp">Journal of Molecular Pathology</option> <option value="jnt">Journal of Nanotheranostics</option> <option value="jne">Journal of Nuclear Engineering</option> <option value="ohbm">Journal of Otorhinolaryngology, Hearing and Balance Medicine</option> <option value="jop">Journal of Parks</option> <option value="jpm">Journal of Personalized Medicine</option> <option value="jpbi">Journal of Pharmaceutical and BioTech Industry</option> <option value="jor">Journal of Respiration</option> <option value="jrfm">Journal of Risk and Financial Management</option> <option value="jsan">Journal of Sensor and Actuator Networks</option> <option value="joma">Journal of the Oman Medical Association</option> <option value="jtaer">Journal of Theoretical and Applied Electronic Commerce Research</option> <option value="jvd">Journal of Vascular Diseases</option> <option value="jox">Journal of Xenobiotics</option> <option value="jzbg">Journal of Zoological and Botanical Gardens</option> <option value="journalmedia">Journalism and Media</option> <option value="kidneydial">Kidney and Dialysis</option> <option value="kinasesphosphatases">Kinases and Phosphatases</option> <option value="knowledge">Knowledge</option> <option value="labmed">LabMed</option> <option value="laboratories">Laboratories</option> <option value="land">Land</option> <option value="languages">Languages</option> <option value="laws">Laws</option> <option value="life">Life</option> <option value="limnolrev">Limnological Review</option> <option value="lipidology">Lipidology</option> <option value="liquids">Liquids</option> <option value="literature">Literature</option> <option value="livers">Livers</option> <option value="logics">Logics</option> <option value="logistics">Logistics</option> <option value="lubricants">Lubricants</option> <option value="lymphatics">Lymphatics</option> <option value="make">Machine Learning and Knowledge Extraction</option> <option value="machines">Machines</option> <option value="macromol">Macromol</option> <option value="magnetism">Magnetism</option> <option value="magnetochemistry">Magnetochemistry</option> <option value="marinedrugs">Marine Drugs</option> <option value="materials">Materials</option> <option value="materproc">Materials Proceedings</option> <option value="mca">Mathematical and Computational Applications</option> <option value="mathematics">Mathematics</option> <option value="medsci">Medical Sciences</option> <option value="msf">Medical Sciences Forum</option> <option value="medicina">Medicina</option> <option value="medicines">Medicines</option> <option value="membranes">Membranes</option> <option value="merits">Merits</option> <option value="metabolites">Metabolites</option> <option value="metals">Metals</option> <option value="meteorology">Meteorology</option> <option value="methane">Methane</option> <option value="mps">Methods and Protocols</option> <option value="metrics">Metrics</option> <option value="metrology">Metrology</option> <option value="micro">Micro</option> <option value="microbiolres">Microbiology Research</option> <option value="micromachines">Micromachines</option> <option value="microorganisms">Microorganisms</option> <option value="microplastics">Microplastics</option> <option value="minerals">Minerals</option> <option value="mining">Mining</option> <option value="modelling">Modelling</option> <option value="mmphys">Modern Mathematical Physics</option> <option value="molbank">Molbank</option> <option value="molecules">Molecules</option> <option value="mti">Multimodal Technologies and Interaction</option> <option value="muscles">Muscles</option> <option value="nanoenergyadv">Nanoenergy Advances</option> <option value="nanomanufacturing">Nanomanufacturing</option> <option value="nanomaterials">Nanomaterials</option> <option value="ndt">NDT</option> <option value="network">Network</option> <option value="neuroglia">Neuroglia</option> <option value="neurolint">Neurology International</option> <option value="neurosci">NeuroSci</option> <option value="nitrogen">Nitrogen</option> <option value="ncrna">Non-Coding RNA</option> <option value="nursrep">Nursing Reports</option> <option value="nutraceuticals">Nutraceuticals</option> <option value="nutrients">Nutrients</option> <option value="obesities">Obesities</option> <option value="oceans">Oceans</option> <option value="onco">Onco</option> <option value="optics">Optics</option> <option value="oral">Oral</option> <option value="organics">Organics</option> <option value="organoids">Organoids</option> <option value="osteology">Osteology</option> <option value="oxygen">Oxygen</option> <option value="parasitologia">Parasitologia</option> <option value="particles">Particles</option> <option value="pathogens">Pathogens</option> <option value="pathophysiology">Pathophysiology</option> <option value="pediatrrep">Pediatric Reports</option> <option value="pets">Pets</option> <option value="pharmaceuticals">Pharmaceuticals</option> <option value="pharmaceutics">Pharmaceutics</option> <option value="pharmacoepidemiology">Pharmacoepidemiology</option> <option value="pharmacy">Pharmacy</option> <option value="philosophies">Philosophies</option> <option value="photochem">Photochem</option> <option value="photonics">Photonics</option> <option value="phycology">Phycology</option> <option value="physchem">Physchem</option> <option value="psf">Physical Sciences Forum</option> <option value="physics">Physics</option> <option value="physiologia">Physiologia</option> <option value="plants">Plants</option> <option value="plasma">Plasma</option> <option value="platforms">Platforms</option> <option value="pollutants">Pollutants</option> <option value="polymers">Polymers</option> <option value="polysaccharides">Polysaccharides</option> <option value="populations">Populations</option> <option value="poultry">Poultry</option> <option value="powders">Powders</option> <option value="proceedings">Proceedings</option> <option value="processes">Processes</option> <option value="prosthesis">Prosthesis</option> <option value="proteomes">Proteomes</option> <option value="psychiatryint">Psychiatry International</option> <option value="psychoactives">Psychoactives</option> <option value="psycholint">Psychology International</option> <option value="publications">Publications</option> <option value="qubs">Quantum Beam Science</option> <option value="quantumrep">Quantum Reports</option> <option value="quaternary">Quaternary</option> <option value="radiation">Radiation</option> <option value="reactions">Reactions</option> <option value="realestate">Real Estate</option> <option value="receptors">Receptors</option> <option value="recycling">Recycling</option> <option value="rsee">Regional Science and Environmental Economics</option> <option value="religions">Religions</option> <option value="remotesensing">Remote Sensing</option> <option value="reports">Reports</option> <option value="reprodmed">Reproductive Medicine</option> <option value="resources">Resources</option> <option value="rheumato">Rheumato</option> <option value="risks">Risks</option> <option value="robotics">Robotics</option> <option value="ruminants">Ruminants</option> <option value="safety">Safety</option> <option value="sci">Sci</option> <option value="scipharm">Scientia Pharmaceutica</option> <option value="sclerosis">Sclerosis</option> <option value="seeds">Seeds</option> <option value="sensors">Sensors</option> <option value="separations">Separations</option> <option value="sexes">Sexes</option> <option value="signals">Signals</option> <option value="sinusitis">Sinusitis</option> <option value="smartcities">Smart Cities</option> <option value="socsci">Social Sciences</option> <option value="siuj">Société Internationale d’Urologie Journal</option> <option value="societies">Societies</option> <option value="software">Software</option> <option value="soilsystems">Soil Systems</option> <option value="solar">Solar</option> <option value="solids">Solids</option> <option value="spectroscj">Spectroscopy Journal</option> <option value="sports">Sports</option> <option value="standards">Standards</option> <option value="stats">Stats</option> <option value="stresses">Stresses</option> <option value="surfaces">Surfaces</option> <option value="surgeries">Surgeries</option> <option value="std">Surgical Techniques Development</option> <option value="sustainability">Sustainability</option> <option value="suschem">Sustainable Chemistry</option> <option value="symmetry">Symmetry</option> <option value="synbio">SynBio</option> <option value="systems">Systems</option> <option value="targets">Targets</option> <option value="taxonomy">Taxonomy</option> <option value="technologies">Technologies</option> <option value="telecom">Telecom</option> <option value="textiles">Textiles</option> <option value="thalassrep">Thalassemia Reports</option> <option value="therapeutics">Therapeutics</option> <option value="thermo">Thermo</option> <option value="timespace">Time and Space</option> <option value="tomography">Tomography</option> <option value="tourismhosp">Tourism and Hospitality</option> <option value="toxics">Toxics</option> <option value="toxins">Toxins</option> <option value="transplantology">Transplantology</option> <option value="traumacare">Trauma Care</option> <option value="higheredu">Trends in Higher Education</option> <option value="tropicalmed">Tropical Medicine and Infectious Disease</option> <option value="universe">Universe</option> <option value="urbansci">Urban Science</option> <option value="uro">Uro</option> <option value="vaccines">Vaccines</option> <option value="vehicles">Vehicles</option> <option value="venereology">Venereology</option> <option value="vetsci">Veterinary Sciences</option> <option value="vibration">Vibration</option> <option value="virtualworlds">Virtual Worlds</option> <option value="viruses">Viruses</option> <option value="vision">Vision</option> <option value="waste">Waste</option> <option value="water">Water</option> <option value="wild">Wild</option> <option value="wind">Wind</option> <option value="women">Women</option> <option value="world">World</option> <option value="wevj">World Electric Vehicle Journal</option> <option value="youth">Youth</option> <option value="zoonoticdis">Zoonotic Diseases</option> </select> <input name="email" type="email" placeholder="Enter your email address..." required="required" /> <button class="genericCaptcha button button--dark UA_FooterNewsletterSubscribeButton" type="submit">Subscribe</button> </form> </div> </div> </div> <div id="footer-copyright"> <div class="row"> <div class="columns large-6 medium-6 small-12 text-left"> © 1996-2024 MDPI (Basel, Switzerland) unless otherwise stated </div> <div class="columns large-6 medium-6 small-12 small-text-left medium-text-right large-text-right"> <a data-dropdown="drop-view-disclaimer" aria-controls="drop-view-disclaimer" aria-expanded="false" data-options="align:top; is_hover:true; hover_timeout:2000;"> Disclaimer </a> <div id="drop-view-disclaimer" class="f-dropdown label__btn__dropdown label__btn__dropdown--wide text-left" data-dropdown-content aria-hidden="true" tabindex="-1"> Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. </div> <a href="/about/terms-and-conditions"> Terms and Conditions </a> <a href="/about/privacy"> Privacy Policy </a> </div> </div> </div> </div> <div id="cookie-notification" class="js-allow-cookies" style="display: none;"> <div class="columns large-10 medium-10 small-12"> We use cookies on our website to ensure you get the best experience.<br class="show-for-medium-up"/> Read more about our cookies <a href="/about/privacy">here</a>. </div> <div class="columns large-2 medium-2 small-12 small-only-text-left text-right"> <a class="button button--default" href="/accept_cookies">Accept</a> </div> </div> </div> <div id="main-share-modal" class="reveal-modal reveal-modal-new reveal-modal-new--small" data-reveal aria-labelledby="modalTitle" aria-hidden="true" role="dialog"> <div class="row"> <div class="small-12 columns"> <h2 style="margin: 0;">Share Link</h2> </div> <div class="small-12 columns"> <div class="social-media-links UA_ShareModalLinks" style="text-align: left;"> <a href="/cdn-cgi/l/email-protection#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" title="Email"> <i class="fa fa-envelope-square" style="font-size: 30px;"></i> </a> <a href="https://twitter.com/intent/tweet?text=Mechanisms+of+Resistance+to+Second-Generation+Antiandrogen+Therapy+for+Prostate+Cancer%3A+Actual+Knowledge+and+Perspectives&hashtags=mdpimedsci&url=https%3A%2F%2Fwww.mdpi.com%2F1608304&via=medsci_MDPI" onclick="windowOpen(this.href,600,800); return false" title="Twitter" target="_blank" rel="noopener noreferrer"> <i class="fa fa-twitter-x-square" style="font-size: 30px;"></i> </a> <a href=" http://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.mdpi.com%2F1608304&title=Mechanisms%20of%20Resistance%20to%20Second-Generation%20Antiandrogen%20Therapy%20for%20Prostate%20Cancer%3A%20Actual%20Knowledge%20and%20Perspectives%26source%3Dhttps%3A%2F%2Fwww.mdpi.com%26summary%3DProstate%20cancer%20therapy%20for%20locally%20advanced%20and%20metastatic%20diseases%20includes%20androgen%20deprivation%20therapy%20%28ADT%29.%20Second-generation%20antiandrogens%20have%20a%20role%20in%20castration-resistant%20prostate%20cancer.%20Nevertheless%2C%20some%20patients%20do%20not%20respond%20to%20this%20%5B...%5D" onclick="windowOpen(this.href,600,800); return false" title="LinkedIn" target="_blank" rel="noopener noreferrer"> <i class="fa fa-linkedin-square" style="font-size: 30px;"></i> </a> <a href="https://www.facebook.com/sharer.php?u=https://www.mdpi.com/1608304" title="facebook" target="_blank" rel="noopener noreferrer"> <i class="fa fa-facebook-square" style="font-size: 30px;"></i> </a> <a href="javascript:void(0);" title="Wechat" data-reveal-id="weixin-share-modal"> <i class="fa fa-weixin-square" style="font-size: 26px;"></i> </a> <a href="http://www.reddit.com/submit?url=https://www.mdpi.com/1608304" title="Reddit" target="_blank" rel="noopener noreferrer"> <i class="fa fa-reddit-square" style="font-size: 30px;"></i> </a> <a href="http://www.mendeley.com/import/?url=https://www.mdpi.com/1608304" title="Mendeley" target="_blank" rel="noopener noreferrer"> <i class="fa fa-mendeley-square" style="font-size: 30px;"></i> </a> <a href="http://www.citeulike.org/posturl?url=https://www.mdpi.com/1608304" title="CiteULike" target="_blank" rel="noopener noreferrer"> <i class="fa fa-citeulike-square" style="font-size: 30px;"></i> </a> </div> </div> <div class="small-9 columns"> <input id="js-clipboard-text" type="text" readonly value="https://www.mdpi.com/1608304" /> </div> <div class="small-3 columns text-left"> <a class="button button--color js-clipboard-copy" data-clipboard-target="#js-clipboard-text">Copy</a> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> <div id="weixin-share-modal" class="reveal-modal reveal-modal-new" data-reveal aria-labelledby="weixin-share-modal-title" aria-hidden="true" role="dialog"> <div class="row"> <div class="small-12 columns"> <h2 id="weixin-share-modal-title" style="margin: 0;">Share</h2> </div> <div class="small-12 columns"> <div class="weixin-qr-code-section"> <?xml version="1.0" standalone="no"?> <!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd"> <svg width="300" height="300" version="1.1" xmlns="http://www.w3.org/2000/svg"> <desc>https://www.mdpi.com/1608304</desc> <g id="elements" fill="black" stroke="none"> <rect x="0" y="0" width="12" height="12" /> <rect x="12" y="0" width="12" height="12" /> <rect x="24" y="0" width="12" height="12" /> <rect x="36" y="0" width="12" height="12" /> <rect x="48" y="0" width="12" height="12" /> <rect x="60" y="0" width="12" height="12" /> <rect x="72" y="0" width="12" height="12" /> <rect x="96" y="0" width="12" height="12" /> <rect x="108" y="0" width="12" height="12" /> <rect x="120" y="0" width="12" height="12" /> <rect x="132" y="0" width="12" height="12" /> <rect x="156" y="0" width="12" height="12" /> <rect x="168" y="0" width="12" height="12" /> <rect x="216" y="0" width="12" height="12" /> <rect x="228" y="0" width="12" height="12" /> <rect x="240" y="0" width="12" height="12" /> <rect x="252" y="0" width="12" height="12" /> <rect x="264" y="0" width="12" height="12" /> <rect x="276" y="0" width="12" height="12" /> <rect x="288" y="0" width="12" height="12" /> <rect x="0" y="12" width="12" height="12" /> <rect x="72" y="12" width="12" height="12" /> <rect x="96" y="12" width="12" height="12" /> <rect x="132" y="12" width="12" height="12" /> <rect x="156" y="12" width="12" height="12" /> <rect x="216" y="12" width="12" height="12" /> <rect x="288" y="12" width="12" height="12" /> <rect x="0" y="24" width="12" height="12" /> <rect x="24" y="24" width="12" height="12" /> <rect x="36" y="24" width="12" height="12" /> <rect x="48" y="24" width="12" height="12" /> <rect x="72" y="24" width="12" height="12" /> <rect x="108" y="24" width="12" height="12" /> <rect x="156" y="24" width="12" height="12" /> <rect x="216" y="24" width="12" height="12" /> <rect x="240" y="24" width="12" height="12" /> <rect x="252" y="24" width="12" height="12" /> <rect x="264" y="24" width="12" height="12" /> <rect x="288" y="24" width="12" height="12" /> <rect x="0" y="36" width="12" height="12" /> <rect x="24" y="36" width="12" height="12" /> <rect x="36" y="36" width="12" height="12" /> <rect x="48" y="36" width="12" height="12" /> <rect x="72" y="36" width="12" height="12" /> <rect x="132" y="36" width="12" height="12" /> <rect x="156" y="36" width="12" height="12" /> <rect x="168" y="36" width="12" height="12" /> <rect x="180" y="36" width="12" height="12" /> <rect x="216" y="36" width="12" height="12" /> <rect x="240" y="36" width="12" height="12" /> <rect x="252" y="36" width="12" height="12" /> <rect x="264" y="36" width="12" height="12" /> <rect x="288" y="36" width="12" height="12" /> <rect x="0" y="48" width="12" height="12" /> <rect x="24" y="48" width="12" height="12" /> <rect x="36" y="48" width="12" height="12" /> <rect x="48" y="48" width="12" height="12" /> <rect x="72" y="48" width="12" height="12" /> <rect x="96" y="48" width="12" height="12" /> <rect x="132" y="48" width="12" height="12" /> <rect x="144" y="48" width="12" height="12" /> <rect x="168" y="48" width="12" height="12" /> <rect x="192" y="48" width="12" height="12" /> <rect x="216" y="48" width="12" height="12" /> <rect x="240" y="48" width="12" height="12" /> <rect x="252" y="48" width="12" height="12" /> <rect x="264" y="48" width="12" height="12" /> <rect x="288" y="48" width="12" height="12" /> <rect x="0" y="60" width="12" height="12" /> <rect x="72" y="60" width="12" height="12" /> <rect x="96" y="60" width="12" height="12" /> <rect x="108" y="60" width="12" height="12" /> <rect x="120" y="60" width="12" height="12" /> <rect x="156" y="60" width="12" height="12" /> <rect x="168" y="60" width="12" height="12" /> <rect x="192" y="60" width="12" height="12" /> <rect x="216" y="60" width="12" height="12" /> <rect x="288" y="60" width="12" height="12" /> <rect x="0" y="72" width="12" height="12" /> <rect x="12" y="72" width="12" height="12" /> <rect x="24" y="72" width="12" height="12" /> <rect x="36" y="72" width="12" height="12" /> <rect x="48" y="72" width="12" height="12" /> <rect x="60" y="72" width="12" height="12" /> <rect x="72" y="72" width="12" height="12" /> <rect x="96" y="72" width="12" height="12" /> <rect x="120" y="72" width="12" height="12" /> <rect x="144" y="72" width="12" height="12" /> <rect x="168" y="72" width="12" height="12" /> <rect x="192" y="72" width="12" height="12" /> <rect x="216" y="72" width="12" height="12" /> <rect x="228" y="72" width="12" height="12" /> <rect x="240" y="72" width="12" height="12" /> <rect x="252" y="72" width="12" height="12" /> <rect x="264" y="72" width="12" height="12" /> <rect x="276" y="72" width="12" height="12" /> <rect x="288" y="72" width="12" height="12" /> <rect x="96" y="84" width="12" height="12" /> <rect x="108" y="84" width="12" height="12" /> <rect x="168" y="84" width="12" height="12" /> <rect x="0" y="96" width="12" height="12" /> <rect x="12" y="96" width="12" height="12" /> <rect x="24" y="96" width="12" height="12" /> <rect x="60" y="96" width="12" height="12" /> <rect x="72" y="96" width="12" height="12" /> <rect x="96" y="96" width="12" height="12" /> <rect x="108" y="96" width="12" height="12" /> <rect x="132" y="96" width="12" height="12" /> <rect x="144" y="96" width="12" height="12" /> <rect x="192" y="96" width="12" height="12" /> <rect x="204" y="96" width="12" height="12" /> <rect x="216" y="96" width="12" height="12" /> <rect x="228" y="96" width="12" height="12" /> <rect x="240" y="96" width="12" height="12" /> <rect x="276" y="96" width="12" height="12" /> <rect x="288" y="96" width="12" height="12" /> <rect x="12" y="108" width="12" height="12" /> <rect x="24" y="108" width="12" height="12" /> <rect x="60" y="108" width="12" height="12" /> <rect x="156" y="108" width="12" height="12" /> <rect x="180" y="108" width="12" height="12" /> <rect x="192" y="108" width="12" height="12" /> <rect x="204" y="108" width="12" height="12" /> <rect x="216" y="108" width="12" height="12" /> <rect x="228" y="108" width="12" height="12" /> <rect x="252" y="108" width="12" height="12" /> <rect x="276" y="108" width="12" height="12" /> <rect x="288" y="108" width="12" height="12" /> <rect x="36" y="120" width="12" height="12" /> <rect x="60" y="120" width="12" height="12" /> <rect x="72" y="120" width="12" height="12" /> <rect x="108" y="120" width="12" height="12" /> <rect x="120" y="120" width="12" height="12" /> <rect x="132" y="120" width="12" height="12" /> <rect x="144" y="120" width="12" height="12" /> <rect x="156" y="120" width="12" height="12" /> <rect x="180" y="120" width="12" height="12" /> <rect x="192" y="120" width="12" height="12" /> <rect x="216" y="120" width="12" height="12" /> <rect x="252" y="120" width="12" height="12" /> <rect x="264" y="120" width="12" height="12" /> <rect x="288" y="120" width="12" height="12" /> <rect x="0" y="132" width="12" height="12" /> <rect x="24" y="132" width="12" height="12" /> <rect x="36" y="132" width="12" height="12" /> <rect x="48" y="132" width="12" height="12" /> <rect x="120" y="132" width="12" height="12" /> <rect x="132" y="132" width="12" height="12" /> <rect x="168" y="132" width="12" height="12" /> <rect x="204" y="132" width="12" height="12" /> <rect x="216" y="132" width="12" height="12" /> <rect x="228" y="132" width="12" height="12" /> <rect x="252" y="132" width="12" height="12" /> <rect x="24" y="144" width="12" height="12" /> <rect x="48" y="144" width="12" height="12" /> <rect x="72" y="144" width="12" height="12" /> <rect x="96" y="144" width="12" height="12" /> <rect x="108" y="144" width="12" height="12" /> <rect x="120" y="144" width="12" height="12" /> <rect x="132" y="144" width="12" height="12" /> <rect x="144" y="144" width="12" height="12" /> <rect x="168" y="144" width="12" height="12" /> <rect x="180" y="144" width="12" height="12" /> <rect x="216" y="144" width="12" height="12" /> <rect x="288" y="144" width="12" height="12" /> <rect x="48" y="156" width="12" height="12" /> <rect x="96" y="156" width="12" height="12" /> <rect x="120" y="156" width="12" height="12" /> <rect x="180" y="156" width="12" height="12" /> <rect x="192" y="156" width="12" height="12" /> <rect x="204" y="156" width="12" height="12" /> <rect x="216" y="156" width="12" height="12" /> <rect x="228" y="156" width="12" height="12" /> <rect x="276" y="156" width="12" height="12" /> <rect x="288" y="156" width="12" height="12" /> <rect x="0" y="168" width="12" height="12" /> <rect x="12" y="168" width="12" height="12" /> <rect x="36" y="168" width="12" height="12" /> <rect x="48" y="168" width="12" height="12" /> <rect x="60" y="168" width="12" height="12" /> <rect x="72" y="168" width="12" height="12" /> <rect x="84" y="168" width="12" height="12" /> <rect x="108" y="168" width="12" height="12" /> <rect x="120" y="168" width="12" height="12" /> <rect x="132" y="168" width="12" height="12" /> <rect x="144" y="168" width="12" height="12" /> <rect x="156" y="168" width="12" height="12" /> <rect x="168" y="168" width="12" height="12" /> <rect x="180" y="168" width="12" height="12" /> <rect x="192" y="168" width="12" height="12" /> <rect x="216" y="168" width="12" height="12" /> <rect x="252" y="168" width="12" height="12" /> <rect x="264" y="168" width="12" height="12" /> <rect x="288" y="168" width="12" height="12" /> <rect x="24" y="180" width="12" height="12" /> <rect x="84" y="180" width="12" height="12" /> <rect x="96" y="180" width="12" height="12" /> <rect x="120" y="180" width="12" height="12" /> <rect x="144" y="180" width="12" height="12" /> <rect x="192" y="180" width="12" height="12" /> <rect x="204" y="180" width="12" height="12" /> <rect x="216" y="180" width="12" height="12" /> <rect x="228" y="180" width="12" height="12" /> <rect x="240" y="180" width="12" height="12" /> <rect x="252" y="180" width="12" height="12" /> <rect x="0" y="192" width="12" height="12" /> <rect x="12" y="192" width="12" height="12" /> <rect x="24" y="192" width="12" height="12" /> <rect x="60" y="192" width="12" height="12" /> <rect x="72" y="192" width="12" height="12" /> <rect x="84" y="192" width="12" height="12" /> <rect x="120" y="192" width="12" height="12" /> <rect x="144" y="192" width="12" height="12" /> <rect x="156" y="192" width="12" height="12" /> <rect x="180" y="192" width="12" height="12" /> <rect x="192" y="192" width="12" height="12" /> <rect x="204" y="192" width="12" height="12" /> <rect x="216" y="192" width="12" height="12" /> <rect x="228" y="192" width="12" height="12" /> <rect x="240" y="192" width="12" height="12" /> <rect x="276" y="192" width="12" height="12" /> <rect x="96" y="204" width="12" height="12" /> <rect x="108" y="204" width="12" height="12" /> <rect x="132" y="204" width="12" height="12" /> <rect x="192" y="204" width="12" height="12" /> <rect x="240" y="204" width="12" height="12" /> <rect x="288" y="204" width="12" height="12" /> <rect x="0" y="216" width="12" height="12" /> <rect x="12" y="216" width="12" height="12" /> <rect x="24" y="216" width="12" height="12" /> <rect x="36" y="216" width="12" height="12" /> <rect x="48" y="216" width="12" height="12" /> <rect x="60" y="216" width="12" height="12" /> <rect x="72" y="216" width="12" height="12" /> <rect x="108" y="216" width="12" height="12" /> <rect x="192" y="216" width="12" height="12" /> <rect x="216" y="216" width="12" height="12" /> <rect x="240" y="216" width="12" height="12" /> <rect x="288" y="216" width="12" height="12" /> <rect x="0" y="228" width="12" height="12" /> <rect x="72" y="228" width="12" height="12" /> <rect x="96" y="228" width="12" height="12" /> <rect x="108" y="228" width="12" height="12" /> <rect x="144" y="228" width="12" height="12" /> <rect x="156" y="228" width="12" height="12" /> <rect x="168" y="228" width="12" height="12" /> <rect x="180" y="228" width="12" height="12" /> <rect x="192" y="228" width="12" height="12" /> <rect x="240" y="228" width="12" height="12" /> <rect x="0" y="240" width="12" height="12" /> <rect x="24" y="240" width="12" height="12" /> <rect x="36" y="240" width="12" height="12" /> <rect x="48" y="240" width="12" height="12" /> <rect x="72" y="240" width="12" height="12" /> <rect x="132" y="240" width="12" height="12" /> <rect x="144" y="240" width="12" height="12" /> <rect x="156" y="240" width="12" height="12" /> <rect x="168" y="240" width="12" height="12" /> <rect x="180" y="240" width="12" height="12" /> <rect x="192" y="240" width="12" height="12" /> <rect x="204" y="240" width="12" height="12" /> <rect x="216" y="240" width="12" height="12" /> <rect x="228" y="240" width="12" height="12" /> <rect x="240" y="240" width="12" height="12" /> <rect x="288" y="240" width="12" height="12" /> <rect x="0" y="252" width="12" height="12" /> <rect x="24" y="252" width="12" height="12" /> <rect x="36" y="252" width="12" height="12" /> <rect x="48" y="252" width="12" height="12" /> <rect x="72" y="252" width="12" height="12" /> <rect x="144" y="252" width="12" height="12" /> <rect x="168" y="252" width="12" height="12" /> <rect x="180" y="252" width="12" height="12" /> <rect x="240" y="252" width="12" height="12" /> <rect x="264" y="252" width="12" height="12" /> <rect x="276" y="252" width="12" height="12" /> <rect x="0" y="264" width="12" height="12" /> <rect x="24" y="264" width="12" height="12" /> <rect x="36" y="264" width="12" height="12" /> <rect x="48" y="264" width="12" height="12" /> <rect x="72" y="264" width="12" height="12" /> <rect x="96" y="264" width="12" height="12" /> <rect x="108" y="264" width="12" height="12" /> <rect x="120" y="264" width="12" height="12" /> <rect x="156" y="264" width="12" height="12" /> <rect x="168" y="264" width="12" height="12" /> <rect x="204" y="264" width="12" height="12" /> <rect x="228" y="264" width="12" height="12" /> <rect x="240" y="264" width="12" height="12" /> <rect x="252" y="264" width="12" height="12" /> <rect x="276" y="264" width="12" height="12" /> <rect x="288" y="264" width="12" height="12" /> <rect x="0" y="276" width="12" height="12" /> <rect x="72" y="276" width="12" height="12" /> <rect x="96" y="276" width="12" height="12" /> <rect x="108" y="276" width="12" height="12" /> <rect x="120" y="276" width="12" height="12" /> <rect x="192" y="276" width="12" height="12" /> <rect x="204" y="276" width="12" height="12" /> <rect x="216" y="276" width="12" height="12" /> <rect x="228" y="276" width="12" height="12" /> <rect x="240" y="276" width="12" height="12" /> <rect x="0" y="288" width="12" height="12" /> <rect x="12" y="288" width="12" height="12" /> <rect x="24" y="288" width="12" height="12" /> <rect x="36" y="288" width="12" height="12" /> <rect x="48" y="288" width="12" height="12" /> <rect x="60" y="288" width="12" height="12" /> <rect x="72" y="288" width="12" height="12" /> <rect x="96" y="288" width="12" height="12" /> <rect x="108" y="288" width="12" height="12" /> <rect x="132" y="288" width="12" height="12" /> <rect x="144" y="288" width="12" height="12" /> <rect x="168" y="288" width="12" height="12" /> <rect x="192" y="288" width="12" height="12" /> <rect x="204" y="288" width="12" height="12" /> <rect x="252" y="288" width="12" height="12" /> <rect x="288" y="288" width="12" height="12" /> </g> </svg> </div> </div> </div> <a class="close-reveal-modal" aria-label="Close"> <i class="material-icons">clear</i> </a> </div> <a href="#" class="back-to-top"><span class="show-for-medium-up">Back to Top</span><span class="show-for-small">Top</span></a> <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script src="https://pub.mdpi-res.com/assets/js/modernizr-2.8.3.min.js?5227e0738f7f421d?1732615622"></script> <script src="https://pub.mdpi-res.com/assets/js/jquery-1.12.4.min.js?4f252523d4af0b47?1732615622"></script> <script src="https://pub.mdpi-res.com/assets/js/foundation-5.5.3.min.js?6b2ec41c18b29054?1732615622"></script> <script src="https://pub.mdpi-res.com/assets/js/foundation-5.5.3.equalizer.min.js?0f6c549b75ec554c?1732615622"></script> <script src="https://pub.mdpi-res.com/assets/js/jquery.multiselect.js?0edd3998731d1091?1732615622"></script> <script src="https://pub.mdpi-res.com/assets/js/jquery.cycle2.min.js?63413052928f97ee?1732615622"></script> <script> // old browser fix - this way the console log rows won't throw (silent) errors in browsers not supporting console log if (!window.console) window.console = {}; if (!window.console.log) window.console.log = function () { }; var currentJournalNameSystem = "medsci"; $(document).ready(function() { $('select.foundation-select').multiselect({ search: true, minHeight: 130, maxHeight: 130, }); $(document).foundation({ orbit: { timer_speed: 4000, }, reveal: { animation: 'fadeAndPop', animation_speed: 100, } }); $(".chosen-select").each(function(element) { var maxSelected = (undefined !== $(this).data('maxselectedoptions') ? $(this).data('maxselectedoptions') : 100); $(this).on('chosen:ready', function(event, data) { var select = $(data.chosen.form_field); if (select.attr('id') === 'journal-browser-volume') { $(data.chosen.dropdown).addClass('UI_JournalBrowser_Volume_Options'); } if (select.attr('id') === 'journal-browser-issue') { $(data.chosen.dropdown).addClass('UI_JournalBrowser_Issue_Options'); } }).chosen({ display_disabled_options: false, disable_search_threshold: 7, max_selected_options: maxSelected, width: "100%" }); }); $(".toEncode").each(function(e) { var oldHref = $(this).attr("href"); var newHref = oldHref.replace('.botdefense.please.enable.javascript.','@'); $(this).attr("href", newHref); if (!$(this).hasClass("emailCaptcha")) { $(this).html(newHref.replace('mailto:', '')); } $(this).removeClass("visibility-hidden"); }); $(document).on('opened.fndtn.reveal', '[data-reveal]', function() { $(document).foundation('equalizer', 'reflow'); }); // fix the images that have tag height / width defined // otherwise the default foundation styles overwrite the tag definitions $("img").each(function() { if ($(this).attr('width') != undefined || $(this).attr('height') != undefined) { $(this).addClass("img-fixed"); } }); $("#basic_search, #advanced_search").submit(function(e) { var searchArguments = false; $(this).find("input,select").not("#search,.search-button").each(function() { if (undefined === $(this).val() || "" === $(this).val()) { $(this).attr('name', null); } else { $(this).attr('name'); searchArguments = true; } }); if (!searchArguments) { window.location = $(this).attr('action'); return false; } }); $(".hide-show-desktop-option").click(function(e) { e.preventDefault(); var parentDiv = $(this).closest("div"); $.ajax({ url: $(this).attr('href'), success: function(msg) { parentDiv.removeClass().hide(); } }); }); $(".generic-toggleable-header").click(function(e) { $(this).toggleClass("active"); $(this).next(".generic-toggleable-content").toggleClass("active"); }); /* * handle whole row as a link if the row contains only one visible link */ $("table.new tr").hover(function() { if ($(this).find("td:visible a").length == 1) { $(this).addClass("single-link"); } }, function() { $(this).removeClass("single-link"); }); $("table.new:not(.table-of-tables)").on("click", "tr.single-link", function(e) { var target = $(e.target); if (!e.ctrlKey && !target.is("a")) { $(this).find("td:visible a")[0].click(); } }); $(document).on("click", ".custom-accordion-for-small-screen-link", function(e) { if ($(this).closest("#basic_search").length > 0) { if ($(".search-container__advanced").first().is(":visible")) { openAdvanced() } } if (Foundation.utils.is_small_only()) { if ($(this).hasClass("active")) { $(this).removeClass("active"); $(this).next(".custom-accordion-for-small-screen-content").addClass("show-for-medium-up"); } else { $(this).addClass("active"); $(this).next(".custom-accordion-for-small-screen-content").removeClass("show-for-medium-up"); $(document).foundation('orbit', 'reflow'); } } if (undefined !== $(this).data("callback")) { var customCallback = $(this).data("callback"); func = window[customCallback]; func(); } }); $(document).on("click", ".js-open-small-search", function(e) { e.preventDefault(); $(this).toggleClass("active").closest(".tab-bar").toggleClass("active"); $(".search-container").toggleClass("hide-for-small-down"); }); $(document).on("click", ".js-open-menu", function(e) { $(".search-container").addClass("hide-for-small-down"); }); $(window).on('resize', function() { recalculate_main_browser_position(); recalculate_responsive_moving_containers(); }); updateSearchLabelVisibilities(); recalculate_main_browser_position(); recalculate_responsive_moving_containers(); if (window.document.documentMode == 11) { $("<link/>", { rel: "stylesheet", type: "text/css", href: "https://fonts.googleapis.com/icon?family=Material+Icons"}).appendTo("head"); } }); function recalculate_main_browser_position() { if (Foundation.utils.is_small_only()) { if ($("#js-main-top-container").parent("#js-large-main-top-container").length > 0) { $("#js-main-top-container").appendTo($("#js-small-main-top-container")); } } else { if ($("#js-main-top-container").parent("#js-small-main-top-container").length > 0) { $("#js-main-top-container").appendTo($("#js-large-main-top-container")); } } } function recalculate_responsive_moving_containers() { $(".responsive-moving-container.large").each(function() { var previousParent = $(".responsive-moving-container.active[data-id='"+$(this).data("id")+"']"); var movingContent = previousParent.html(); if (Foundation.utils.is_small_only()) { var currentParent = $(".responsive-moving-container.small[data-id='"+$(this).data("id")+"']"); } else if (Foundation.utils.is_medium_only()) { var currentParent = $(".responsive-moving-container.medium[data-id='"+$(this).data("id")+"']"); } else { var currentParent = $(".responsive-moving-container.large[data-id='"+$(this).data("id")+"']"); } if (previousParent.attr("class") !== currentParent.attr("class")) { currentParent.html(movingContent); previousParent.html(); currentParent.addClass("active"); previousParent.removeClass("active"); } }); } // cookies allowed is checked from a) local storage and b) from server separately so that the footer bar doesn't // get included in the custom page caches function checkCookiesAllowed() { var cookiesEnabled = localStorage.getItem("mdpi_cookies_enabled"); if (null === cookiesEnabled) { $.ajax({ url: "/ajax_cookie_value/mdpi_cookies_accepted", success: function(data) { if (data.value) { localStorage.setItem("mdpi_cookies_enabled", true); checkDisplaySurvey(); } else { $(".js-allow-cookies").show(); } } }); } else { checkDisplaySurvey(); } } function checkDisplaySurvey() { } window.addEventListener('CookiebotOnAccept', function (e) { var CookieDate = new Date; if (Cookiebot.consent.preferences) { CookieDate.setFullYear(CookieDate.getFullYear() + 1); document.cookie = "mdpi_layout_type_v2=mobile; path=/; expires=" + CookieDate.toUTCString() + ";"; $(".js-toggle-desktop-layout-link").css("display", "inline-block"); } }, false); window.addEventListener('CookiebotOnDecline', function (e) { if (!Cookiebot.consent.preferences) { $(".js-toggle-desktop-layout-link").hide(); if ("" === "desktop") { window.location = "/toggle_desktop_layout_cookie"; } } }, false); var hash = $(location).attr('hash'); if ("#share" === hash) { if (1 === $("#main-share-modal").length) { $('#main-share-modal').foundation('reveal', 'open'); } } </script> <script src="https://pub.mdpi-res.com/assets/js/lib.js?f8d3d71b3a772f9d?1732615622"></script> <script src="https://pub.mdpi-res.com/assets/js/mdpi.js?c267ce58392b15da?1732615622"></script> <script>var banners_url = 'https://serve.mdpi.com';</script> <script type='text/javascript' src='https://pub.mdpi-res.com/assets/js/ifvisible.min.js?c621d19ecb761212?1732615622'></script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/affix.js?ac4ea55275297c15?1732615622"></script> <script src="https://pub.mdpi-res.com/assets/js/clipboard.min.js?3f3688138a1b9fc4?1732615622"></script> <script type="text/javascript"> $(document).ready(function() { var helpFunctions = $(".middle-column__help__fixed"); var leftColumnAffix = $(".left-column__fixed"); var middleColumn = $("#middle-column"); var clone = null; helpFunctions.affix({ offset: { top: function() { return middleColumn.offset().top - 8 - (Foundation.utils.is_medium_only() ? 30 : 0); }, bottom: function() { return $("#footer").innerHeight() + 74 + (Foundation.utils.is_medium_only() ? 0 : 0); } } }); if (leftColumnAffix.length > 0) { clone = leftColumnAffix.clone(); clone.addClass("left-column__fixed__affix"); clone.insertBefore(leftColumnAffix); clone.css('width', leftColumnAffix.outerWidth() + 50); clone.affix({ offset: { top: function() { return leftColumnAffix.offset().top - 30 - (Foundation.utils.is_medium_only() ? 50 : 0); }, bottom: function() { return $("#footer").innerHeight() + 92 + (Foundation.utils.is_medium_only() ? 0 : 0); } } }); } $(window).on("resize", function() { if (clone !== null) { clone.css('width', leftColumnAffix.outerWidth() + 50); } }); new ClipboardJS('.js-clipboard-copy'); }); </script> <script src="https://pub.mdpi-res.com/assets/js/jquery-ui-1.13.2.min.js?1e2047978946a1d2?1732615622"></script> <script src="https://pub.mdpi-res.com/assets/js/slick.min.js?d5a61c749e44e471?1732615622"></script> <script> $(document).ready(function() { $(".link-article-menu").click(function(e) { e.preventDefault(); $(this).find('span').toggle(); $(this).next("div").toggleClass("active"); }); $(".js-similarity-related-articles").click(function(e) { e.preventDefault(); if ('' !== $('#recommended-articles-modal').attr('data-url')) { $('#recommended-articles-modal').foundation('reveal', 'open', $('#recommended-articles-modal').attr('data-url')); } }); $.ajax({ url: "/article/804152/similarity-related/show-link", success: function(result) { if (result.show) { $('#recommended-articles-modal').attr('data-url', result.link); $('.js-article-similarity-container').show(); } } }); $(document).on('opened.fndtn.reveal', '[data-reveal]', function() { var modal = $(this); if (modal.attr('id') === "author-biographies-modal") { modal.find('.multiple-items').slick({ slidesToShow: 1, nextArrow: '<a class="slick-next" href="#"><i class="material-icons">chevron_right</i></a>', prevArrow: '<a class="slick-prev" href="#"><i class="material-icons">chevron_left</i></a>', slidesToScroll: 1, draggable: false, }); modal.find('.multiple-items').slick('refresh'); } }); }); </script> <script> $(document).ready(function() { $(document).on('keyup', function (e) { if (e.keyCode == 27) { var hElem = $(this).find(".annotator-adder"); if (hElem.length){ hElem.css({'visibility':'hidden'}); } else { document.querySelector("hypothesis-adder").shadowRoot.querySelector(".annotator-adder").style.visibility = "hidden"; } } }); }); </script> <script> window.hypothesisConfig = function () { return { sidebarAppUrl: 'https://commenting.mdpi.com/app.html', showHighlights: 'whenSidebarOpen' , openSidebar: false , assetRoot: 'https://commentingres.mdpi.com/hypothesis', services: [{ apiUrl: 'https://commenting.mdpi.com/api/', authority: 'mdpi', grantToken: '', doi: '10.3390/medsci10020025' }], }; }; </script> <script async id="hypothesis_frame"></script> <script type="text/javascript"> if (-1 !== window.location.href.indexOf("?src=")) { window.history.replaceState({}, '', `${location.pathname}`); } $(document).ready(function() { var scifeedCounter = 0; var search = window.location.search; var mathjaxReady = false; // late image file loading $("img[data-lsrc]").each(function() { $(this).attr("src", $(this).data("lsrc")); }); // late mathjax initialization var head = document.getElementsByTagName("head")[0]; var script = document.createElement("script"); script.type = "text/x-mathjax-config"; script[(window.opera ? "innerHTML" : "text")] = "MathJax.Hub.processSectionDelay = 0;\n" + "MathJax.Hub.Config({\n" + " \"menuSettings\": {\n" + " CHTMLpreview: false\n" + " },\n" + " \"CHTML-preview\":{\n" + " disabled: true\n" + " },\n" + " \"HTML-CSS\": {\n" + " scale: 90,\n" + " availableFonts: [],\n" + " preferredFont: null,\n" + " preferredFonts: null,\n" + " webFont:\"Gyre-Pagella\",\n" + " imageFont:'TeX',\n" + " undefinedFamily:\"'Arial Unicode MS',serif\",\n" + " linebreaks: { automatic: false }\n" + " },\n" + " \"TeX\": {\n" + " extensions: ['noErrors.js'],\n" + " noErrors: {\n" + " inlineDelimiters: [\"\",\"\"],\n" + " multiLine: true,\n" + " style: {\n" + " 'font-size': '90%',\n" + " 'text-align': 'left',\n" + " 'color': 'black',\n" + " 'padding': '1px 3px',\n" + " 'border': '1px solid'\n" + " }\n" + " }\n" + " }\n" + "});\n" + "MathJax.Hub.Register.StartupHook('End', function() {\n" + " refreshMathjaxWidths();\n" + " mathjaxReady = true;\n" + "});\n" + "MathJax.Hub.Startup.signal.Interest(function (message) {\n" + " if (message == 'End') {\n" + " var hypoLink = document.getElementById('hypothesis_frame');\n" + " if (null !== hypoLink) {\n" + " hypoLink.setAttribute('src', 'https://commenting.mdpi.com/embed.js');\n" + " }\n" + " }\n" + "});"; head.appendChild(script); script = document.createElement("script"); script.type = "text/javascript"; script.src = "https://pub.mdpi-res.com/bundles/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"; head.appendChild(script); // article version checker if (0 === search.indexOf('?type=check_update&version=')) { $.ajax({ url: "/2076-3271/10/2/25" + "/versioncheck" + search, success: function(result) { $(".js-check-update-container").html(result); } }); } $('#feed_option').click(function() { // tracker if ($('#scifeed_clicked').length<1) { $(this).append('<span style="display:none" id="scifeed_clicked">done</span>'); } $('#feed_data').toggle('slide', { direction: 'up'}, '1000'); // slideToggle(700); OR toggle(700) $("#scifeed_error_msg").html('').hide(); $("#scifeed_notice_msg").html('').hide(); }); $('#feed_option').click(function(event) { setTimeout(function(){ var captchaSection = $("#captchaSection"); captchaSection.removeClass('ui-helper-hidden').find('input').prop('disabled', false); // var img = captchaSection.find('img'); // img.attr('src', img.data('url') + "?" + (new Date()).getTime()); // $(".captcha_reload").trigger("click"); var img = document.getElementById('gregwar_captcha_scifeed'); img.src = '/generate-captcha/gcb_captcha?n=' + (new Date()).getTime(); },800); }); $(document).on('click', '.split_feeds', function() { var name = $( this ).attr('name'); var flag = 1 - ($(this).is(":checked")*1); $('.split_feeds').each(function (index) { if ($( this ).attr('name') !== name) { $(this)[0].checked = flag; } }); }); $(document).on('click', '#scifeed_submit, #scifeed_submit1', function(event) { event.preventDefault(); $(".captcha_reload").trigger("click"); $("#scifeed_error_msg").html(""); $("#scifeed_error_msg").hide(); }); $(document).on('click', '.subscription_toggle', function(event) { if ($(this).val() === 'Create SciFeed' && $('#scifeed_hidden_flag').length>0) { event.preventDefault(); // alert('Here there would be a captcha because user is not logged in'); var captchaSection = $("#captchaSection"); if (captchaSection.hasClass('ui-helper-hidden')) { captchaSection.removeClass('ui-helper-hidden').find('input').prop('disabled', false); var img = captchaSection.find('img'); img.attr('src', img.data('url') + "?" + (new Date()).getTime()); $("#reloadCaptcha").trigger("click"); } } }); $(document).on('click', '.scifeed_msg', function(){ $(this).hide(); }); $(document).on('click', '.article-scilit-search', function(e) { e.preventDefault(); var data = $(".article-scilit-search-data").val(); var dataArray = data.split(';').map(function(keyword) { return "(\"" + keyword.trim() + "\")"; }); var searchQuery = dataArray.join(" OR "); var searchUrl = encodeURI("https://www.scilit.net/articles/search?q="+ searchQuery + "&advanced=1&highlight=1"); var win = window.open(searchUrl, '_blank'); if (win) { win.focus(); } else { window.location(searchUrl); } }); display_stats(); citedCount(); follow_goto(); // Select the node that will be observed for mutations const targetNodes = document.getElementsByClassName('hypothesis-count-container'); // Options for the observer (which mutations to observe) const config = { attributes: false, childList: true, subtree: false }; // Callback function to execute when mutations are observed const callback = function(mutationList, observer) { for(const mutation of mutationList) { if (mutation.type === 'childList') { let node = $(mutation.target); if (parseInt(node.html()) > 0) { node.show(); } } } }; // Create an observer instance linked to the callback function const observer = new MutationObserver(callback); // Start observing the target node for configured mutations for(const targetNode of targetNodes) { observer.observe(targetNode, config); } // Select the node that will be observed for mutations const mathjaxTargetNode = document.getElementById('middle-column'); // Callback function to execute when mutations are observed const mathjaxCallback = function(mutationList, observer) { if (mathjaxReady && typeof(MathJax) !== 'undefined') { refreshMathjaxWidths(); } }; // Create an observer instance linked to the callback function const mathjaxObserver = new ResizeObserver(mathjaxCallback); // Start observing the target node for configured mutations mathjaxObserver.observe(mathjaxTargetNode); }); /* END $(document).ready */ function refreshMathjaxWidths() { let width = ($('.html-body').width()*0.9) + "px"; $('.MathJax_Display').css('max-width', width); $('.MJXc-display').css('max-width', width); } function sendScifeedFrom(form) { if (!$('#scifeed_email').val().trim()) { // empty email alert('Please, provide an email for subscribe to this scifeed'); return false; } else if (!$('#captchaSection').hasClass('ui-helper-hidden') && !$('#captchaSection').find('input').val().trim()) { // empty captcha alert('Please, fill the captcha field.'); return false; } else if( ((($('#scifeed_form').find('input:checkbox:checked').length)-($('#split_feeds:checked').length))<1) || ($('#scifeed_kwd_txt').length < 0 && !$('#scifeed_kwd_txt').val().trim()) || ($('#scifeed_author_txt').length<0 &&!$('#scifeed_author_txt').val().trim()) ) { alert('You did not select anything to subscribe'); return false; } else if(($('#scifeed_form').find('input:checkbox:checked').length)-($('#split_feeds2:checked').length)<1){ alert("You did not select anything to subscribe"); return false; } else { var url = $('#scifeed_subscribe_url').html(); var formData = $(form).serializeArray(); $.post(url, formData).done(function (data) { if (JSON.parse(data)) { $('.scifeed_msg').hide(); var res = JSON.parse(data); var successFeeds = 0; var errorFeeds = 0; if (res) { $('.scifeed_msg').html(''); $.each(res, function (index, val) { if (val) { if (val.error) { errorFeeds++; $("#scifeed_error_msg").append(index+' - '+val.error+'<br>'); } if (val.notice) // for successful feed creation { successFeeds++; // $("#scifeed_notice_msg").append(index+' - '+val.notice+'<br>'); $("#scifeed_notice_msg").append('<li>'+index+'</li>'); } } }); if (successFeeds>0) { text = $('#scifeed_notice_msg').html(); text = 'The following feed'+(successFeeds>1?'s have':' has')+ ' been sucessfully created:<br><ul>'+ text + '</ul>' +($('#scifeed_hidden_flag').length>0 ? 'You are not logged in, so you probably need to validate '+ (successFeeds>1?'them':' it')+'.<br>' :'' ) +'Please check your email'+(successFeeds>1?'s':'')+' for more details.'; //(successFeeds>1?' for each of them':'')+'.<br>'; $("#scifeed_notice_msg").html(text); $("#scifeed_notice_msg").show(); } if (errorFeeds>0) { $("#scifeed_error_msg").show();; } } $("#feed_data").hide(); } }); } } function follow_goto() { var hashStr = location.hash.replace("#",""); if(typeof hashStr !== 'undefined') { if( hashStr == 'supplementary') { document.getElementById('suppl_id').scrollIntoView(); } if( hashStr == 'citedby') { document.getElementById('cited_id').scrollIntoView(); } } } function cited() { $("#framed_div").toggle('fast', function(){ if ($(this).css('display') != 'none') { var loaded = document.getElementById("loaded"); if(loaded.innerHTML == "No") { // Load Xref result var container = document.getElementById("framed_div"); // This replace the content container.innerHTML = "<img src=\"https://pub.mdpi-res.com/img/loading_circle.gif?9a82694213036313?1732615622\" height=\"20\" width=\"20\" alt=\"Processing...\" style=\"vertical-align:middle; margin-right:0.6em;\">"; var url = "/citedby/10.3390%252Fmedsci10020025/81"; $.post(url, function(result) { if (result.success) { container.innerHTML = result.view; } loaded.innerHTML = "Yes"; }); } } return true; // for not going at the beginning of the page... }) return true; // for not going at the beginning of the page... } function detect_device() { // Added by Bastien (18/08/2014): based on the http://detectmobilebrowsers.com/ detector var check = false; (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows (ce|phone)|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4)))check = true})(navigator.userAgent||navigator.vendor||window.opera); return check; } function display_stats(){ $("#article_stats_div").toggle(); return false; } /* * Cited By Scopus */ function citedCount(){ $("#framed_div_cited_count").toggle('fast', function(){ if ($(this).css('display') != 'none') { var loaded = document.getElementById("loaded_cite_count"); // to load only once the result! if(loaded.innerHTML == "No") { // Load Xref result var d = document.getElementById("framed_div_cited_count"); // This replace the content d.innerHTML = "<img src=\"https://pub.mdpi-res.com/img/loading_circle.gif?9a82694213036313?1732615622\" height=\"20\" width=\"20\" alt=\"Processing...\" style=\"vertical-align:middle; margin-right:0.6em;\">"; $.ajax({ method : "POST", url : "/cite-count/10.3390%252Fmedsci10020025", success : function(data) { if (data.succ) { d.innerHTML = data.view; loaded.innerHTML = "Yes"; follow_goto(); } } }); } } // end else return true; // for not going at the beginning of the page... }) return true; // for not going at the beginning of the page... } </script><script type="text/javascript" src="https://pub.mdpi-res.com/assets/js/third-party/highcharts/highcharts.js?bdd06f45e34c33df?1732615622"></script><script type="text/javascript" src="https://pub.mdpi-res.com/assets/js/third-party/highcharts/modules/exporting.js?944dc938d06de3a8?1732615622"></script><script type="text/javascript" defer="defer"> var advancedStatsData; var selectedStatsType = "abstract"; $(function(){ var countWrapper = $('#counts-wrapper'); $('#author_stats_id #type_links a').on('click', function(e) { e.preventDefault(); selectedStatsType = $(this).data('type'); $('#article_advanced_stats').vectorMap('set', 'values', advancedStatsData[selectedStatsType]); $('#advanced_stats_max').html(advancedStatsData[selectedStatsType].max); $('#type_links a').removeClass('active'); $(this).addClass('active'); }); $.get('/2076-3271/10/2/25/stats', function (result) { if (!result.success) { return; } // process article metrics part in left column var viewNumber = countWrapper.find(".view-number"); viewNumber.html(result.metrics.views); viewNumber.parent().toggleClass("count-div--grey", result.metrics.views == 0); var downloadNumber = countWrapper.find(".download-number"); downloadNumber.html(result.metrics.downloads); downloadNumber.parent().toggleClass("count-div--grey", result.metrics.downloads == 0); var citationsNumber = countWrapper.find(".citations-number"); citationsNumber.html(result.metrics.citations); citationsNumber.parent().toggleClass("count-div--grey", result.metrics.citations == 0); if (result.metrics.views > 0 || result.metrics.downloads > 0 || result.metrics.citations > 0) { countWrapper.find("#js-counts-wrapper__views, #js-counts-wrapper__downloads").addClass("visible").show(); if (result.metrics.citations > 0) { countWrapper.find('.citations-number').html(result.metrics.citations).show(); countWrapper.find("#js-counts-wrapper__citations").addClass("visible").show(); } else { countWrapper.find("#js-counts-wrapper__citations").remove(); } $("[data-id='article-counters']").removeClass("hidden"); } if (result.metrics.altmetrics_score > 0) { $("#js-altmetrics-donut").show(); } // process view chart in main column var jsondata = result.chart; var series = new Array(); $.each(jsondata.elements, function(i, element) { var dataValues = new Array(); $.each(element.values, function(i, value) { dataValues.push(new Array(value.tip, value.value)); }); series[i] = {name: element.text, data:dataValues}; }); Highcharts.setOptions({ chart: { style: { fontFamily: 'Arial,sans-serif' } } }); $('#article_stats_swf').highcharts({ chart: { type: 'line', width: $("#tabs").width() //* 0.91 }, credits: { enabled: false }, exporting: { enabled: true }, title: { text: jsondata.title.text, x: -20 //center }, xAxis: { categories: jsondata.x_axis.labels.labels, offset: jsondata.x_axis.offset, labels:{ step: jsondata.x_axis.labels.steps, rotation: 30 } }, yAxis: { max: jsondata.y_axis.max, min: jsondata.y_axis.min, offset: jsondata.y_axis.offset, labels: { steps: jsondata.y_axis.steps }, title: { enabled: false } }, tooltip: { formatter: function (){ return this.key.replace("#val#", this.y); } }, legend: { align: 'top', itemDistance: 50 }, series: series }); }); $('#supplement_link').click(function() { document.getElementById('suppl_id').scrollIntoView(); }); $('#stats_link').click(function() { document.getElementById('stats_id').scrollIntoView(); }); // open mol viewer for molbank special supplementary files $('.showJmol').click(function(e) { e.preventDefault(); var jmolModal = $("#jmolModal"); var url = "/article/804152/jsmol_viewer/__supplementary_id__"; url = url.replace(/__supplementary_id__/g, $(this).data('index')); $('#jsmol-content').attr('src', url); jmolModal.find(".content").html($(this).data('description')); jmolModal.foundation("reveal", "open"); }); }); !function() { "use strict"; function e(e) { try { if ("undefined" == typeof console) return; "error"in console ? console.error(e) : console.log(e) } catch (e) {} } function t(e) { return d.innerHTML = '<a href="' + e.replace(/"/g, """) + '"></a>', d.childNodes[0].getAttribute("href") || "" } function n(n, c) { var o = ""; var k = parseInt(n.substr(c + 4, 2), 16); for (var i = c; i < n.length; i += 2) { if (i != c + 4) { var s = parseInt(n.substr(i, 2), 16) ^ k; o += String.fromCharCode(s); } } try { o = decodeURIComponent(escape(o)); } catch (error) { console.error(error); } return t(o); } function c(t) { for (var r = t.querySelectorAll("a"), c = 0; c < r.length; c++) try { var o = r[c] , a = o.href.indexOf(l); a > -1 && (o.href = "mailto:" + n(o.href, a + l.length)) } catch (i) { e(i) } } function o(t) { for (var r = t.querySelectorAll(u), c = 0; c < r.length; c++) try { var o = r[c] , a = o.parentNode , i = o.getAttribute(f); if (i) { var l = n(i, 0) , d = document.createTextNode(l); a.replaceChild(d, o) } } catch (h) { e(h) } } function a(t) { for (var r = t.querySelectorAll("template"), n = 0; n < r.length; n++) try { i(r[n].content) } catch (c) { e(c) } } function i(t) { try { c(t), o(t), a(t) } catch (r) { e(r) } } var l = "/cnd-cgi/l/email-protection#" , u = ".__cf_email__" , f = "data-cfemail" , d = document.createElement("div"); i(document), function() { var e = document.currentScript || document.scripts[document.scripts.length - 1]; e.parentNode.removeChild(e) }() }(); </script><script type="text/javascript"> function setCookie(cname, cvalue, ctime) { ctime = (typeof ctime === 'undefined') ? 10*365*24*60*60*1000 : ctime; // default => 10 years var d = new Date(); d.setTime(d.getTime() + ctime); // ==> 1 hour = 60*60*1000 var expires = "expires="+d.toUTCString(); document.cookie = cname + "=" + cvalue + "; " + expires +"; path=/"; } function getCookie(cname) { var name = cname + "="; var ca = document.cookie.split(';'); for(var i=0; i<ca.length; i++) { var c = ca[i]; while (c.charAt(0)==' ') c = c.substring(1); if (c.indexOf(name) == 0) return c.substring(name.length, c.length); } return ""; } </script><script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script><script> $(document).ready(function() { if ($("#js-similarity-related-data").length > 0) { $.ajax({ url: '/article/804152/similarity-related', success: function(response) { $("#js-similarity-related-data").html(response); $("#js-related-articles-menu").show(); $(document).foundation('tab', 'reflow'); MathJax.Hub.Queue(["Typeset", MathJax.Hub]); } }); } }); </script><link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/jquery-ui-1.10.4.custom.min.css?80647d88647bf347?1732615622"><link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/magnific-popup.min.css?04d343e036f8eecd?1732615622"><script type="text/javascript" src="https://pub.mdpi-res.com/assets/js/magnific-popup.min.js?2be3d9e7dc569146?1732615622"></script><script> $(function() { $(".js-show-more-academic-editors").on("click", function(e) { e.preventDefault(); $(this).hide(); $(".academic-editor-container").removeClass("hidden"); }); }); </script> <link rel="stylesheet" href="https://pub.mdpi-res.com/assets/css/vmap/jqvmap.min.css?126a06688aa11c13?1732615622"> <script src="https://pub.mdpi-res.com/assets/js/vmap/jquery.vmap.min.js?935f68d33bdd88a1?1732615622"></script> <script src="https://pub.mdpi-res.com/assets/js/vmap/jquery.vmap.world.js?16677403c0e1bef1?1732615622"></script> <script> function updateSlick() { $('.multiple-items').slick('setPosition'); } $(document).ready(function() { $('.multiple-items').slick({ slidesToShow: 1, nextArrow: '<a class="slick-next" href="#"><i class="material-icons">chevron_right</i></a>', prevArrow: '<a class="slick-prev" href="#"><i class="material-icons">chevron_left</i></a>', slidesToScroll: 1, responsive: [ { breakpoint: 1024, settings: { slidesToShow: 1, slidesToScroll: 1, } }, { breakpoint: 600, settings: { slidesToShow: 1, slidesToScroll: 1, } }, { breakpoint: 480, settings: { slidesToShow: 1, slidesToScroll: 1, } } ] }); $('.multiple-items').show(); $(document).on('click', '.reviewReportSelector', function(e) { let path = $(this).attr('data-path'); handleReviews(path, $(this)); }); $(document).on('click', '.viewReviewReports', function(e) { let versionOne = $('#versionTab_1'); if (!versionOne.hasClass('activeTab')) { let path = $(this).attr('data-path'); handleReviews(path, versionOne); } location.href = "#reviewReports"; }); $(document).on('click', '.reviewersResponse, .authorResponse', function(e) { let version = $(this).attr('data-version'); let targetVersion = $('#versionTab_' + version); if (!targetVersion.hasClass('activeTab')) { let path = targetVersion.attr('data-path'); handleReviews(path, targetVersion); } location.href = $(this).attr('data-link'); }); $(document).on('click', '.tab', function (e) { e.preventDefault(); $('.tab').removeClass('activeTab'); $(this).addClass('activeTab') $('.tab').each(function() { $(this).closest('.tab-title').removeClass('active'); }); $(this).closest('.tab-title').addClass('active') }); }); function handleReviews(path, target) { $.ajax({ url: path, context: this, success: function (data) { $('.activeTab').removeClass('activeTab'); target.addClass('activeTab'); $('#reviewSection').html(data.view); }, error: function (xhr, ajaxOptions, thrownError) { console.log(xhr.status); console.log(thrownError); } }); } </script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/affix.js?v1?1732615622"></script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/storage.js?e9b262d3a3476d25?1732615622"></script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/jquery-scrollspy.js?09cbaec0dbb35a67?1732615622"></script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/magnific-popup.js?4a09c18460afb26c?1732615622"></script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/underscore.js?f893e294cde60c24?1732615622"></script> <script type="text/javascript"> $('document').ready(function(){ $("#left-column").addClass("show-for-large-up"); $("#middle-column").removeClass("medium-9").removeClass("left-bordered").addClass("medium-12"); $(window).on('resize scroll', function() { /* if ($('.button--drop-down').isInViewport($(".top-bar").outerHeight())) { */ if ($('.button--drop-down').isInViewport()) { $("#js-button-download").hide(); } else { $("#js-button-download").show(); } }); }); $(document).on('DOMNodeInserted', function(e) { var element = $(e.target); if (element.hasClass('menu') && element.hasClass('html-nav') ) { element.addClass("side-menu-ul"); } }); </script> <script src="https://pub.mdpi-res.com/assets/js/xmltohtml/articles.js?5118449d9ad8913a?1732615622"></script> <script> repositionOpenSideBar = function() { $('#left-column').addClass("show-for-large-up show-for-medium-up").show(); $('#middle-column').removeClass('large-12').removeClass('medium-12'); $('#middle-column').addClass('large-9'); } repositionCloseSideBar = function() { $('#left-column').removeClass("show-for-large-up show-for-medium-up").hide(); $('#middle-column').removeClass('large-9'); $('#middle-column').addClass('large-12').addClass('medium-12'); } </script>   <script type="text/plain" data-cookieconsent="marketing"> !function(e,t,n,s,u,a){e.twq||(s=e.twq=function(){s.exe?s.exe.apply(s,arguments):s.queue.push(arguments); },s.version='1.1',s.queue=[],u=t.createElement(n),u.async=!0,u.src='//static.ads-twitter.com/uwt.js', a=t.getElementsByTagName(n)[0],a.parentNode.insertBefore(u,a))}(window,document,'script'); // Insert Twitter Pixel ID and Standard Event data below twq('init','o2pip'); twq('track','PageView'); </script>  <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'8e8f87432fc33f75',t:'MTczMjY4MzM1MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html>

CINXE.COM

Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives